| FN | ISI Export Format | | VR | 1.0 |
| PT |
J |
| AU |
Aitini, E
Sempreboni, A
Aleotti, P
Zamagni, D
Cavazzini, G
Barbieri, R
Cengarle, R
Rabbi, C
Pari, F
Vivorio, B |
| AF |
Aitini, Enrico
Sempreboni, Alessia
Aleotti, Paola
Zamagni, Donatella
Cavazzini, Giovanna
Barbieri, Roberto
Cengarle, Rita
Rabbi, Carla
Pari, Franca
Vivorio, Beatrice |
| TI |
Anxiety levels in cancer patients and "life sound" experience |
| SO |
TUMORI |
| AB |
Aims and background: For the hospitalized cancer patient, time takes on
a rhythm which is very different from the external reality. Based on
the idea that time represents a fundamental dimension of human
existence and is connected to future plans, time spent waiting and
memories, we carried out this experience entitled "Life Sound" project.
The objectives of the project were to experiment different and unusual
ways of spending time in hospital in order to improve the quality of
life of the hospitalized cancer patient, to help the patient adapt to
the hospital environment, to encourage awareness of self and to give a
different meaning to time spent in the hospital. In particular, we
evaluated the reduction in the levels of anxiety, in psychological
suffering and the improvement in communication.
Methods: We met with patients, family members, friends, volunteers and
department personnel (doctors, psychologists, nurses) in a room in the
Oncology and Hematology Department set aside specifically for
recreation activities such as having a cup of tea while listening to
music, talking, joking, listening to people's memories and celebrating
birthdays, anniversaries and other special days. The study, which
involved 109 patients, was carried out through the use of the
questionnaire STAI-Y distributed before and after the event.
Results: The results showed a statistically significant difference in
anxiety levels 2 hrs before participation (mean = 38.33) and 2 hrs
after participation (mean = 34.77) in the program. This variation was
also assessed based on gender, age, cancer stage, time since diagnosis
and performance status but did not result in any statistically
significant difference.
Conclusions: The "Life Sound" project encourages the emergence of
positive feelings, of a renewed willingness to invest in personal and
caring relationships, which are connected to the patient's ability to
face this illness, and the opening of new channels of communication
with family members and hospital staff. |
| SN |
0300-8916 |
| PD |
JAN-FEB |
| PY |
2007 |
| VL |
93 |
| IS |
1 |
| BP |
75 |
| EP |
77 |
| UT |
ISI:000247166900013 |
| ER |
|
| PT |
J |
| AU |
Badger, T
Segrin, C
Dorros, SM
Meek, P
Lopez, AM |
| AF |
Badger, Terry
Segrin, Chris
Dorros, Sybilla M.
Meek, Paula
Lopez, Ana Maria |
| TI |
Depression and anxiety in women with breast cancer and their partners |
| SO |
NURSING RESEARCH |
| AB |
Background: Psychosocial interventions can improve psychological
quality of life (symptoms of depression and anxiety) of both women with
breast cancer and their partners, but are not offered routinely to
women and their partners.
Objective: To test the. hypotheses that telephone-delivered
psychosocial interventions decrease depression and anxiety in women
with breast cancer and their partners.
Methods: The design of the study was a three-wave repeated measures
with a between-subjects factor (treatment group). Ninety-six women and
their 96 partners were assigned randomly to participate in one of three
different 6-week programs: (a) telephone interpersonal counseling
(TIP-C); (b) self-managed exercise; or (c) attention control (AC).
Results: The mixed-model analysis of variance for symptoms of
depression among women with breast cancer revealed women's depressive
symptom scores decreased over time in all groups. For anxiety, women's
symptoms of anxiety decreased in the TIP-C and exercise groups over
time, but not in the AC group. A parallel set of analyses was conducted
on partners' depression and anxiety data, Symptoms of depression and
anxiety among the partners decreased substantially over the course of
the investigation. Similar to the women, partners' symptoms of anxiety
decreased significantly in the TIP-C and exercise groups, but not in
the AC group.
Discussion: Findings from this study support that these
telephone-delivered psychosocial interventions were effective for
decreasing symptoms of depression and anxiety to improve psychological
quality of life when compared to an AC group. |
| SN |
0029-6562 |
| PD |
JAN-FEB |
| PY |
2007 |
| VL |
56 |
| IS |
1 |
| BP |
44 |
| EP |
53 |
| UT |
ISI:000247102400006 |
| ER |
|
| PT |
J |
| AU |
Dale, W
Hemmerich, J
Meltzer, D |
| AF |
Dale, William
Hemmerich, Joshua
Meltzer, David |
| TI |
Extending the validity of the Prostate Cancer (MAX-PC) Memorial Anxiety
Scale for at the time of prostate biopsy in a racially-mixed population |
| SO |
PSYCHO-ONCOLOGY |
| AB |
The Memorial Anxiety Scale for Prostate Cancer (MAX-PC) has been
validated for assessing men with prostate cancer for cancer-specific
anxiety. It was originally validated in a predominantly white
population. The MAX-PC Prostate Cancer Anxiety Subscale (MAX-PC-PCAS)
may be relevant for measuring cancer-specific anxiety in undiagnosed
men at risk for prostate cancer. We assess the validity of the
MAX-PC-PCAS at the time of prostate biopsy (n = 178). Questions
assessed socio-demographic information, health status,
patient-estimated risk of cancer, the Hospital Anxiety and Depression
Scale-Anxiety Subscale (HADS-A), and the MAX-PC-PCAS. The patients'
most recent PSA was recorded. Cronbach's alpha, inter-item
correlations, and Pearson correlations with both the HADS-A and
clinical variables were compared with the original validation sample.
Our sample was younger (63.1 vs 71.1 years), had a larger fraction of
African-Americans (43 vs 10%), and had higher PSAs. Cronbach's alpha
was equivalent (0.91 vs 0.90), median inter-item correlation was
equivalent (0.63 vs 0.61), and Pearson correlation with HADS-A was
higher (0.71 vs 0.57). Anxiety levels were not correlated with PSA
levels, and there were minor differences in the validation findings by
race. The validity of the MAX-PC-PCAS extends to men without cancer
undergoing biopsy and to African-Americans. Copyright (c) 2006 John
Wiley & Sons, Ltd. |
| SN |
1057-9249 |
| PD |
MAY |
| PY |
2007 |
| VL |
16 |
| IS |
5 |
| BP |
493 |
| EP |
498 |
| UT |
ISI:000246783300011 |
| ER |
|
| PT |
J |
| AU |
Midtqaard, J
Rorth, M
Steller, R
Tveteras, A
Andersen, C
Quist, M
Moller, T
Adamsen, L |
| AF |
Midtqaard, J.
Rorth, M.
Steller, R.
Tveteras, A.
Andersen, C.
Quist, M.
Moller, T.
Adamsen, L. |
| TI |
Exercise during cytostatic treatment: correlates of cancer patients'
self-reported anxiety and depression |
| SO |
EJC SUPPLEMENTS |
| SN |
1359-6349 |
| PD |
OCT |
| PY |
2005 |
| VL |
3 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
369 |
| EP |
369 |
| UT |
ISI:000247564801434 |
| ER |
|
| PT |
J |
| AU |
Iconomou, G
Koutras, AK
Assimakopoulos, K
Mega, V
Viha, A
Iconomou, AV
Kalofonos, HP |
| AF |
Iconomou, G.
Koutras, A. K.
Assimakopoulos, K.
Mega, V.
Viha, A.
Iconomou, A. V.
Kalofonos, H. P. |
| TI |
Anxiety, depression and quality of life in cancer patients treated with
chemotherapy: a prospective examination |
| SO |
EJC SUPPLEMENTS |
| SN |
1359-6349 |
| PD |
OCT |
| PY |
2005 |
| VL |
3 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
380 |
| EP |
381 |
| UT |
ISI:000247564801473 |
| ER |
|
| PT |
J |
| AU |
Reineke, A
Sowder, E
Gevirtz, R |
| AF |
Reineke, Anke
Sowder, Erik
Gevirtz, Richard |
| TI |
Effects of an inter-active biofeedback game on anxiety and pain in
children with cancer |
| SO |
BIOLOGICAL PSYCHOLOGY |
| SN |
0301-0511 |
| PD |
MAY |
| PY |
2007 |
| VL |
75 |
| IS |
2 |
| BP |
213 |
| EP |
214 |
| UT |
ISI:000246753200047 |
| ER |
|
| PT |
J |
| AU |
Cousson-Gelie, F
Bruchon-Schweitzer, M
Dilhuydy, JM
Jutand, MA |
| AF |
Cousson-Gelie, Florence
Bruchon-Schweitzer, Marilou
Dilhuydy, Jean Marie
Jutand, Marthe-Aline |
| TI |
Do anxiety, body image, social support and coping strategies predict
survival in breast cancer? A ten-year follow-up study |
| SO |
PSYCHOSOMATICS |
| AB |
A longitudinal study enrolled 75 women with primary breast cancer.
Before the confirmation of diagnosis, authors measured trait-anxiety
and body satisfaction. Three weeks after diagnosis, coping strategies
and state-anxiety were evaluated. The number of days of survival was
measured 10 years after diagnosis. In Cox proportional-hazards models
adjusting for severity of disease and age, high social support and low
state-anxiety predicted an increased risk of death from breast cancer.
A significant increased risk of death in women with low scores on the
Body Image Questionnaire appeared only in the univariate model. |
| SN |
0033-3182 |
| PD |
JUN |
| PY |
2007 |
| VL |
48 |
| IS |
3 |
| BP |
211 |
| EP |
216 |
| UT |
ISI:000246210400004 |
| ER |
|
| PT |
J |
| AU |
Trumbo, CW
McComas, KA
Kannaovakun, P |
| AF |
Trumbo, Craig W.
McComas, Katherine A.
Kannaovakun, Prathana |
| TI |
Cancer anxiety and the perception of risk in alarmed communities |
| SO |
RISK ANALYSIS |
| AB |
Cancer is a significant public health topic and is frequently a factor
in public reactions to environmental hazards. It may be reasonable to
suggest that a unique form of health anxiety exists-one specific to
cancer. In this article, we explore a measure of cancer anxiety that
has applicability to risk perception in the specific context of
communities that are alarmed over suspect cancer rates thought to be
associated with environmental hazards. A literature search was used to
identify survey questions previously used to measure cancer worry,
fear, anxiety, etc. A list of 24 items was employed in a mail survey
sent to 30 communities in which cancer rates were under investigation
(part of a broader study). An analysis of the dataset of 1,111
responses yields two versions of a cancer anxiety scale: one an
additive combination of 21 items (alpha= 0.77) and the other a
two-factor model consisting of nine- and four-item subscales (alpha =
0.74 and 0.69). The resulting scales are evaluated for their ability to
predict perception of risk from the environmental hazards in these
cases. Controlling for age, sex, and cancer status, the scales explain
between 2% and 10% of risk perception (full R-2 values ranging from
0.17 to 0.24). Given the range of concepts required to model risk
perception, we conclude that this measure of cancer anxiety is
sufficiently reliable and robust to be recommended for use in
circumstances involving hazards associated with cancer. Other uses and
further development of the measure are discussed. |
| SN |
0272-4332 |
| PD |
APR |
| PY |
2007 |
| VL |
27 |
| IS |
2 |
| BP |
337 |
| EP |
350 |
| UT |
ISI:000246625600007 |
| ER |
|
| PT |
J |
| AU |
Tagay, VS
Senf, W
Schopper, N
Mewes, R
Bockisch, A
Gorges, R |
| AF |
Tagay, Von Sefik
Senf, Wolfgang
Schoepper, Nicole
Mewes, Ricarda
Bockisch, Andreas
Goerges, Rainer |
| TI |
Protective factors for anxiety and depression in thyroid cancer patients |
| SO |
ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE |
| AB |
Objectives: Depression and anxiety are the most common mental symptoms
in patients with thyroid cancer (DTC) and have an important influence
on the quality of life. The aim of the current study was to identify
protective factors of depression and anxiety in DTC patients.
Methods: In a cross-sectional study 230 DTC patients were examined with
Hospital Anxiety and Depression Scale (HADS-D), the Sense of Coherence
Scale (SOC-13) and the Questionnaire of Social Support (F-SOZU).
Results: Depression correlated highly significantly with anxiety (r =
.633, p = 0,001). Social support and sense of coherence correlated
highly significantly negative with depression as well as with anxiety
(both p <= 0,001). Although still significant, the correlation between
age and anxiety was lower (r = -19; p <= 0,005). The TSH level as an
indicator of hypothyreodism did not correlate with depression or with
anxiety on a significant statistical level. Furthermore, variables such
as education, religiosity and elapsed time interval since initial
diagnosis were not correlated with depression and anxiety.
Discussion: Our results support the thesis that low social support and
low sense of coherence enhance vulnerability to depressive and anxiety
symptoms. |
| SN |
1438-3608 |
| PY |
2007 |
| VL |
53 |
| IS |
1 |
| BP |
62 |
| EP |
74 |
| UT |
ISI:000244928300007 |
| ER |
|
| PT |
J |
| AU |
Sharp, DM
Walker, AA
Walker, MB
Walker, LG |
| AF |
Sharp, D. M.
Walker, A. A.
Walker, M. B.
Walker, L. G. |
| TI |
Are high levels of clinically significant anxiety and depression
inevitable in the six months following the diagnosis of early breast
cancer? |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
MAR |
| PY |
2007 |
| VL |
16 |
| IS |
3 |
| BP |
272 |
| EP |
273 |
| UT |
ISI:000244976700041 |
| ER |
|
| PT |
J |
| AU |
Greer, J
Temel, J
Pirl, W
Lynch, T |
| AF |
Greer, J.
Temel, J.
Pirl, W.
Lynch, T. |
| TI |
Anxiety, quality of life and chemotherapy adherence among patients with
advanced non-small cell lung cancer |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
MAR |
| PY |
2007 |
| VL |
16 |
| IS |
3 |
| SU |
Suppl. S |
| BP |
S13 |
| EP |
S13 |
| UT |
ISI:000245044900023 |
| ER |
|
| PT |
J |
| AU |
Zhang, A
Cooper, G |
| AF |
Zhang, A.
Cooper, G. |
| TI |
Recognition of depression and anxiety among colorectal cancer patients |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
MAR |
| PY |
2007 |
| VL |
16 |
| IS |
3 |
| SU |
Suppl. S |
| BP |
S23 |
| EP |
S24 |
| UT |
ISI:000245044900042 |
| ER |
|
| PT |
J |
| AU |
BrintzenhofeSzoc, KM
Levin, TT
Li, Y
Zabora, J |
| AF |
BrintzenhofeSzoc, K. M.
Levin, T. T.
Li, Y.
Zabora, J. |
| TI |
The prevalence of mixed anxiety-depression by cancer type |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
MAR |
| PY |
2007 |
| VL |
16 |
| IS |
3 |
| SU |
Suppl. S |
| BP |
S31 |
| EP |
S32 |
| UT |
ISI:000245044900057 |
| ER |
|
| PT |
J |
| AU |
Doyle, K
Fitzgibbons, L
Rollins, P
Stringer, CA |
| AF |
Doyle, K.
Fitzgibbons, L.
Rollins, P.
Stringer, C. A. |
| TI |
Changes in depression, anxiety and psychosocial adjustment to illness
following an individual intervention for women with advanced stage
ovarian cancer |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
MAR |
| PY |
2007 |
| VL |
16 |
| IS |
3 |
| SU |
Suppl. S |
| BP |
S37 |
| EP |
S37 |
| UT |
ISI:000245044900068 |
| ER |
|
| PT |
J |
| AU |
West, L
Bauer-Wu, S
Liem, J
Powell, M |
| AF |
West, L.
Bauer-Wu, S.
Liem, J.
Powell, M. |
| TI |
Factors associated with anxiety and depression in young women recently
diagnosed with breast cancer |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
MAR |
| PY |
2007 |
| VL |
16 |
| IS |
3 |
| SU |
Suppl. S |
| BP |
S92 |
| EP |
S93 |
| UT |
ISI:000245044900178 |
| ER |
|
| PT |
J |
| AU |
Pandey, M
Sarita, G
Devi, N
Thomas, B
Hussain, BM
Krishnan, R |
| AF |
Pandey, M.
Sarita, G.
Devi, N.
Thomas, B.
Hussain, B. M.
Krishnan, R. |
| TI |
Distress, anxiety and depression in cancer patients undergoing
chemotherapy |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
MAR |
| PY |
2007 |
| VL |
16 |
| IS |
3 |
| SU |
Suppl. S |
| BP |
S98 |
| EP |
S98 |
| UT |
ISI:000245044900189 |
| ER |
|
| PT |
J |
| AU |
Pressley, Z
DeLong, L
Curiel-Lewandrowski, C
Chen, S |
| AF |
Pressley, Zakiya
DeLong, Laura
Curiel-Lewandrowski, Clara
Chen, Suephy |
| TI |
Quality of life and cancer anxiety impact of total body digital
photography in patients with atypical mole syndrome |
| SO |
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY |
| SN |
0190-9622 |
| PD |
FEB |
| PY |
2007 |
| VL |
56 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
AB144 |
| EP |
AB144 |
| UT |
ISI:000243972801116 |
| ER |
|
| PT |
J |
| AU |
Chauhan, D
Sharpe, L
Clarke, S
Thewes, B
Rickard, J |
| AF |
Chauhan, D.
Sharpe, L.
Clarke, S.
Thewes, B.
Rickard, J. |
| TI |
Using different screening modalities to assess for anxiety and
depression amongst cancer patients |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S105 |
| EP |
S106 |
| UT |
ISI:000242413900251 |
| ER |
|
| PT |
J |
| AU |
Alvarado, MC |
| AF |
Alvarado, M. C. |
| TI |
Anxiety in children with cancer and their parents |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S157 |
| EP |
S157 |
| UT |
ISI:000242413900370 |
| ER |
|
| PT |
J |
| AU |
Grassi, L
Sabato, S
Rossi, E
Marmai, L
Biancosino, B
Gatti, M |
| AF |
Grassi, L.
Sabato, S.
Rossi, E.
Marmai, L.
Biancosino, B.
Gatti, M. |
| TI |
Depressive and anxiety disorders among cancer patients: Screening
methods hy using the distress thermometer compared to the ICD-10 |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S162 |
| EP |
S162 |
| UT |
ISI:000242413900382 |
| ER |
|
| PT |
J |
| AU |
Cankurtaran, ES
Ozalp, E
Soygur, H
Turhan, L |
| AF |
Cankurtaran, E. S.
Ozalp, E.
Soygur, H.
Turhan, L. |
| TI |
The effect of mirtazapine on depression, anxiety symptoms and quality
of life in cancer patients |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S192 |
| EP |
S193 |
| UT |
ISI:000242413900452 |
| ER |
|
| PT |
J |
| AU |
Ciaramella, A
Lucente, F
Paroli, M
Poli, P |
| AF |
Ciaramella, A.
Lucente, F.
Paroli, M.
Poli, P. |
| TI |
Differences in pain perception between patients with and without
cancer. Role of anxiety and depression |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S200 |
| EP |
S201 |
| UT |
ISI:000242413900471 |
| ER |
|
| PT |
J |
| AU |
Cousson-Gelie, F
Bruchon-Schweitzer, M
Dilhuydy, JM
Jutand, MA |
| AF |
Cousson-Gelie, F.
Bruchon-Schweitzer, M.
Dilhuydy, J. M.
Jutand, M. A. |
| TI |
Impact of social support, anxiety and coping on survival after breast
cancer: A ten year followup study |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S213 |
| EP |
S214 |
| UT |
ISI:000242413900503 |
| ER |
|
| PT |
J |
| AU |
Cross, LJ
Clover, KA
Adams, CA
Utram, SC
Ponman, LK |
| AF |
Cross, L. J.
Clover, K. A.
Adams, C. A.
Utram, S. C.
Ponman, L. K. |
| TI |
A multidisciplinary pilot study to screen for anxiety and distress in
cancer patients when a head immobilization device is used for
radiotherapy treatment |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S214 |
| EP |
S214 |
| UT |
ISI:000242413900504 |
| ER |
|
| PT |
J |
| AU |
Geinitz, H
Thamm, R
Keller, M
Molls, M
Zimmermann, F |
| AF |
Geinitz, H.
Thamm, R.
Keller, M.
Molls, M.
Zimmermann, F. |
| TI |
Longitudinal evaluation of anxiety, depression and quality of life in
patients with conformal radiation therapy (CRT) for prostate cancer |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S246 |
| EP |
S247 |
| UT |
ISI:000242413901025 |
| ER |
|
| PT |
J |
| AU |
Gorayeb, R
Matthes, HTZ
Andrade, JM |
| AF |
Gorayeb, R.
Matthes, H. T. Z.
Andrade, J. M. |
| TI |
Anxiety, depression and level of knowledge in breast and gynaecological
cancer patients in a public University Hospital in Brazil |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S252 |
| EP |
S253 |
| UT |
ISI:000242413901039 |
| ER |
|
| PT |
J |
| AU |
Lopez Soler, C
Hernandez, S
Fernandez, V |
| AF |
Lopez Soler, C.
Hernandez, S.
Fernandez, V |
| TI |
Affective and anxiety problems of childhood cancer |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S259 |
| EP |
S260 |
| UT |
ISI:000242413901056 |
| ER |
|
| PT |
J |
| AU |
Helmes, AW
Vogel, BA
Bengel, J |
| AF |
Helmes, A. W.
Vogel, B. A.
Bengel, J. |
| TI |
Predictors of anxiety and depression in breast cancer patients:
Physician-patient communication or coping? |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S264 |
| EP |
S265 |
| UT |
ISI:000242413901067 |
| ER |
|
| PT |
J |
| AU |
Hill, KA
Warner, E
Esplen, MJ
Butler, K
Bieenwald, R |
| AF |
Hill, K. A.
Warner, E.
Esplen, M. J.
Butler, K.
Bieenwald, R. |
| TI |
Distress and breast cancer anxiety among BRCA mutation carriers
participating in MRI-based screening |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S267 |
| EP |
S267 |
| UT |
ISI:000242413901073 |
| ER |
|
| PT |
J |
| AU |
Yamashita, M
Saeki, T
Inoue, S
Mantani, T
Okamura, H |
| AF |
Yamashita, M.
Saeki, T.
Inoue, S.
Mantani, T.
Okamura, H. |
| TI |
Family functioning as a predictor of depression and anxiety in breast
cancer survivors: 3-year prospective study |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S279 |
| EP |
S279 |
| UT |
ISI:000242413901101 |
| ER |
|
| PT |
J |
| AU |
Lienard, A
Merckaert, I
Libert, Y
Marchal, S
Razavi, D |
| AF |
Lienard, A.
Merckaert, I
Libert, Y.
Marchal, S.
Razavi, D. |
| TI |
Factors that influence cancer patients' anxiety following a medical
consultation. Impact of a communication skills training program for
physicians |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S308 |
| EP |
S308 |
| UT |
ISI:000242413901169 |
| ER |
|
| PT |
J |
| AU |
Mehnert, A
Lehmann, C
Koch, U
Schulte, T |
| AF |
Mehnert, A.
Lehmann, C.
Koch, U.
Schulte, T. |
| TI |
Presence of prostate cancer related anxiety and psychosocial distress
in patients during rehabilitative follow-up care |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S322 |
| EP |
S322 |
| UT |
ISI:000242413901201 |
| ER |
|
| PT |
J |
| AU |
Neumann, M
Pfaff, H |
| AF |
Neumann, M.
Pfaff, H. |
| TI |
Sex and empathy of physicians and affection of nurses can improve
patients' anxiety level in first months after cancer diagnosis - An
explorative, retrospective study in patients with bronchial,
oesophagus, colorectal, breast, prostate and skin cancer |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S346 |
| EP |
S347 |
| UT |
ISI:000242413901258 |
| ER |
|
| PT |
J |
| AU |
Pandey, M
Devi, N
Ramdas, K
Krishnan, R
Thomas, BC |
| AF |
Pandey, M.
Devi, N.
Ramdas, K.
Krishnan, R.
Thomas, B. C. |
| TI |
Distress, anxiety and depression in patients with head neck cancer
undergoing treatment with curative intent |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S359 |
| EP |
S359 |
| UT |
ISI:000242413901288 |
| ER |
|
| PT |
J |
| AU |
Pikunas, JDKA
Springer, C |
| AF |
Pikunas, J. D. K. A.
Springer, C. |
| TI |
Anxiety and depression at the point of cancer diagnosis and its
relationship to coping |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S369 |
| EP |
S369 |
| UT |
ISI:000242413901312 |
| ER |
|
| PT |
J |
| AU |
Reis, JC
Lucas, HM |
| AF |
Reis, J. C.
Lucas, H. M. |
| TI |
Illness representation and levels of quality of life, anxiety and
depression in patients with prostate cancer |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S380 |
| EP |
S380 |
| UT |
ISI:000242413901339 |
| ER |
|
| PT |
J |
| AU |
Schillani, G
Malagoli, M
Tuveri, G
Giraldi, T |
| AF |
Schillani, G.
Malagoli, M.
Tuveri, G.
Giraldi, T. |
| TI |
Anxiety, depression and mental adaptation in cancer patients - Role of
serotonin transporter and monoamine oxidase polymorphism |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S399 |
| EP |
S399 |
| UT |
ISI:000242413901384 |
| ER |
|
| PT |
J |
| AU |
Snoj, Z
Primic Aakelj, M
Milan, L |
| AF |
Snoj, Z.
Primic Aakelj, M.
Milan, L. |
| TI |
Depression and anxiety in Slovenian breast cancer patients |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S416 |
| EP |
S416 |
| UT |
ISI:000242413901424 |
| ER |
|
| PT |
J |
| AU |
Walker, MB
Walker, AA
Walker, LG
Sharp, DM |
| AF |
Walker, M. B.
Walker, A. A.
Walker, L. G.
Sharp, D. M. |
| TI |
What happens to anxiety and depression in women with early breast
cancer accessing an integrated oncology health service? |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S452 |
| EP |
S452 |
| UT |
ISI:000242413901508 |
| ER |
|
| PT |
J |
| AU |
Stephenson, NLN
Swanson, M
Dalton, J
Keefe, FJ
Engelke, M |
| AF |
Stephenson, Nancy L. N.
Swanson, Melvin
Dalton, JoAnn
Keefe, Francis J.
Engelke, Martha |
| TI |
Partner-delivered reflexology: Effects on cancer pain and anxiety (vol
34, pg 127, 2007) |
| SO |
ONCOLOGY NURSING FORUM |
| SN |
0190-535X |
| PD |
MAR |
| PY |
2007 |
| VL |
34 |
| IS |
2 |
| BP |
280 |
| EP |
280 |
| UT |
ISI:000244949700012 |
| ER |
|
| PT |
J |
| AU |
Frick, E
Tyroller, M
Panzer, M |
| AF |
Frick, E.
Tyroller, M.
Panzer, M. |
| TI |
Anxiety, depression and quality of life of cancer patients undergoing
radiation therapy: a cross-sectional study in a community hospital
outpatient centre |
| SO |
EUROPEAN JOURNAL OF CANCER CARE |
| AB |
The purpose of the present study is to determine the impact of illness
characteristics and psychopathological comorbidity on the quality of
life (QoL) of radio-oncological patients in health-related and
individual dimensions. Sixty-three of 93 eligible patients (40 women
and 23 men) were included in the study during their radiation therapy
visit to an outpatient centre annexed to a community hospital in
Southern Bavaria, Germany. In a semi-structured interview, we elicited
individually relevant life domains rated by the patients according to
the 'Schedule for the Evaluation of Individual Quality of Life - Direct
Weighting'. In addition, the participants completed the 'European
Organization for Research and Treatment of Cancer (EORTC) QoL
Questionnaire Core 30' and the 'Hospital Anxiety and Depression Scale'.
We also assessed the demand for psychotherapy and utilization of
psycho-oncological services. In total, 9.5% of the examined patients
suffer from clinically relevant anxiety and/or depression [total
Hospital Anxiety and Depression Scale (HADS) score > 19]. There was a
weak positive correlation between Karnofsky's Performance Status and
QoL. Anxiety and depression were significantly correlated with impaired
QoL, especially with impaired individual QoL. There was no association
between psychopathological comorbidity and the requirement for
psycho-oncological support. Conversely, patients who report
difficulties in accepting help had a significantly lower QoL.
Psychopathological comorbidity has a considerable influence on QoL of
patients undergoing radiotherapy. Measuring the individual QoL appears
as an adapted needs assessment and helps the psychotherapist in
focusing on the patient's problems and desires. Furthermore, the
patient's QoL is a main target in providing or planning mental health
care in non-university oncological services. |
| SN |
0961-5423 |
| PD |
MAR |
| PY |
2007 |
| VL |
16 |
| IS |
2 |
| BP |
130 |
| EP |
136 |
| UT |
ISI:000244942500004 |
| ER |
|
| PT |
J |
| AU |
Takahashi, K
Ida, I
Kumano, H
Oshima, A
Yuuki, N
Aihara, M
Sato, H
Majima, T
Yonemura, K
Fukuda, M
Oriuchi, N
Amanuma, M
Endo, K
Matsuda, H
Mikuni, M |
| AF |
Takahashi, K.
Ida, I.
Kumano, H.
Oshima, A.
Yuuki, N.
Aihara, M.
Sato, H.
Majima, T.
Yonemura, K.
Fukuda, M.
Oriuchi, N.
Amanuma, M.
Endo, K.
Matsuda, H.
Mikuni, M. |
| TI |
Brain metabolic changes associated with the onset of depression and
anxiety in cancer patients |
| SO |
PSYCHIATRY AND CLINICAL NEUROSCIENCES |
| SN |
1323-1316 |
| PD |
APR |
| PY |
2007 |
| VL |
61 |
| IS |
2 |
| BP |
S7 |
| EP |
S7 |
| UT |
ISI:000244600300040 |
| ER |
|
| PT |
J |
| AU |
Stephenson, NLN
Swanson, M
Dalton, J
Keefe, FJ
Engelke, M |
| AF |
Stephenson, Nancy L. N.
Swanson, Melvin
Dalton, JoAnn
Keefe, Frances J.
Engelke, Martha |
| TI |
Partner-delivered reflexology: Effects on cancer pain and anxiety |
| SO |
ONCOLOGY NURSING FORUM |
| AB |
Purpose/Objectives: To compare the effects of partner-delivered foot
reflexology and usual care plus attention on patients' perceived pain
and anxiety.
Design: The experimental pretest/post-test design included
patient-partner dyads randomly assigned to an experimental or control
group.
Setting: Four hospitals in the southeastern United States.
Sample: 42 experimental and 44 control subjects comprised 86 dyads of
patients with metastatic cancer and their partners, representing 16
different types of cancer; 23% of patients had lung cancer, followed by
breast, colorectal, and head and neck cancer and lymphoma. The subjects
had a mean age of 58.3 years, 51% were female, 66% had a high school
education or less, and 58% were Caucasian, 40% were African American,
and 1% were Filipino.
Methods: The intervention included a 15-to 30-minute teaching session
on foot reflexology to the partner by a certified reflexologist, an
optional 15-to 30-minute foot reflexology session for the partner, and
a 30-minute, partner-delivered foot reflexology intervention for the
patient. The control group received a 30-minute reading session from
their partners.
Main Research Variables: Pain and anxiety. Findings: Following the
initial partner-delivered foot reflexology, patients experienced a
significant decrease in pain intensity and anxiety.
Conclusions: A nurse reflexologist taught partners how to perform
reflexology on patients with metastatic cancer pain in the hospital,
resulting in an immediate decrease in pain intensity and anxiety;
minimal changes were seen in the control group, who received usual care
plus attention.
Implications for Nursing: Hospitals could have qualified professionals
offer reflexology as a complementary therapy and teach interested
partners the modality. |
| SN |
0190-535X |
| PD |
JAN |
| PY |
2007 |
| VL |
34 |
| IS |
1 |
| BP |
127 |
| EP |
132 |
| UT |
ISI:000243441000022 |
| ER |
|
| PT |
J |
| AU |
Schoen, M
Roth, A
Nelson, C
Bhaskaran, V |
| AF |
Schoen, Mary
Roth, Andrew
Nelson, Christian
Bhaskaran, Vidhya |
| TI |
Anxiety and depression in prostate cancer survivors, postprostatectomy. |
| SO |
ONCOLOGY NURSING FORUM |
| SN |
0190-535X |
| PD |
JAN |
| PY |
2007 |
| VL |
34 |
| IS |
1 |
| BP |
172 |
| EP |
173 |
| UT |
ISI:000243441000041 |
| ER |
|
| PT |
J |
| AU |
Wilson, KG
Chochinov, HM
Skirko, MG
Allard, P
Chary, S
Gagnon, PR
Macmillan, K
De Luca, M
O'Shea, F
Kuhl, D
Fainsinger, RL
Clinch, JJ |
| AF |
Wilson, Keith G.
Chochinov, Harvey Max
Skirko, Merika Graham
Allard, Pierre
Chary, Srini
Gagnon, Pierre R.
Macmillan, Karen
De Luca, Marina
O'Shea, Fiona
Kuhl, David
Fainsinger, Robin L.
Clinch, Jennifer J. |
| TI |
Depression and anxiety disorders in palliative cancer care |
| SO |
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT |
| AB |
Depression and anxiety disorders are thought to be common in palliative
cancer care, but there is inconsistent evidence regarding their
relevance for other aspects of quality of life. In the Canadian
National Palliative Care Survey, semi-structured interviews assessing
depression and anxiety disorders were administered to 381 patients who
were receiving palliative care for cancer. There were 212 women and 169
men, with a median survival of, 63 days. We found that 93 participants
(24.4 %, 95 % confidence interval= 20.2-29.0) fulfilled Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition diagnostic
criteria for at least one anxiety or depressive disorder (20.7%
prevalence of depressive disorders, 13.9% prevalence of anxiety
disorders). The most frequent individual diagnosis was major depression
(13.1%, 95% confidence interval = 9.9-16.9). Comorbidity was common,
with 10.2% of participants meeting criteria for more than one disorder.
Those diagnosed with a disorder were significantly younger than other
participants (P = 0.002). They also had lower performance status (P =
0.017), smaller social networks (P = 0.008), and less participation in
organized religious services (P = 0.007). In addition, they reported
more severe distress on 14 of 18 physical symptoms, social concerns,
and existential issues. Of those with a disorder, 39.8% were being
treated, with antidepressant medication, and 66.7% bad been prescribed
a benzodiazepine. In conclusion, it appears that, de/nession, and
anxiety disorders are indeed common among patients receiving palliative
care. The disorders contribute to a greatly diminished quality of life
among people who are dying of cancer. |
| SN |
0885-3924 |
| PD |
FEB |
| PY |
2007 |
| VL |
33 |
| IS |
2 |
| BP |
118 |
| EP |
129 |
| UT |
ISI:000244268800004 |
| ER |
|
| PT |
J |
| AU |
Andrews, A
Rosenbaum, EH
Garlan, R
Siegal, A
Hirschberger, N
Butler, LD
Esserman, L
Spiegel, D |
| AF |
Andrews, A.
Rosenbaum, E. H.
Garlan, R.
Siegal, A.
Hirschberger, N.
Butler, L. D.
Esserman, L.
Spiegel, D. |
| TI |
The life tape project: a psychosocial intervention for cancer patients
and their families to increase communication and support, and reduce
isolation and existential anxiety. |
| SO |
BREAST CANCER RESEARCH AND TREATMENT |
| SN |
0167-6806 |
| PY |
2006 |
| VL |
100 |
| SU |
Suppl. 1 |
| BP |
S99 |
| EP |
S99 |
| UT |
ISI:000242047100287 |
| ER |
|
| PT |
J |
| AU |
Wilkinson, SM
Love, SB
Westcombe, AM
Gambles, MA
Burgess, CC
Cargill, A
Young, T
Maher, EJ
Ramirez, AJ |
| AF |
Wilkinson, Susie M.
Love, Sharon B.
Westcombe, Alex M.
Gambles, Maureen A.
Burgess, Caroline C.
Cargill, Anna
Young, Teresa
Maher, E. Jane
Ramirez, Amanda J. |
| TI |
Effectiveness of aromatherapy massage in the management of anxiety and
depression in patients with cancer: A multicenter randomized controlled
trial |
| SO |
JOURNAL OF CLINICAL ONCOLOGY |
| AB |
Purpose
To test the effectiveness of supplementing usual supportive care with
aromatherapy massage in the management of anxiety and depression in
cancer patients through a pragmatic two-arm randomized controlled trial
in four United Kingdom cancer centers and a hospice.
Patients and Methods
Two hundred eighty-eight cancer patients, referred to complementary
therapy services with clinical anxiety and/or depression, were
allocated randomly to a course of aromatherapy massage or usual
supportive care alone.
Results
Patients who received aromatherapy massage had no significant
improvement in clinical anxiety and/or depression compared with those
receiving usual care at 10 weeks postrandomization ( odds ratio [ OR],
1.3; 95% CI, 0.9 to 1.7; P =.1), but did at 6 weeks postrandomization (
OR, 1.4; 95% CI, 1.1 to 1.9; P =.01). Patients receiving aromatherapy
massage also described greater improvement in self-reported anxiety at
both 6 and 10 weeks postrandomization ( OR, 3.4; 95% CI, 0.2 to 6.7; P
=.04 and OR, 3.4; 95% CI, 0.2 to 6.6; P =.04), respectively.
Conclusion
Aromatherapy massage does not appear to confer benefit on cancer
patients' anxiety and/or depression in the long-term, but is associated
with clinically important benefit up to 2 weeks after the intervention. |
| SN |
0732-183X |
| PD |
FEB 10 |
| PY |
2007 |
| VL |
25 |
| IS |
5 |
| BP |
532 |
| EP |
539 |
| UT |
ISI:000244176000012 |
| ER |
|
| PT |
J |
| AU |
Filipovic, BR
Filipovic, BF
Kerkez, M
Milinic, N
Randelovic, T |
| AF |
Filipovic, Branislav R.
Filipovic, Branka F.
Kerkez, Mirko
Milinic, Nikola
Randelovic, Tomislav |
| TI |
Depression and anxiety levels in therapy-naive patients with
inflammatory bowel disease and cancer of the colon |
| SO |
WORLD JOURNAL OF GASTROENTEROLOGY |
| AB |
AIM: To assess whether depression and anxiety are more expressed in
patients with the first episode of inflammatory bowel disease (IBD)
than in individuals with newly discovered cancer of the colon (CCa).
METHODS: A total of 32 patients with IBD including 13 males and 19
females, aged 27 to 74, and 30 patients with CCa including 20 males and
10 females, aged 39-78, underwent a structured interview, which
comprised Hamilton's Depression Rating Inventory, Hamilton's Anxiety
Rating Inventory and Paykel's Stressful Events Rating Scale.
RESULTS: Patients of the IBD group expressed both depression and
anxiety. Depressive mood, sense of guilt, psychomotor retardation and
somatic anxiety were also more pronounced in IBD patients. The
discriminant function analysis revealed the total depressive score was
of high importance for the classification of a newly diagnosed patient
into one of the groups.
CONCLUSION: Newly diagnosed patients with IBD have higher levels of
depression and anxiety. Moreover, a psychiatrist in the treatment team
is advisable from the beginning. (c) 2007 The WJG Press. All rights
reserved. |
| SN |
1007-9327 |
| PD |
JAN 21 |
| PY |
2007 |
| VL |
13 |
| IS |
3 |
| BP |
438 |
| EP |
443 |
| UT |
ISI:000243613900017 |
| ER |
|
| PT |
J |
| AU |
Bekher, OA
Slonimskaya, EM
Kupriyanova, IE |
| AF |
Bekher, O. A.
Slonimskaya, E. M.
Kupriyanova, I. E. |
| TI |
Level of anxiety in breast cancer women |
| SO |
NEURO-ONCOLOGY |
| SN |
1522-8517 |
| PD |
OCT |
| PY |
2006 |
| VL |
8 |
| IS |
4 |
| BP |
360 |
| EP |
361 |
| UT |
ISI:000240877300271 |
| ER |
|
| PT |
J |
| AU |
Tsutsumi, S
Yamaki, S
Yamaguchi, S
Asao, T
Kuwano, H |
| AF |
Tsutsumi, Soichi
Yamaki, Sayaka
Yamaguchi, Satoru
Asao, Takayuki
Kuwano, Hiroyuki |
| TI |
Anxiety in outpatients receiving chemotherapy for solid cancer |
| SO |
HEPATO-GASTROENTEROLOGY |
| AB |
Background/Aims: We conducted this prospective study to assess the
anxiety in outpatients receiving chemotherapy for solid cancers.
Methodology: Patients were eligible if they were receiving chemotherapy
for solid cancer in an outpatient setting, had a life expectancy of
more than 6 months, and were able to complete self-administered
questionnaires. The State-Trait Anxiety Inventory (STAI) was used to
measure the anxiety levels.
Results: From January to December 2004, 119 patients were recruited,
and, of these, 114 completed the questionnaires. Their median age was
60.6 years, and the male-to-female ratio was 1.04:1. Of the 114
patients, 36 had breast cancer, 35, colorectal cancer, 23, gastric
cancer, 8, esophageal cancer, 5, non-small-cell cancer, 4, pancreatic
cancer, and 3, liver cancer. The state- and trait-anxiety levels were
higher for women (p=0.019). Age did not influence the trait-anxiety
level, but the state-anxiety levels of younger patients were higher.
The periods of chemotherapy raised the state and trait-anxiety levels
(p=0.023 and 0.015, respectively). No statistically significant
differences were observed according to the type of cancer.
Conclusions: The anxiety levels of outpatients with solid cancer
receiving chemotherapy were significantly high. Having access to such
information will help oncologists provide appropriate support to their
patients. |
| SN |
0172-6390 |
| PD |
NOV-DEC |
| PY |
2006 |
| VL |
53 |
| IS |
72 |
| BP |
828 |
| EP |
830 |
| UT |
ISI:000242306400005 |
| ER |
|
| PT |
J |
| AU |
Dell'Agostino, K
Fiumano, M
Fusco, O
Malugani, F
Berardi, E
Menatti, E
Bartolini, A |
| AF |
Dell'Agostino, K.
Fiumano, M.
Fusco, O.
Malugani, F.
Berardi, E.
Menatti, E.
Bartolini, A. |
| TI |
Anxiety/depression screening in cancer patient by Zung evaluation form |
| SO |
ANNALS OF ONCOLOGY |
| SN |
0923-7534 |
| PY |
2006 |
| VL |
17 |
| SU |
Suppl. 11 |
| BP |
XI34 |
| EP |
XI34 |
| UT |
ISI:000242379800128 |
| ER |
|
| PT |
J |
| AU |
Seo, PH
Sloane, R
Ingram, SS
Misra, D
Clipp, EC
Montana, GS
Cohen, HJ |
| AF |
Seo, P. H.
Sloane, R.
Ingram, S. S.
Misra, D.
Clipp, E. C.
Montana, G. S.
Cohen, H. J. |
| TI |
The relationship between older cancer survivors' reports of depression,
anxiety and pain to health providers' findings and mortality. |
| SO |
JOURNAL OF CLINICAL ONCOLOGY |
| SN |
0732-183X |
| PD |
JUN 20 |
| PY |
2006 |
| VL |
24 |
| IS |
18 |
| PN |
Part 1 Suppl. S |
| BP |
492S |
| EP |
492S |
| UT |
ISI:000239009403269 |
| ER |
|
| PT |
J |
| AU |
Pasquini, M
Biondi, M
Costantini, A
Cairoli, F
Ferrarese, G
Picardi, A
Sternberg, C |
| AF |
Pasquini, M.
Biondi, M.
Costantini, A.
Cairoli, F.
Ferrarese, G.
Picardi, A.
Sternberg, C. |
| TI |
Detection and treatment of depressive and anxiety disorders among
cancer patients: Feasibility and preliminary findings from a liaison
service in an oncology division |
| SO |
DEPRESSION AND ANXIETY |
| AB |
Our aim in this observational study was to evaluate the feasibility of
a multiphasic screening project for the detection and treatment of mood
and anxiety disorders among cancer patients in a natural setting. One
hundred sixty-five patients with cancer, consecutively admitted to the
Oncology Division of San Camillo-Forlanini Hospital, were recruited to
the study. All patients had solid tumors; the majority of them were.
colon, breast, and lung cancers. All patients completed the Hospital
Anxiety and Depression Scale (HADS). Patients screened as positive were
administered the following instruments by a psychiatrist. the
Structured Clinical Interview for DSM-IV (SCID-I), the Beck Depression
Inventory (BDI), the Hamilton Anxiety Rating Scale (HARS), and a
validated scale for the rapid dimensional assessment of psychopathology
(SVARAD). The BDI, HARS, and SVARAD were administered again at 4 and 10
weeks to all treated patients. Out of 45 patients administered the
SCID-I, 37 had a mood or anxiety disorder. Adjustment disorders were
identified in 20 patients, depressive disorders in 14, and anxiety
disorders in three patients. Most patients were prescribed psychotropic
medications: mirtazapine was prescribed to 15 patients, citalopram to
13 patients, and escitalopram to four patients. A significant
improvement in symptoms of depression and anxiety was observed on all
measures (P <.001). Although the design of the study prevents any firm
conclusions about effectiveness, this study suggests that including
psychiatric expertise in an oncology division is feasible and may lead
to improved detection and treatment of psychiatric disorders among
cancer patients. Further randomized trials are needed to elaborate on
our findings. |
| SN |
1091-4269 |
| PY |
2006 |
| VL |
23 |
| IS |
7 |
| BP |
441 |
| EP |
448 |
| UT |
ISI:000241907600010 |
| ER |
|
| PT |
J |
| AU |
Cankurtaran, ES
Soygur, AH
Ozalp, E
Turhan, L |
| AF |
Cankurtaran, E. S.
Soygur, A. H.
Ozalp, E.
Turhan, L. |
| TI |
Mirtazapine versus tricyclic antidepressants for the treatment of
depression, anxiety and distressing symptoms of cancer |
| SO |
EUROPEAN NEUROPSYCHOPHARMACOLOGY |
| SN |
0924-977X |
| PD |
SEP |
| PY |
2006 |
| VL |
16 |
| SU |
Suppl. 4 |
| BP |
S324 |
| EP |
S325 |
| UT |
ISI:000240771301022 |
| ER |
|
| PT |
J |
| AU |
Robb, KA
Miles, A
Campbell, J
Evans, P
Wardle, J |
| AF |
Robb, Kathryn A.
Miles, Anne
Campbell, John
Evans, Philip
Wardle, Jane |
| TI |
Can cancer risk information raise awareness without increasing anxiety?
A randomized trial |
| SO |
PREVENTIVE MEDICINE |
| AB |
Objective. Promoting public awareness of cancer risk factors is an
important public health goal, but there is concern that it could
heighten anxiety. This study examined the impact of mailed information
about colorectal cancer on awareness of risk factors, emotional
well-being, and interest in attending screening in a population not
previously exposed to screening.
Method. Individuals (3,185) aged 45-66 years registered with general
practitioners in South-West England in 2004 were randomized to (1)
control group (no information), (2) information on colorectal cancer
risk factors, or (3) information on risk factors and colorectal
screening. All participants were sent a questionnaire assessing
knowledge, anxiety, worry about colorectal cancer, and interest in
screening.
Results. Questionnaires (1,945; 61%) were returned. As expected,
participants receiving information had significantly greater knowledge
than the control group. Anxiety scores were in the normal range and
neither anxiety nor worry about cancer differed significantly between
the groups. Ninety-three percent of respondents indicated they would be
interested in screening, with equally high levels across groups.
Conclusion. This study suggests that information leaflets can promote
knowledge of cancer risk factors without increasing anxiety. Low-cost
educational materials have the potential to contribute to public
engagement with health promotion and disease prevention. (c) 2006
Elsevier Inc. All rights reserved. |
| SN |
0091-7435 |
| PD |
SEP |
| PY |
2006 |
| VL |
43 |
| IS |
3 |
| BP |
187 |
| EP |
190 |
| UT |
ISI:000240876000007 |
| ER |
|
| PT |
J |
| AU |
Antoni, MH
Wimberly, SR
Lechner, SC
Kazi, A
Sifre, T
Urcuyo, KR
Phillips, K
Smith, RG
Petronis, VM
Guellati, S
Wells, KA
Blomberg, B
Carver, CS |
| AF |
Antoni, Michael H.
Wimberly, Sarah R.
Lechner, Suzanne C.
Kazi, Aisha
Sifre, Tammy
Urcuyo, Kenya R.
Phillips, Kristin
Smith, Roselyn G.
Petronis, Vida M.
Guellati, Sophie
Wells, Kurrie A.
Blomberg, Bonnie
Carver, Charles S. |
| TI |
Reduction of cancer-specific thought intrusions and anxiety symptoms
with a stress management intervention among women undergoing treatment
for breast cancer |
| SO |
AMERICAN JOURNAL OF PSYCHIATRY |
| AB |
Objective: After surgery for breast cancer, many women experience
anxiety relating to the cancer that can adversely affect quality of
life and emotional functioning during the year postsurgery. Symptoms
such as intrusive thoughts may be ameliorated during this period with a
structured, group-based cognitive behavior intervention.
Method: A 10-week group cognitive behavior stress management
intervention that included anxiety reduction ( relaxation training),
cognitive restructuring, and coping skills training was tested among
199 women newly treated for stage 0-111 breast cancer. They were then
followed for 1 year after recruitment.
Results: The intervention reduced reports of thought intrusion,
interviewer ratings of anxiety, and emotional distress across 1 year
significantly more than was seen with the control condition. The
beneficial effects were maintained well past the completion of adjuvant
therapy.
Conclusions: Structured, group-based cognitive behavior stress
management may ameliorate cancer-related anxiety during active medical
treatment for breast cancer and for 1 year following treatment.
Group-based cognitive behavior stress management is a clinically useful
adjunct to offer to women treated for breast cancer. |
| SN |
0002-953X |
| PD |
OCT |
| PY |
2006 |
| VL |
163 |
| IS |
10 |
| BP |
1791 |
| EP |
1797 |
| UT |
ISI:000240906800024 |
| ER |
|
| PT |
J |
| AU |
Lienard, A
Merckaert, I
Libert, Y
Delvaux, N
Marchal, S
Boniver, J
Etienne, AM
Klastersky, J
Reynaert, C
Scalliet, P
Slachmuylder, JL
Razavi, D |
| AF |
Lienard, A.
Merckaert, I.
Libert, Y.
Delvaux, N.
Marchal, S.
Boniver, J.
Etienne, A. -M.
Klastersky, J.
Reynaert, C.
Scalliet, P.
Slachmuylder, J. -L.
Razavi, D. |
| TI |
Factors that influence cancer patients' anxiety following a medical
consultation: impact of a communication skills training programme for
physicians |
| SO |
ANNALS OF ONCOLOGY |
| AB |
Background: No study has yet assessed the impact of physicians' skills
acquisition after a communication skills training programme on the
evolution of patients' anxiety following a medical consultation. This
study aimed to compare the impact, on patients' anxiety, of a basic
communication skills training programme (BT) and the same programme
consolidated by consolidation workshops (CW), and to investigate
physicians' communication variables associated with patients' anxiety.
Patients and methods: Physicians, after attending the BT, were randomly
assigned to CW or to a waiting list. The control group was not a
non-intervention group. Consultations with a cancer patient were
recorded. Patients' anxiety was assessed with the State Trait Anxiety
Inventory before and after a consultation. Communication skills were
analysed according to the Cancer Research Campaign Workshop Evaluation
Manual.
Results: No statistically significant change over time and between
groups was observed. Mixed-effects modelling showed that a decrease in
patients' anxiety was linked with screening questions (P = 0.045),
physicians' satisfaction about support given (P = 0.004) and with
patients' distress (P < 0.001). An increase in anxiety was linked with
breaking bad news (P = 0.050) and with supportive skills (P = 0.013).
No impact of the training programme was observed.
Conclusions: This study shows the influence of some communication
skills on the evolution of patients' anxiety. Physicians should be
aware of these influences. |
| SN |
0923-7534 |
| PD |
SEP |
| PY |
2006 |
| VL |
17 |
| IS |
9 |
| BP |
1450 |
| EP |
1458 |
| UT |
ISI:000240587900017 |
| ER |
|
| PT |
J |
| AU |
Osborn, RL
Demoncada, AC
Feuerstein, M |
| AF |
Osborn, Robyn L.
Demoncada, Angelique C.
Feuerstein, Michael |
| TI |
Psychosocial interventions for depression, anxiety, and quality of life
in cancer survivors: Meta-analyses |
| SO |
INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE |
| AB |
Objective: The purpose of this meta-analysis was to investigate the
effects of cognitive behavioral therapy (CBT) and patient education
(PE) on commonly reported problems (depression, anxiety, pain, physical
functioning, and quality of life (QOL)) in adult cancer survivors.
Methods: Meta analyses of randomized controlled trials of CBT and PE
were conducted. MEDLINE, PSYCHINFO and the Cochrane Database were
searched from 1993-2004. The effects of individual versus group
interventions and short (< 8 months) versus long (> 8 months) term
follow up are also reported. Results: Fifteen studies met quality
criteria. The sample size was 1,492 adult cancer survivors with an age
range of 18-84. 790 were randomly assigned to intervention groups and
702 to control groups. CBT varied in duration from 4 weekly one-hour
sessions to 55 weekly two-hour sessions. PE ranged from a single
20-minute session to 6 weekly one-hour sessions. Follow up ranged from
I week to 14 months. CBT was effective for depression (ES = 1.2; 95% Cl
= 0.22-2.19), anxiety (ES = 1.99; 95% Cl = 0.69-3.31), and QOL (ES =
0.91; 95% CI = 0.38-1.44). QOL was improved at both short and (ES =
1.45, 95% CI =.43-2.47) and long term (ES =.26; 95% Cl =.06-.46) follow
up. PE was not related to improved outcomes. Conclusions: CBT is
related to short-term effects on depression and anxiety and both short
and long term effects on QOL. Individual interventions were more
effective than group. Various CBT approaches provided in an individual
format can assist cancer survivors in reducing emotional distress and
improving quality of life. |
| SN |
0091-2174 |
| PY |
2006 |
| VL |
36 |
| IS |
1 |
| BP |
13 |
| EP |
34 |
| UT |
ISI:000239498300002 |
| ER |
|
| PT |
J |
| AU |
Kahan, Z
Varga, K
Dudas, R
Nyari, T
Thurzo, L |
| AF |
Kahan, Zsuzsanna
Varga, Katalin
Dudas, Rita
Nyari, Tibor
Thurzo, Laszlo |
| TI |
Collaborative/active participation per se does not decrease anxiety in
breast cancer |
| SO |
PATHOLOGY & ONCOLOGY RESEARCH |
| AB |
The information needs of breast cancer patients on their disease, its
treatment, the prognosis, and their attitude to decision-making
concerning treatment were assessed. One hundred and fifty early and 45
metastatic breast cancer patients were recruited into the study. The
amount of information and role in the treatment decision-making process
preferred by the patient were independently estimated by the patient
and the oncologist, using questionnaires. Information was provided in
accordance with the wishes of the patient as perceived by the
physician. Test of anxiety was performed before, and one week after the
consultation. Most of the patients claimed to anticipate the provision
of extensive information and an active role in the decision-making, but
real interest during the consultation was found less frequently. The
post-consultation anxiety test revealed a significant decrease in
situational anxiety; this was not related to the patient's information
needs or her attitude to the decision-making concerning treatment. Our
study demonstrates that a significant decrease in anxiety may be
achieved via a consultation tailored to the needs of the patient.
Loading the patient with information and involvement in the decision
regarding therapy as much as the patient seems comfortable with lowers
distress. |
| SN |
1219-4956 |
| PY |
2006 |
| VL |
12 |
| IS |
2 |
| BP |
93 |
| EP |
101 |
| UT |
ISI:000239140500006 |
| ER |
|
| PT |
J |
| AU |
Rogers, SN
Rajlawat, B
Goru, J
Lowe, D
Humphris, GM |
| AF |
Rogers, Simon N.
Rajlawat, Bijaya
Goru, Janaki
Lowe, Derek
Humphris, Gerry M. |
| TI |
Comparison of the domains of anxiety and mood of the University of
Washington Head and Neck Cancer Questionnaire (UW-QOL v4) with the
CES-D and HADS |
| SO |
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND
NECK |
| AB |
Background. Version 4 of the University of Washington Head and Neck
Cancer Questionnaire (UW-QOLv4) includes items on mood and anxiety. The
aim of this study was to compare the responses to these single items
with the Centre for Epidemiology Studies Depression Scale (CES-D) and
the Hospital Anxiety Depression Scale (HADS).
Methods. A cross-sectional postal survey was undertaken in April 2003.
The survey was composed of all patients treated for oral and
oropharyngeal squamous cell carcinoma between 1992 and 2002 who were
alive and disease free.
Results. We distributed 306 questionnaires; there were 197 replies
(65%) from 110 male and 87 female patients. Most patients reported
relatively little depression, with 170 of 190 (89%) reporting a HADS
depression score of less than 11. Similarly, most patients were not
anxious, with 158 of 183 (86%) reporting a HADS anxiety score of less
than 11. UW-QOL mood, UW-QOL anxiety, HADS anxiety, HADS depression,
and CES-D scores were all moderately intercorrelated (Spearman
correlations from 0.39-0.68 ignoring the signs, all p < .001). The
UW-COIL mood correlated with the scores and "case-ness" categories of
the HADS depression and CES-D scales, whereas the UW-QOL anxiety
correlated with the scores and "case-ness" of the HADS anxiety.
Conclusions. Questions on mood and anxiety can help identify
significant psychological 'morbidity, taking a score of less than 75
for UW-QOL mood and less than 70 for UW-OOL anxiety. This could be used
to trigger formal psychological assessment and with a view to possible
therapeutic intervention. (c) 2006 Wiley Periodicals, Inc. |
| SN |
1043-3074 |
| PD |
AUG |
| PY |
2006 |
| VL |
28 |
| IS |
8 |
| BP |
697 |
| EP |
704 |
| UT |
ISI:000239179900005 |
| ER |
|
| PT |
J |
| AU |
Roth, A
Nelson, CJ
Rosenfeld, B
Warshowski, A
O'Shea, N
Scher, H
Holland, JC
Slovin, S
Curley-Smart, T
Reynolds, T
Breitbart, W |
| TI |
Assessing anxiety in men with prostate cancer: Further data on the
reliability and validity of the Memorial Anxiety Scale for Prostate
Cancer (MAX-PC) |
| SO |
PSYCHOSOMATICS |
| AB |
Identifying which men with prostate cancer might benefit from mental
health treatment has proven to be a challenging task. The authors
developed the Memorial Anxiety Scale for Prostate Cancer (MAX-PC) in
order to facilitate the identification of prostate cancer-related
anxiety. A revised version of this scale was tested in a more
clinically varied population. Ambulatory men with prostate cancer (N =
367) completed a baseline assessment packet that included the MAXPC and
other psychosocial questionnaires. The MAX-PC showed high internal
consistency and concurrent and discriminant validity. Factor analysis
identified three distinct factors for the MAX-PC that corresponded to
the intended subscales (General Prostate Cancer Anxiety, PSA
(prostate-specific antigen) Anxiety, and Fear of Recurrence). PSA
levels were not correlated with anxiety overall; however, anxiety was
significantly higher among patients whose PSA levels were changing
(i.e., rising, falling, and unstable), versus those with stable PSA
levels. Also, in a multivariate analysis, the change in PSA levels was
a significant predictor of MAX-PC scores, but not Hospital Anxiety and
Depression Scale (HADS) scores. These results indicate that the MAX-PC
is a valid and reliable measure of anxiety that assesses aspects of
anxiety unique to men with prostate cancer and it may provide a more
sensitive measure of anxiety than the HADS for this population. |
| SN |
0033-3182 |
| PD |
JUL-AUG |
| PY |
2006 |
| VL |
47 |
| IS |
4 |
| BP |
340 |
| EP |
347 |
| UT |
ISI:000238767900011 |
| ER |
|
| PT |
J |
| AU |
Tagay, S
Herpertz, S
Langkafel, M
Erim, Y
Bockisch, A
Senf, W
Gorges, R |
| TI |
Health-related quality of life, depression and anxiety in thyroid
cancer patients |
| SO |
QUALITY OF LIFE RESEARCH |
| AB |
Objectives: We examined the relationships among physical complaints,
health-related quality of life (HRQL), anxiety and depression in
differentiated thyroid cancer (DTC) patients under short-term
hypothyroidism.
Methods: We conducted a cross-sectional study in 136 patients
hypothyroid on thyroid hormone withdrawal (THW) hospitalized for
radioiodine administration. Patients were assessed using Short Form
SF-36 (SF-36), Hospital Anxiety and Depression Scale (HADS), Profile of
Mood States (POMS), Beck Depression Inventory (BDI), and physical
complaints.
Results: Compared to the German general population, hypothyroid
patients had significantly impaired HRQL. Surprisingly, the prevalence
of anxiety (62.5%), but not depression (17.9%) was much higher in
hypothyroid DTC patients than in the general population. In
multivariate analysis, depression and age were independently associated
with the physical health score (R-2 = 0.21), but only psychological
variables (depression, mood disturbance, and anxiety) were associated
with the mental health score (R-2 = 0.43), on the SF-36 HRQL instrument.
Conclusions: HRQL is severely impaired in DTC patients under short-term
hypothyroidism. As potential predictors of generic HRQL impairment,
depression, anxiety, and mood disturbance could be used to preselect
the patients most needing psychiatric care. The high frequency of
anxiety should be considered in the aftercare of thyroid cancer
patients. |
| SN |
0962-9343 |
| PD |
MAY |
| PY |
2006 |
| VL |
15 |
| IS |
4 |
| BP |
695 |
| EP |
703 |
| UT |
ISI:000237489100012 |
| ER |
|
| PT |
J |
| AU |
Hedstrom, M
Kreuger, A
Ljungman, G
Nygren, P
von Essen, L |
| TI |
Accuracy of assessment of distress, anxiety, and depression by
physicians and nurses in adolescents recently diagnosed with cancer |
| SO |
PEDIATRIC BLOOD & CANCER |
| AB |
Background. As staff members prioritize medical resources for patients,
it is imperative to find Out whether their assessments of patients'
health status agree with patients' assessments. The degree to which
physicians and nurses can identify the distress, anxiety, and
depression experienced by adolescents recently diagnosed with cancer
was examined here. Procedure. Adolescents undergoing chemotherapy
(13-19 years, n = 53), physicians (n 48), and nurses (n=53) completed a
structured telephone interview, 4-8 weeks after diagnosis or relapse,
investigating disease and treatment-related distress, anxiety, and
depression. Results. The accuracy of staff ratings of physical distress
could be considered acceptable. However, problems of a psychosocial
nature, which were frequently overestimated, were difficult for staff
to identify. Staff underestimated the distress caused by mucositis and
worry about missing school more than they overestimated distress. These
aspects were some of the most prevalent and overall worst according to
the adolescents. Both physicians and nurses overestimated levels of
anxiety and depression. Nurses tended to show higher sensitivity than
physicians for distress related to psychosocial aspects of distress,
while physicians tended to show higher accuracy than nurses for
physical distress. Conclusions. Staff was reasonably accurate at
identifying physical distress in adolescents recently diagnosed with
cancer whereas psychosocial problems were generally poorly identified.
Thus, the use of staff ratings as a "test" to guide specific Support
seems problematic. Considering that the accuracy of staff ratings
outside a research study is probably lower, identification of and
action taken on adolescent problems in relation to cancer diagnosis and
treatment need to rely on direct communication. |
| SN |
1545-5009 |
| PD |
JUN |
| PY |
2006 |
| VL |
46 |
| IS |
7 |
| BP |
773 |
| EP |
779 |
| UT |
ISI:000237304100013 |
| ER |
|
| PT |
J |
| AU |
Norberg, AL
Lindblad, F
Boman, KK |
| TI |
Support-seeking, perceived support, and anxiety in mothers and fathers
after children's cancer treatment |
| SO |
PSYCHO-ONCOLOGY |
| AB |
The objective was to examine the relationships between anxiety, the
seeking of social support as a coping strategy, and perceived social
support among mothers (n = 103) and fathers (n = 8 1) of children with
successfully completed treatment for cancer. Assessments were done
using self-report instruments. The mediating effect of perceived
support on the relationship between social support-seeking and anxiety
was evaluated through path analysis, and comparisons were done in order
to evaluate effects of gender.
For mothers and fathers alike, a positive relationship of moderate
strength between support-seeking and perceived support was found.
Anxiety was negatively related to support-seeking (mothers r = -0.22, p
= 0.025; fathers r = -0.21, p = 0.063) as well as perceived support
(mothers r = -0.55, p < 0.001; fathers r = -0.41 p < 0.001), although
the relationship for support-seeking was weak. The path analysis showed
that perceived support only to a minor extent could strengthen this
association. The significance of support-seeking and perceived support
was stronger for mothers than for fathers, as regards their association
with anxiety. However, the patterns of interrelations were similar for
mothers and fathers. In conclusion, parents' subjectively perceived
support appears to be more important for anxiety regulation than their
support-seeking coping. In clinical practice, individual variation
should be acknowledged, and presumptions of general gender differences
avoided. Copyright (c) 2005 John Wiley & Sons, Ltd. |
| SN |
1057-9249 |
| PD |
APR |
| PY |
2006 |
| VL |
15 |
| IS |
4 |
| BP |
335 |
| EP |
343 |
| UT |
ISI:000236993400006 |
| ER |
|
| PT |
J |
| AU |
Jones, RB
Pearson, J
Cawsey, AJ
Bental, D
Barrett, A
White, J
White, CA
Gilmour, WH |
| TI |
Effect of different forms of information produced for cancer patients
on their use of the information, social support, and anxiety:
randomised trial |
| SO |
BRITISH MEDICAL JOURNAL |
| AB |
Objective To explore the hypothesis that different methods of selecting
and printing information for cancer patients could improve emotional
support by affecting interaction with others, and so lead to improved
psychological wellbeing.
Design Randomised trial with eight groups (three factors, 2x2x2). Data
collected at recruitment and three month follow-up.
Participants 400 patients starting radiotherapy, Of whom 325 with
breast or prostate cancer and complete anxiety and depression data were
included in the analysis.
Interventions Printed booklets: half had only general information from
CancerBACUP about each patients cancer and half had personalised
information from the patient's medical record plus selected general
information; half were composed of information chosen interactively by
the patient and half were produced automatically with a larger volume
of material; mid half had additional advice on anxiety management.
Main outcome measures Patients' views of the information, use of their
booklets with others; change in reported social support; change in
anxiety and depression.
Results The larger booklets produced automatically were more likely to
be found useful and to tell patients something new and less likely to
be seen as too limited than the booklets produced interactively, but
they were also more likely to overwhelm some patients. Personalised
booklets were more likely than general booklets to tell patients
something new. There was no difference in patients' perceived
understanding of their cancer by any of the intervention factors.
Patients with personalised information were more likely to show their
booklets to others and to think it helped in discussing their, cancer
or its treatment. There were no major differences in social support,
anxiety, or depression by an), intervention factors.
Conclusions Patients were more likely to show personalised information
to their confidants than general information. Further research is
needed into the effects of sharing information on patients' social
Support and anxiety. |
| SN |
0959-8146 |
| PD |
APR 22 |
| PY |
2006 |
| VL |
332 |
| IS |
7547 |
| BP |
942 |
| EP |
946A |
| UT |
ISI:000237143900016 |
| ER |
|
| PT |
J |
| AU |
McCoubrie, R
Davies, A |
| TI |
Is there a correlation between spirituality and anxiety and depression
in patients with advanced cancer? |
| SO |
SUPPORTIVE CARE IN CANCER |
| AB |
Aims and objectives: To establish whether there is a correlation
between spirituality and anxiety and depression in patients with
advanced cancer. Patients and methods: Patients with a diagnosis of
cancer at St. Peter's day hospice in Bristol were asked to complete
three questionnaires to assess anxiety, depression and spirituality.
Informed consent was obtained. Anxiety and depression are indicated by
the Hospital Anxiety and Depression Scale score, and spirituality is
indicated by scores on the Spiritual Well-Being Scale (SWBS) and the
Royal Free Interview for Spiritual and Religious Beliefs. As will be
explained, religion and spirituality are generally recognised as having
different meanings-religion entailing a relationship with a higher
being, while spirituality can be thought of in terms of meaning and
purpose in life. Results: Eighty-five complete data sets were obtained.
A significant negative correlation was found between both anxiety and
depression scores and overall spiritual well-being scores (p < 0.0001).
When the SWBS subscale scores were analysed individually, a significant
negative correlation was found between the existential well-being
scores and the anxiety and depression scores (p < 0.001). However, no
correlation was found between the religious well-being scores and
anxiety or depression. Conclusions: This study found a significant
negative correlation between spirituality (in particular, the
existential aspect) and anxiety and depression in patients with
advanced cancer. Religious well-being and strength of belief had no
impact on psychological well-being in this study. |
| SN |
0941-4355 |
| PD |
APR |
| PY |
2006 |
| VL |
14 |
| IS |
4 |
| BP |
379 |
| EP |
385 |
| UT |
ISI:000236983200012 |
| ER |
|
| PT |
J |
| AU |
Korfage, IJ
Esskink-Bot, ML
Janssens, ACJW
Schroder, FH
de Koning, HJ |
| TI |
Anxiety and depression after prostate cancer diagnosis and treatment:
5-year follow-up |
| SO |
BRITISH JOURNAL OF CANCER |
| AB |
To document anxiety and depression from pretreatment till 5-year
follow-up in 299 men with localized prostate cancer. To assess, if
baseline scores were predictive for anxiety and depression at 1-year
follow-up. Respondents completed four assessments (pretreatment, at 6
and 12 months, and at 5-year follow-up) on anxiety, depression and
mental health. Respondents were subdivided according to therapy
(prostatectomy or radiotherapy) and high vs low-anxiety. Pretreatment
28% of all patients were classified as 'high-anxiety'; their average
anxiety scores decreased significantly post-treatment, that is towards
less anxiety. At all assessments, high-anxiety men treated by
prostatectomy reported less depression than high-anxiety men treated by
radiotherapy. Of men treated by radiotherapy, 27% reported clinical
significant levels of depression while 20% is expected in a general
population. The improvement in mental health at 6-months follow-up was
statistically significant and clinically meaningful in all respondent
groups. Sensitivity of anxiety at baseline as a screening tool was 71%
for anxiety and 60% for symptoms of depression. We recommend clinicians
to attempt early detection of patients at risk of high levels of
anxiety and depression after prostate cancer diagnosis since prevalence
is high. STAI-State can be a useful screening tool but needs further
development. |
| SN |
0007-0920 |
| PD |
APR 24 |
| PY |
2006 |
| VL |
94 |
| IS |
8 |
| BP |
1093 |
| EP |
1098 |
| UT |
ISI:000236910300002 |
| ER |
|
| PT |
J |
| AU |
Rimes, KA
Salkovskis, PA
Jones, L
Lucassen, AA |
| TI |
Applying a cognitive-behavioral model of health anxiety in a cancer
genetics service |
| SO |
HEALTH PSYCHOLOGY |
| AB |
A cognitive-behavioral model of health anxiety was used to investigate
reactions to genetic counseling for cancer. Participants (N = 218) were
asked to complete a questionnaire beforehand and 6 months later. There
was an overall decrease in levels of cancer-related anxiety, although
24% of participants showed increased cancer-related anxiety at
follow-up. People who had a general tendency to worry about their
health reported more cancer-related anxiety than those who did not at
both time points. This health-anxious group also showed a
postcounseling anxiety reduction, whereas the others showed no
significant change. Participants with breast or ovarian cancer in their
family were more anxious than participants with colon cancer in their
family. Preexisting beliefs were significant predictors of anxiety,
consistent with a cognitive-behavioral approach. |
| SN |
0278-6133 |
| PD |
MAR |
| PY |
2006 |
| VL |
25 |
| IS |
2 |
| BP |
171 |
| EP |
180 |
| UT |
ISI:000236681200005 |
| ER |
|
| PT |
J |
| AU |
Saevarsdottir, T
Fridriksdottir, N
Gunnarsdottir, S |
| TI |
Quality of life, symptoms of anxiety and depression, and rehabilitation
needs of people receiving chemotherapy for cancer at the initiation of
chemotherapy and three months later. |
| SO |
ONCOLOGY NURSING FORUM |
| SN |
0190-535X |
| PD |
MAR |
| PY |
2006 |
| VL |
33 |
| IS |
2 |
| BP |
469 |
| EP |
469 |
| UT |
ISI:000236697600285 |
| ER |
|
| PT |
J |
| AU |
[Anon] |
| TI |
Trait anxiety predicts fatigue in women with early stage breast cancer |
| SO |
EJC SUPPLEMENTS |
| SN |
1359-6349 |
| PD |
MAR |
| PY |
2006 |
| VL |
4 |
| IS |
2 |
| BP |
91 |
| EP |
92 |
| UT |
ISI:000236447700183 |
| ER |
|
| PT |
J |
| AU |
Mehnert, A
Cao, P
Graefen, M
Huland, H
Koch, U |
| TI |
Prevalence of post-traumatic stress disorder, anxiety and depression in
patients with prostate cancer |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
FEB |
| PY |
2006 |
| VL |
15 |
| IS |
1 |
| SU |
Suppl. S |
| BP |
S66 |
| EP |
S66 |
| UT |
ISI:000235659000125 |
| ER |
|
| PT |
J |
| AU |
Greer, JA
Zhang, BH
Vanderwerker, LC
Prigerson, HG |
| TI |
Prevalence and correlates of anxiety in patients with advanced cancer |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
FEB |
| PY |
2006 |
| VL |
15 |
| IS |
1 |
| SU |
Suppl. S |
| BP |
S81 |
| EP |
S82 |
| UT |
ISI:000235659000152 |
| ER |
|
| PT |
J |
| AU |
Thomas, BC
Devi, N
Sarita, GP
Rita, K
Ramdas, K
Hussain, BM
Rejnish, R
Pandey, M |
| TI |
Reliability & validity of the Malayalam hospital anxiety & depression
scale (HADS) in cancer patients |
| SO |
INDIAN JOURNAL OF MEDICAL RESEARCH |
| AB |
Background & objectives: The hospital anxiety and depression scale
(HADS) has been widely used on cancer patients as an indicator of
psychological morbidity. Though the scale has been used in India, no
reports are available on translation of HADS in any Indian language and
testing the reliability. The present study describes the translation
process of HADS into Malayalam and testing its reliability and validity
on psychological morbidity in cancer patients.
Methods: The English version of the HADS was translated into Malayalam
and was used in this study. The questionnaire was administered to 240
cancer patients and statistical analysis was carried out using
Chronbach's alpha to test the internal consistancy of the HADS scale
while confirmatory factor analysis was carried out using principal axis
factoring with equimax rotation and Kaiser Normalization to test its
construct validity.
Results: The Cronbach's alpha was found to be 0.81 for the HADS anxiety
subscale, 0.71 for the BADS depression subscale, and 0.85 for RADS
tool. Confirmatory factor analysis (CFA) indicated two depression items
(i.e., enjoyment and anhedonia) loading onto the anxiety subscale.
Clinical caseness for anxiety was observed in 8 per cent, while 11 per
cent of the patients had borderline mood disorder. Clinical caseness
for depression was identified in 7.6 and 13 per cent of patients were
found to have borderline mood disturbances.
Interpretation & conclusion: This preliminary validation study of the
Malayalam version of the HADS showed it as an acceptable, and reliable
measure of psychological morbidity among cancer patients. The
prevalence of anxiety and depression in Indian population was low and
enjoyment and anhedonia might present as anxiety initially. |
| SN |
0971-5916 |
| PD |
NOV |
| PY |
2005 |
| VL |
122 |
| IS |
5 |
| BP |
395 |
| EP |
399 |
| UT |
ISI:000235017900007 |
| ER |
|
| PT |
J |
| AU |
Tagay, S
Herpertz, S
Langkafel, M
Erim, Y
Freudenberg, L
Schopper, N
Bockisch, A
Senf, W
Gorges, R |
| TI |
Health-related quality of life, anxiety and depression in thyroid
cancer patients under short-term hypothyroidism and TSH-suppressive
levothyroxine treatment |
| SO |
EUROPEAN JOURNAL OF ENDOCRINOLOGY |
| AB |
Objective: Very few previous studies have compared the degree of
health-related quality of life (HRQL), depression and anxiety of
differentiated thyroid cancer patients (DTC) under short-term
hypothyroidism and levothyroxine treatment.
Methods: Using patient-completed instruments, we examined the frequency
of physical complaints, HRQL, anxiety and depression in 130 DTC
patients hospitalized for radioiodine therapy or whole-body diagnostics
(age 52 years, female 71%) under short-term hypothyroidism (4 weeks of
levothyroxine withdrawal; DTC-H) and in 100 DTC out-patients under
TSH-suppressive doses of levothyroxine subsequent to radioiodine
therapy (DTC-L; age 49 years, female 81%).
Results: Compared with the German general population, DTC-H as well as
DTC-L patients had significantly impaired HRQL. Notably, the decrease
in HRQL was significantly higher in DTC-H than in DTC-L patients.
Surprisingly, the prevalence of anxiety (44.6%) but not depression
(17.7%) was much higher in the DTC-H patients than in the general
population. In contrast to expectations, similar results for anxiety
(44.0%) and depression (17.6%) were observed in the DTC-L patients.
Conclusions: This mounting evidence suggests that a consistent pattern
of HRQL impairment is experienced by patients with DTC. The high
frequency of anxiety and the significantly reduced HRQL should be
considered in the aftercare of DTC patients. |
| SN |
0804-4643 |
| PD |
DEC |
| PY |
2005 |
| VL |
153 |
| IS |
6 |
| BP |
755 |
| EP |
763 |
| UT |
ISI:000234216100005 |
| ER |
|
| PT |
J |
| AU |
Gothelf, D
Rubinstein, M
Shemesh, E
Miller, O
Farbstein, I
Klein, A
Weizman, A
Apter, A
Yaniv, I |
| TI |
Pilot study: Fluvoxamine treatment for depression and anxiety disorders
in children and adolescents with cancer |
| SO |
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY |
| AB |
Objective: To evaluate the safety, tolerability, and benefit of
fluvoxamine for the treatment of major depressive disorder or anxiety
disorders in children and adolescents with cancer. Method: The study
was conducted from 2001 to 2004 at a pediatric hematology-oncology
center. Fifteen children and adolescents with cancer were treated with
fluvoxamine 100 mg/day in an open prospective 8-week trial. Safety and
tolerability were evaluated at baseline and at weeks 4 and 8 by blood
tests and the Side Effects Checklist. Clinical benefit was assessed
with the Clinical Global ImpressionsImprovement, the Children's
Depression Rating Scale-Revised, and the Pediatric Anxiety Rating
Scale. Results: Fluvoxamine was well tolerated by all subjects.
Psychiatric symptoms improved significantly. Conclusions: In this open
trial, fluvoxamine appeared to be well tolerated and was associated
with a promising reduction in the depression and anxiety symptoms of
pediatric patients with cancer. |
| SN |
0890-8567 |
| PD |
DEC |
| PY |
2005 |
| VL |
44 |
| IS |
12 |
| BP |
1258 |
| EP |
1262 |
| UT |
ISI:000233470000007 |
| ER |
|
| PT |
J |
| AU |
Bez, Y
Topcuoglu, V
Kemal, KM
Demir, A
Turkeri, L |
| TI |
Comparison of depression, anxiety and quality of life in prostate
cancer patients with and without sexual dysfunctions |
| SO |
JOURNAL OF PSYCHOSOMATIC RESEARCH |
| SN |
0022-3999 |
| PD |
JUL |
| PY |
2005 |
| VL |
59 |
| IS |
1 |
| BP |
23 |
| EP |
24 |
| UT |
ISI:000232433800011 |
| ER |
|
| PT |
J |
| AU |
Ozkan, M
Kurt, A |
| TI |
The comparison of anxiety and depression in patients with cancer pain
and non-cancer chronic pain |
| SO |
JOURNAL OF PSYCHOSOMATIC RESEARCH |
| SN |
0022-3999 |
| PD |
JUL |
| PY |
2005 |
| VL |
59 |
| IS |
1 |
| BP |
42 |
| EP |
42 |
| UT |
ISI:000232433800084 |
| ER |
|
| PT |
J |
| AU |
Ozkan, S
Sipahi, B |
| TI |
Evaluation of anxiety, depression expressive motions of mothers with
children who has cancer from a psychosocial perspective |
| SO |
JOURNAL OF PSYCHOSOMATIC RESEARCH |
| SN |
0022-3999 |
| PD |
JUL |
| PY |
2005 |
| VL |
59 |
| IS |
1 |
| BP |
43 |
| EP |
43 |
| UT |
ISI:000232433800086 |
| ER |
|
| PT |
J |
| AU |
Monti, DA
Mago, R
Kunkel, EJS |
| TI |
Depression, cognition, and anxiety among postmenopausal women with
breast cancer |
| SO |
PSYCHIATRIC SERVICES |
| SN |
1075-2730 |
| PD |
NOV |
| PY |
2005 |
| VL |
56 |
| IS |
11 |
| BP |
1353 |
| EP |
1355 |
| UT |
ISI:000233118200004 |
| ER |
|
| PT |
J |
| AU |
Asanami, C
Tei, K
Totsuka, Y
Katakura, A
Shibahara, T
Ueda, M
Yamashita, T
Nagai, I
Hiratsuka, H
Sakano, Y |
| TI |
Psychological impact of disfigurement on depression and anxiety in
patients with head and neck cancer |
| SO |
JOURNAL OF PSYCHOSOMATIC RESEARCH |
| SN |
0022-3999 |
| PD |
JUN |
| PY |
2005 |
| VL |
58 |
| IS |
6 |
| SU |
Suppl. S |
| BP |
S49 |
| EP |
S49 |
| UT |
ISI:000232375200221 |
| ER |
|
| PT |
J |
| AU |
Vernejoux, J
Grandon, L
Izadifar, A
Decouvelaere, A
Josse, M
Prevot, S
Taytard, A |
| TI |
Quality of life and anxiety-depression in lung cancer patients:
Preliminary results of a French multi-professional interview for
diagnosis disclosure (MIDD) |
| SO |
LUNG CANCER |
| SN |
0169-5002 |
| PD |
JUL |
| PY |
2005 |
| VL |
49 |
| SU |
Suppl. 2 |
| BP |
S343 |
| EP |
S344 |
| UT |
ISI:000231307802330 |
| ER |
|
| PT |
J |
| AU |
Skarstein, J
Bjelland, I
Dahl, AA
Laading, J
Fossa, SD |
| TI |
Is there an association between haemoglobin, depression, and anxiety in
cancer patients? |
| SO |
JOURNAL OF PSYCHOSOMATIC RESEARCH |
| AB |
Objective: The aim of this study was to examine the association between
haemoglobin levels, anxiety disorder, and depression in cancer
patients. Methods: Cancer patients attending The Norwegian Radium
Hospital (NRH) rated themselves on the Hospital Anxiety and Depression
Scale (HADS). Five hundred thirty-two patients also had valid
measurements of haemoglobin at the same time. The associations between
tertile baemoglobin levels (7.0-12.3 g/dl, 12.4-13.8 g/dl, 13.9-17.1
g/dl) and HADS-defined anxiety disorder and depression were analysed by
logistic regression. Results: HADS-defined depression was identified in
116 cases (22%) and anxiety disorder in 149 (28%). The haemoglobin
levels of the lower and middle tertiles were associated with depression
(OR=3.85, 95% CI: 2.06-7.21, and OR=2.45, 95% CI: 1.25-4.81,
respectively). Adjustment for covariates did not change the association
significantly. No association between haemoglobin and anxiety disorder
was found. Conclusion: In cancer patients, the risk of depression
increases with decreasing haemoglobin levels. This should be taken into
account when treatment of anaemic or depressed cancer patients is
decided upon. (c) 2005 Elsevier Inc. All rights reserved. |
| SN |
0022-3999 |
| PD |
JUN |
| PY |
2005 |
| VL |
58 |
| IS |
6 |
| BP |
477 |
| EP |
483 |
| UT |
ISI:000232258500002 |
| ER |
|
| PT |
J |
| AU |
Matsushita, T
Matsushima, E
Maruyama, M |
| TI |
Anxiety and depression of patients with digestive cancer |
| SO |
PSYCHIATRY AND CLINICAL NEUROSCIENCES |
| AB |
This study sought to characterize the psychological status of digestive
cancer patients, and to investigate the relationship between
psychological characteristics and clinical factors. Subjects were 85
inpatients scheduled to undergo surgery for digestive cancer and 26
control patients. The Japanese versions of Hospital Anxiety and
Depression Scale (HADS) and Zung's Self Rating Depression Scale (SDS)
were administered for all subjects before surgery, before discharge,
and 6 months after discharge. Changes in HADS and SDS scores across the
three examination days for three groups of subjects (advanced-phase,
early phase, and control groups) were compared. The mean scores of
anxiety and depression were significantly higher in the advanced-phase
group than in the other two groups. Examination day showed a
significant effect on depression; depression increased from before
surgery to before discharge, and did not return to the preoperative
level at 6 months after discharge, but no significant effect on
anxiety. As for the relationship between psychological trends and
clinical factors, anxiety in the 'middle age' and 'chemotherapy' groups
was more severe than in the 'elderly' and 'no chemotherapy' groups.
Depression in the 'medical treatment equipment', 'chemotherapy', and
'long-term hospitalization' groups was more severe than in the 'no
equipment', 'no chemotherapy', and 'standard-term hospitalization'
groups. These results suggest that we should pay careful attention to
cancer patients undergoing surgery, especially young patients who are
constantly at risk of anxiety, and assess their depression taking into
account their disease and treatment conditions, especially after the
time when their discharge is determined. |
| SN |
1323-1316 |
| PD |
OCT |
| PY |
2005 |
| VL |
59 |
| IS |
5 |
| BP |
576 |
| EP |
583 |
| UT |
ISI:000232230900011 |
| ER |
|
| PT |
J |
| AU |
Boscaglia, N
Clarke, DM
Jobling, TW
Quinn, MA |
| TI |
The contribution of spirituality and spiritual coping to anxiety and
depression in women with a recent diagnosis of gynecological cancer |
| SO |
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| AB |
The objective of this study was to determine whether, after accounting
for illness and demographic variables, spiritual involvement and
beliefs and positive and negative spiritual coping could account for
any of the variation in anxiety and depression among women within 1
year's diagnosis of gynecological cancer (GC). One hundred patients
from outpatient GC clinics at two Melbourne-based hospitals completed a
brief structured interview and self-report measures of anxiety,
depression, spirituality, and spiritual coping. Using two sequential
regression analyses, we found that younger women with more advanced
disease, who used more negative spiritual coping, had a greater
tendency towards depression and that the use of negative spiritual
coping was associated with greater anxiety scores. Although not
statistically significant, patients with lower levels of generalized
spirituality also tended to be more depressed. The site of disease and
phase of treatment were not predictive of either anxiety or depression.
We conclude that spirituality and spiritual coping are important to
women with GC and that health professionals in the area should consider
these issues. |
| SN |
1048-891X |
| PD |
SEP-OCT |
| PY |
2005 |
| VL |
15 |
| IS |
5 |
| BP |
755 |
| EP |
761 |
| UT |
ISI:000231798800007 |
| ER |
|
| PT |
J |
| AU |
Mystakidou, K
Tsilika, E
Parpa, E
Katsouda, E
Galanos, A
Vlahos, L |
| TI |
Assessment of anxiety and depression in advanced cancer patients and
their relationship with quality of life |
| SO |
QUALITY OF LIFE RESEARCH |
| AB |
The growing interest in the mental health and quality of life of cancer
patients, has been the major reason for conducting this study. The aims
were to compare advanced cancer patients' responses to Hospital Anxiety
and Depression (HAD) scale with those to European Organization for
Research and Treatment of Cancer Quality of Life Questionnaire (EORTC
QLQ-C30, version 3.0), as well as the impact of quality of life
dimensions (as measured by EORTC QLQ-C30) on the levels of anxiety and
depression. The analysis, conducted in 120 advanced cancer patients,
showed that the most significant associations were found between
emotional functioning and HAD-T (total sum of scores) (r=-0.747; p <
0.0005), HAD-A (anxiety) (r=-0.725; p < 0.0005) and HAD-D (depression)
(r=-0.553; p < 0.0005). In the prediction of HAD-T, the contribution of
physical, emotional, role, and social functioning along with
nausea-vomiting, dyspnea, sleep disturbance and gender is high. For
anxiety, the predictor variables were physical, role, cognitive,
emotional, and social functioning, followed by dyspnea, sleep
disturbance, and appetite loss, while depression was predicted by
physical, role, emotional, and social functioning, the symptoms of
nausea-vomiting, pain, sleep disturbance, constipation, as well as the
variables of age, gender, anticancer treatment and performance status.
Concluding, psychological morbidity, in this patient population, was
predominantly predicted by the emotional functioning dimension of EORTC
QLQ-C30. |
| SN |
0962-9343 |
| PD |
OCT |
| PY |
2005 |
| VL |
14 |
| IS |
8 |
| BP |
1825 |
| EP |
1833 |
| UT |
ISI:000231807200004 |
| ER |
|
| PT |
J |
| AU |
Jehn, CF
Kuhnhardt, DM
Possinger, K
Flath, B |
| TI |
Plasma IL-6 and HPA-axis function in depression and anxiety in patients
with cancer. |
| SO |
JOURNAL OF CLINICAL ONCOLOGY |
| SN |
0732-183X |
| PD |
JUN 1 |
| PY |
2005 |
| VL |
23 |
| IS |
16 |
| PN |
Part 1 Suppl. S |
| BP |
737S |
| EP |
737S |
| UT |
ISI:000230326604577 |
| ER |
|
| PT |
J |
| AU |
Vora, A
Parikh, PM
Shanthi, N
Pai, VR
Prasad, N
Goswami, S
Shah, S |
| TI |
Role of Hospital Anxiety & Depression scale in reducing need of a
formal psychiatric referral in cancer patients. |
| SO |
JOURNAL OF CLINICAL ONCOLOGY |
| SN |
0732-183X |
| PD |
JUN 1 |
| PY |
2005 |
| VL |
23 |
| IS |
16 |
| PN |
Part 1 Suppl. S |
| BP |
738S |
| EP |
738S |
| UT |
ISI:000230326604581 |
| ER |
|
| PT |
J |
| AU |
Mertens, WC
Katz, D
Quinlan, M
Hoffman, D
Carr, C
Makari-Judson, G |
| TI |
Are oncologists effective in modifying patient-perceived breast cancer
risk and associated anxiety? |
| SO |
JOURNAL OF CLINICAL ONCOLOGY |
| SN |
0732-183X |
| PD |
JUN 1 |
| PY |
2005 |
| VL |
23 |
| IS |
16 |
| PN |
Part 1 Suppl. S |
| BP |
768S |
| EP |
768S |
| UT |
ISI:000230326605120 |
| ER |
|
| PT |
J |
| AU |
Smith, F
Kandahari, M
Tomita, D
Green, J
Dansey, R
Crawford, J |
| TI |
Neutropenia and anxiety in advanced non-small cell lung cancer (NSCLC)
patients: initial report of a randomized controlled trial using
pegfilgrastim to reduce neutropenia complications. |
| SO |
JOURNAL OF CLINICAL ONCOLOGY |
| SN |
0732-183X |
| PD |
JUN 1 |
| PY |
2005 |
| VL |
23 |
| IS |
16 |
| PN |
Part 1 Suppl. S |
| BP |
772S |
| EP |
772S |
| UT |
ISI:000230326605133 |
| ER |
|
| PT |
J |
| AU |
Bylow, KA
Dale, W
Gupta, S
Lacy, M
Rodin, M |
| TI |
Anxiety changes following initiation of treatment in older breast
cancer (BrCa) patients. |
| SO |
JOURNAL OF CLINICAL ONCOLOGY |
| SN |
0732-183X |
| PD |
JUN 1 |
| PY |
2005 |
| VL |
23 |
| IS |
16 |
| PN |
Part 1 Suppl. S |
| BP |
793S |
| EP |
793S |
| UT |
ISI:000230326605220 |
| ER |
|
| PT |
J |
| AU |
Williams, SA
Schreier, AM |
| TI |
The role of education in managing fatigue, anxiety, and sleep disorders
in women undergoing chemotherapy for breast cancer |
| SO |
APPLIED NURSING RESEARCH |
| AB |
This study examined the effect of informational audiotapes on patients'
self-care behaviors (SCBs) to manage chemotherapy side effects of
fatigue, anxiety, and sleep disturbance. Seventy-one women with breast
cancer participated. Thirty-three received audiotapes on SCBs to manage
side effects. Three telephone interviews were conducted. Overall, women
who received education demonstrated more SCBs, a wider range of SCBs,
increased use of SCBs over time, and less anxiety. Nursing time for
education in busy clinics is minimal. Patient anxiety in the clinic
environment interferes with learning. Audiotapes are an effective tool
for use at home, providing for teaching and reinforcement of patient
education. (c) 2005 Elsevier Inc. All rights reserved. |
| SN |
0897-1897 |
| PD |
AUG |
| PY |
2005 |
| VL |
18 |
| IS |
3 |
| BP |
138 |
| EP |
147 |
| UT |
ISI:000231165900003 |
| ER |
|
| PT |
J |
| AU |
Thamm, R
Geinitz, H
Zimmermann, F
Scholz, C
Winkler, C
Prause, N
Keller, M
Busch, R
Molls, M |
| TI |
Longitudinal evaluation of fatigue, anxiety and depression in conformal
radiation therapy (CRT) of prostate cancer |
| SO |
STRAHLENTHERAPIE UND ONKOLOGIE |
| SN |
0179-7158 |
| PD |
MAY |
| PY |
2005 |
| VL |
181 |
| SU |
Suppl. 1 |
| BP |
73 |
| EP |
74 |
| UT |
ISI:000229590600263 |
| ER |
|
| PT |
J |
| AU |
Pieterse, AH
Ausems, MGEM
Van Dulmen, AM
Beemer, FA
Bensing, JM |
| TI |
Initial cancer genetic counseling consultation: Change in counselees'
cognitions and anxiety, and association with addressing their needs and
preferences |
| SO |
AMERICAN JOURNAL OF MEDICAL GENETICS PART A |
| AB |
The fulfillment of counselees' expectations in cancer genetic
counseling and how this affects the outcome of counseling have received
little attention so far. This study investigates how the initial
consultation influences counselees' cognitions and anxiety, whether
counselors address counselees' prior needs and preferences during the
visit, and whether addressing needs is associated with a more positive
outcome of the visit. One hundred twenty-eight affected and unaffected
counselees from families with no known mutation, who were seen by one
of fourteen counselors, participated. Pre- and post-visit
questionnaires assessed correct knowledge about hereditary breast or
colon cancer, perceived personal control (PPC), anxiety (STAI), risk
perceptions, and (fulfillment of) needs (QUOTE-gene(ca)). Results
demonstrated a pre- to post-visit significant increase in correct
knowledge and PPC, and a significant decrease in STAI and risk
perceptions. However, marked overestimation of risks persisted.
Decrease in STAI and risk perceptions was significantly less pronounced
in affected versus unaffected counselees. The majority of counselees
were (very) satisfied about the extent to which their needs were
addressed, albeit about one-fifth were not regarding emotional matters
and explanations about their own cancer risk. Finally, the better
counselees perceived their needs to be fulfilled, the significantly
higher their PPC and the significantly lower their STAi scores were.
Findings suggest that both unaffected and affected counselees should be
counseled carefully. Also, a more effective service may be attained if
counselors pay more attention to counselees' emotional needs and detail
more inheritance and penetrance of mutated genes in relation to
counselees' family history. (c) 2005 Wiley-Liss, Inc. |
| SN |
1552-4825 |
| PD |
AUG 15 |
| PY |
2005 |
| VL |
137A |
| IS |
1 |
| BP |
27 |
| EP |
35 |
| UT |
ISI:000231009900005 |
| ER |
|
| PT |
J |
| AU |
Thorsen, L
Nystad, W
Stigum, H
Dahl, O
Klepp, O
Bremnes, RM
Wist, E
Fossa, SD |
| TI |
The association between self-reported physical activity and prevalence
of depression and anxiety disorder in long-term survivors of testicular
cancer and men in a general population sample |
| SO |
SUPPORTIVE CARE IN CANCER |
| AB |
Goals of work: Physical activity is claimed to have a beneficial
influence on a person's mental health, though its impact may be
different in cancer patients and individuals in the general population.
The objective of this cross-sectional study was (1) to estimate the
associations between the level of self-reported physical activity as a
lifestyle factor (LPA) and the prevalence of depression and anxiety
disorder in testicular cancer survivors (TCSs) and in men of similar
age from the general population (GenPop), and (2) to examine whether
these associations differ in the two groups. Patients and method: A
total of 1260 TCSs and 20,207 men from the GenPop completed a
questionnaire that assessed LPA, and depression and anxiety disorder on
the Hospital Anxiety and Depression Scale (HADS). Main results: The
prevalence of HADS-defined depression was lower among those who were
physically active than in those who were physically inactive (TCSs 9%
vs 17%, P < 0.001; GenPop 8% vs 15%, P < 0.001). Among physically
inactive TCSs there was a trend towards higher a prevalence of
HADS-defined anxiety disorder compared to physically active TCSs
(P=0.07). In the GenPop this difference was statistically significant
(P < 0.001). Multivariate analysis confirmed the association between
LPA and HADS-defined depression in both the TCSs [adjusted odds ratio
(aOR)=0.56; 95% confidence interval (CI) (0.31, 1.02)] and the GenPop
[aOR=0.58; 95% CI (0.51, 0.65)], but not the association between LPA
and HADS-defined anxiety disorder. The associations between LPA and
HADS-defined depression and HADS-defined anxiety disorder did not
differ between the TCSs and the GenPop. Conclusion: In both the TCSs
and the GenPop, the prevalence of HADS-defined depression was higher
among those who were physically inactive than among those who were
physically active, with no intergroup difference. There was no
association between LPA and prevalence of HADS-defined anxiety disorder
in either of the groups after adjusting for background variables.
Prospective studies are needed to allow causal inferences to be drawn. |
| SN |
0941-4355 |
| PD |
AUG |
| PY |
2005 |
| VL |
13 |
| IS |
8 |
| BP |
637 |
| EP |
646 |
| UT |
ISI:000230717900008 |
| ER |
|
| PT |
J |
| AU |
Merrill, R
Brown, J
Byrd, A
Alder, S
Baker, R
White, G
Lyon, J |
| TI |
Risk of anxiety and depressive disorders in children and the parents of
children undergoing cancer workup or treatment. |
| SO |
AMERICAN JOURNAL OF EPIDEMIOLOGY |
| SN |
0002-9262 |
| PD |
JUN 1 |
| PY |
2005 |
| VL |
161 |
| IS |
11 |
| SU |
Suppl. S |
| BP |
S121 |
| EP |
S121 |
| UT |
ISI:000229594100480 |
| ER |
|
| PT |
J |
| AU |
Grov, EK
Dahl, AA
Moum, T
Fossa, SD |
| TI |
Anxiety, depression, and quality of life in caregivers of patients with
cancer in late palliative phase |
| SO |
ANNALS OF ONCOLOGY |
| AB |
Background: Limited research has been done on mental health and
health-related quality of life (QOL) of primary caregivers (PCs) to
patients staying at home with advanced cancer. This study examines
anxiety, depression, and QOL in PCs of patients with cancer in the late
palliative phase.
Patients and methods: The sample consisted of 49 PCs of women with
breast cancer and 47 PCs of men with prostate cancer. QOL was rated
with the Medical Outcome Study Short Form (SF-36), and mental health
with the Hospital Anxiety and Depression Scale (HADS). The findings
were compared with age-adjusted norm data (norm).
Results: Physical QOL was significantly higher than norm in both
genders, while mental QOL was significantly lower in male PCs. The
level of anxiety was significantly higher than norm in both genders. No
significant difference for level of depression was found in either
gender, while caseness of HADS-defined depression was significantly
more prevalent in female PCs compared with norm.
Conclusion: PCs of both genders had significantly more anxiety than
norm samples. Health care personnel in contact with PCs should consider
screening them for mental symptoms and QOL and, if necessary, recommend
further evaluation by their doctors. |
| SN |
0923-7534 |
| PD |
JUL |
| PY |
2005 |
| VL |
16 |
| IS |
7 |
| BP |
1185 |
| EP |
1191 |
| UT |
ISI:000230367500023 |
| ER |
|
| PT |
J |
| AU |
Aarstad, HJ
Aarstad, AKH
Heimdal, JH
Olofsson, J |
| TI |
Mood, anxiety and sense of humor in head and neck cancer patients in
relation to disease stage, prognosis and quality of life |
| SO |
ACTA OTO-LARYNGOLOGICA |
| AB |
Conclusion. At diagnosis, control patients had the lowest depression
levels and anxiety scores, followed by those with limited HNSCC disease
and these with extended HNSCC disease. Anxiety and depression levels at
diagnosis predicted prognosis via an association with extent of
disease. Sense of humor, but not anxiety or depression level, predicted
lower QoL and depression levels at follow-up. Objective. To study the
association between anxiety score, depression level at sense of humor
at diagnosis in head and neck squamous cell carcinoma ( HNSCC) patients
versus TNM stage, prognosis and depression level/quality of life (QOL)
6 years following diagnosis. A control group of patients with benign HN
disease was also included. Material and methods. Male patients with
newly diagnosed HNSCC ( n = 78) or benign HN ( n = 61) disease
completed the following questionnaires: the Beck Depression Inventory,
the Spielberger Trait Anxiety Inventory ( state) and the Svebak humor
questionnaire. Patients with cachexia or those aged > 80 years were
excluded. In the HNSCC patients, TNM stage, prognosis and
QOL/depression level ( n = 27) were determined following successful
therapy. Results. HNSCC patients reported high anxiety scores and lower
depression levels than control patients, although there was overlap
between the groups. N stage was associated with high anxiety scores and
depression levels, whereas T stage was only associated with depression
levels. Both anxiety scores and depression levels at diagnosis
predicted prognosis through an association with TNM stage. Sense of
humor, but not depression levels or anxiety scores, at diagnosis
predicted QoL and depression levels at follow-up. |
| SN |
0001-6489 |
| PD |
MAY |
| PY |
2005 |
| VL |
125 |
| IS |
5 |
| BP |
557 |
| EP |
565 |
| UT |
ISI:000228799700020 |
| ER |
|
| PT |
J |
| AU |
Rispoli, A
Pavone, I
Bongini, A
Di Loro, F
Ponchietti, R
Rizzo, M |
| TI |
Genitourinary cancer: Psychological assessment and gender differences -
Anxiety and depression status among genitourinary cancer patients |
| SO |
UROLOGIA INTERNATIONALIS |
| AB |
Introduction: The study of the psychological impact in patients
diagnosed with cancer is an important topic. Cancer diagnosis can
induce feelings of anxiety, depression, fear of recurrence and produce
treatment side effects. Men and women tend to differ in their way of
dealing with emotional distress and physical illness. The aim of this
study is to investigate and evaluate the prevalence and detection of
psychological disease in patients with genitourinary tumors and outline
the eventual gender differences. Materials and Methods: State-Trait
Anxiety Inventory, Self-Rating Depression Scale and Illness Behavior
Questionnaire were administered to 60 patients with genitourinary
neoplasm. Results: Most patients show symptoms of depression and
anxiety during the hospitalization. We have observed a significant
gender differences in the psycho-emotional assessment. Conclusion: Our
study confirms the importance to make available for the patients a
proper and continuous support in pre- and postsurgery period to prevent
the generation of psychological disorders. Copyright (C) 2005 S. Karger
AG, Basel. |
| SN |
0042-1138 |
| PY |
2005 |
| VL |
74 |
| IS |
3 |
| BP |
246 |
| EP |
249 |
| UT |
ISI:000228254700011 |
| ER |
|
| PT |
J |
| AU |
Grabowski, M
Hawkins, J
Mortimer, J
Ahmad, F
Naughton, M |
| TI |
Perceptions of anxiety and pain in cancer patients undergoing bone
marrow biopsy. |
| SO |
ONCOLOGY NURSING FORUM |
| SN |
0190-535X |
| PD |
MAR |
| PY |
2004 |
| VL |
31 |
| IS |
2 |
| BP |
420 |
| EP |
420 |
| UT |
ISI:000225438400161 |
| ER |
|
| PT |
J |
| AU |
Dahl, AA
Haaland, CF
Mykletun, A
Bremnes, R
Dahl, C
Klepp, O
Wist, E
Fossa, SD |
| TI |
Study of anxiety disorder and depression in long-term survivors of
testicular cancer |
| SO |
JOURNAL OF CLINICAL ONCOLOGY |
| AB |
Purpose To increase our knowledge of the prevalence of anxiety disorder
and depression in long-term testicular cancer survivors (TCSs), and to
identify variables associated with such caseness.
Patients and Methods Participants were 1,408 TCSs treated between 1980
and 1994 in Norway. Participants provided information about their
medical, social, and familial situation on a questionnaire. They also
completed the Hospital Anxiety and Depression Scale (HADS). Anxiety
disorder and depression were defined by a score >= 8 on the HADS
subscales. The prevalence rates were compared with age-adjusted norm
data.
Results HADS-defined anxiety disorder was more prevalent in TCSs
(19.2%; 95% Cl, 17.2% to 21.3%)than in the norm sample (13.5%; 95% Cl,
13.1% to 13.9%; P <.001), whereas the prevalence of HADS-defined
depression did not differ from the norm (TCSs, 9.7%; 95% Cl, 8.1 % to
11.2% v norm, 10.1 %, 95% Cl, 9.5 to 10.5; P =.56). The relative risk
for anxiety disorder was 1.49 (95% Cl, 1.31 to 1.69) and for depression
the relative risk was 0.96 (95% Cl, 0.81 to1.14) in TCSs compared with
norm. In multivariate analyses, HADS-defined anxiety disorder in TCSs
was associated with young age, peripheral neuropathy, economic
problems, alcohol problems, sexual problems, relapse anxiety, and
having been treated for mental problems.
Conclusion Long-term TCSs have an increased risk of HADS-defined
anxiety disorder that warrants clinical attention. Checking easily
available demographic and TC-related data and use of a simple screening
test such as HADS assists the identification of TCSs with anxiety
disorder. |
| SN |
0732-183X |
| PD |
APR 1 |
| PY |
2005 |
| VL |
23 |
| IS |
10 |
| BP |
2389 |
| EP |
2395 |
| UT |
ISI:000228260200034 |
| ER |
|
| PT |
J |
| AU |
Leon, C
Lacorte-Pi, T
Casas, F
Guix-Melcior, B
Alfaro, J
Broome, B |
| TI |
Anxiety, depression and quality of life in men with prostate cancer |
| SO |
RADIOTHERAPY AND ONCOLOGY |
| SN |
0167-8140 |
| PD |
OCT |
| PY |
2004 |
| VL |
73 |
| SU |
Suppl. 1 |
| BP |
S387 |
| EP |
S387 |
| UT |
ISI:000226237701418 |
| ER |
|
| PT |
J |
| AU |
Roth, AJ
Nelson, CJ
Rosenfeld, B
Warshowski, A
O'Shea, N
Scher, HI
Breitbart, W
Holland, JC
Curley-Smart, T
Reynolds, T |
| TI |
The revised Memorial Anxiety Scale for Prostate Cancer (MAX-PC-R):
Validation of a scale to measure anxiety in men with prostate cancer |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
JAN |
| PY |
2005 |
| VL |
14 |
| IS |
1 |
| SU |
Suppl. S |
| BP |
S8 |
| EP |
S8 |
| UT |
ISI:000227182400013 |
| ER |
|
| PT |
J |
| AU |
Haman, KL
Compas, BE
Murphy, BM |
| TI |
Social anxiety in head and neck cancer patients |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
JAN |
| PY |
2005 |
| VL |
14 |
| IS |
1 |
| SU |
Suppl. S |
| BP |
S47 |
| EP |
S47 |
| UT |
ISI:000227182400087 |
| ER |
|
| PT |
J |
| AU |
Burgess, C
Cornelius, V
Love, S
Graham, J
Richards, M
Ramirez, A |
| TI |
Depression and anxiety in women with early breast cancer: five year
observational cohort study |
| SO |
BRITISH MEDICAL JOURNAL |
| AB |
Objective To examine the prevalence of, and risk factors for,
depression and anxiety in women with early breast cancer in the five
years after diagnosis.
Design Observational cohort study.
Setting NHS breast clinic, London.
Participants 222 women with early breast cancer: 170 (77%) provided
complete interview data up to either five years after diagnosis or
recurrence.
Main outcome measures Prevalence of clinically important depression and
anxiety (structured psychiatric interview with standardised diagnostic
criteria) and clinical and patient risk factors, including stressful
life experiences (Bedford College life events and difficulties
schedule).
Results Nearly 50% of the women with early breast cancer had
depression, anxiety, or both in the year after diagnosis, 25% in the
second, third, and fourth years, and 15% in the fifth year. Point
prevalence was 33% at diagnosis, falling to 15% after one year. 45% of
those with recurrence experienced depression, anxiety, or both within
three months of the diagnosis. Previous psychological treatment
predicted depression, anxiety, or both in the period around diagnosis
(one month before diagnosis to four months after diagnosis). Longer
term depression and anxiety were associated with previous psychological
treatment, lack of an intimate confiding relationship, younger age, and
severely stressful non-cancer life experiences. Clinical factors were
not associated with depression and anxiety at any time. Lack of
intimate confiding support also predicted more protracted episodes of
depression and anxiety.
Conclusion Increased levels of depression and anxiety in the first year
after a diagnosis of early breast cancer highlight the need for
dedicated service provision during this time. Psychological
interventions for women with breast cancer who remain disease free
should take account of the broader social context in which the cancer
occurs, with a focus on improving social support. |
| SN |
0959-535X |
| PD |
MAR 26 |
| PY |
2005 |
| VL |
330 |
| IS |
7493 |
| BP |
702 |
| EP |
705 |
| UT |
ISI:000228071900016 |
| ER |
|
| PT |
J |
| AU |
Cho, IH
Bang, YW
Bang, SM
Park, SH |
| TI |
Anxiety, depression and quality of life in patients with solid cancer
during the palliative chemotherapy |
| SO |
EUROPEAN NEUROPSYCHOPHARMACOLOGY |
| SN |
0924-977X |
| PD |
OCT |
| PY |
2004 |
| VL |
14 |
| SU |
Suppl. 3 |
| BP |
S377 |
| EP |
S378 |
| UT |
ISI:000225460400556 |
| ER |
|
| PT |
J |
| AU |
Roth, AJ
Nelson, C
Rosenfeld, B
Warshowsky, A
O'Shea, N
Reynolds, T
Slovin, S
Holland, JC
Scher, H
Curley-Smart, T
Breitbart, WS |
| TI |
The Revised Memorial Anxiety Scale for Prostate Cancer (MAX-PC-R):
Validation of a scale to measure anxiety in men with prostate cancer |
| SO |
PSYCHOSOMATICS |
| SN |
0033-3182 |
| PD |
MAR-APR |
| PY |
2005 |
| VL |
46 |
| IS |
2 |
| BP |
167 |
| EP |
167 |
| UT |
ISI:000227459500036 |
| ER |
|
| PT |
J |
| AU |
Wilson, K
Chochinov, HM
Graham, M
Allard, P
Chary, S
De Luca, M
Gagnon, P |
| TI |
Depression and anxiety disorders in palliative cancer care |
| SO |
JOURNAL OF PALLIATIVE CARE |
| SN |
0825-8597 |
| PD |
FAL |
| PY |
2004 |
| VL |
20 |
| IS |
3 |
| BP |
260 |
| EP |
260 |
| UT |
ISI:000224182900228 |
| ER |
|
| PT |
J |
| AU |
Thamm, R
Geinitz, H
Zimmermann, F
Scholz, C
Winkler, C
Prause, N
Keller, M
Busch, R
Molls, M |
| TI |
Longitudinal evaluation of fatigue, anxiety and depression in patients
with conformal radiation therapy (CRT) for prostate cancer |
| SO |
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
| SN |
0360-3016 |
| PY |
2004 |
| VL |
60 |
| IS |
1 |
| SU |
Suppl. S |
| BP |
S569 |
| EP |
S570 |
| UT |
ISI:000223854700734 |
| ER |
|
| PT |
J |
| AU |
Mantani, T
Saeki, T
Ozono, S
Yamawaki, S
Okamura, H |
| TI |
Factors related to anxiety in women with breast cancer and their
husbands: Relationship between anxiety and alexithymia |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
AUG |
| PY |
2004 |
| VL |
13 |
| IS |
8 |
| SU |
Suppl. S |
| BP |
S61 |
| EP |
S61 |
| UT |
ISI:000223957800130 |
| ER |
|
| PT |
J |
| AU |
Mehnert, A |
| TI |
Prevalence of post-traumatic stress disorder, anxiety and depression in
a representative sample of breast cancer patients |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
AUG |
| PY |
2004 |
| VL |
13 |
| IS |
8 |
| SU |
Suppl. S |
| BP |
S62 |
| EP |
S62 |
| UT |
ISI:000223957800131 |
| ER |
|
| PT |
J |
| AU |
Sadeh-Tassa, D
Yagil, Y
Stadler, J |
| TI |
A comparison between first occurrence and recurrence of breast cancer:
Anxiety, depression, PTSD |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
AUG |
| PY |
2004 |
| VL |
13 |
| IS |
8 |
| SU |
Suppl. S |
| BP |
S66 |
| EP |
S67 |
| UT |
ISI:000223957800141 |
| ER |
|
| PT |
J |
| AU |
Waltz, P
Gex-Fabry, M
Murphy, MA
Hoesli, P
Chappuis, P |
| TI |
Psychosocial issues in predictive oncology: Evaluation of anxiety pre-,
per- and post-genetic counseling and testing for familial breast and
colorectal cancer |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
AUG |
| PY |
2004 |
| VL |
13 |
| IS |
8 |
| SU |
Suppl. S |
| BP |
S83 |
| EP |
S83 |
| UT |
ISI:000223957800175 |
| ER |
|
| PT |
J |
| AU |
Leon, C
Rovirosa, A
Casas, F
Farras, B
Gic, I |
| TI |
Evaluation of depression and anxiety among gynecologic cancer patients.
A clinical controlled trial |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
AUG |
| PY |
2004 |
| VL |
13 |
| IS |
8 |
| SU |
Suppl. S |
| BP |
S144 |
| EP |
S144 |
| UT |
ISI:000223957800312 |
| ER |
|
| PT |
J |
| AU |
Sherman, LK
Khalsa, D |
| TI |
Quetiapine for acute anxiety in cancer inpatients |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
AUG |
| PY |
2004 |
| VL |
13 |
| IS |
8 |
| SU |
Suppl. S |
| BP |
S153 |
| EP |
S154 |
| UT |
ISI:000223957800334 |
| ER |
|
| PT |
J |
| AU |
Bulotiene, G
Veseliunas, J |
| TI |
Women with breast cancer: The relationship of anxiety, depression, age,
stage of cancer and cancer treatment to the quality of life |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
AUG |
| PY |
2004 |
| VL |
13 |
| IS |
8 |
| SU |
Suppl. S |
| BP |
S157 |
| EP |
S157 |
| UT |
ISI:000223957800341 |
| ER |
|
| PT |
J |
| AU |
Wagner, LI
Rosenbloom, S
Purpura-Kilroy, L
Davis, K
Cella, D |
| TI |
Utilizing technology to deliver a patient and provider intervention for
the management of cancer-related fatigue, pain, anxiety, and
depression: Development of a web-based symptom management program |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
AUG |
| PY |
2004 |
| VL |
13 |
| IS |
8 |
| SU |
Suppl. S |
| BP |
S174 |
| EP |
S174 |
| UT |
ISI:000223957800379 |
| ER |
|
| PT |
J |
| AU |
Grov, EK
Fossa, S
Moum, T
Dahl, AA |
| TI |
Anxiety, depression and quality of life in caregivers of patients with
metastatic cancer |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
AUG |
| PY |
2004 |
| VL |
13 |
| IS |
8 |
| SU |
Suppl. S |
| BP |
S190 |
| EP |
S190 |
| UT |
ISI:000223957800414 |
| ER |
|
| PT |
J |
| AU |
Strasser, F
Degracia, B
Palmer, JL
Willey, J
Chang, HM
Bruera, E |
| TI |
Hypogonadism in patients with advanced cancer: Impact on fatigue,
anxiety and depression, hemoglobin, and sexual desire |
| SO |
JOURNAL OF CLINICAL ONCOLOGY |
| SN |
0732-183X |
| PD |
JUL 15 |
| PY |
2004 |
| VL |
22 |
| IS |
14 |
| SU |
Suppl. S |
| BP |
756S |
| EP |
756S |
| UT |
ISI:000223512403001 |
| ER |
|
| PT |
J |
| AU |
Caminiti, C
Campione, F
Sivelli, C
Diodati, F
Passalacqua, R |
| CA |
GICO Grp Study Information |
| TI |
Prevalence, predictors and risk factors of anxiety and depression in
cancer patients. A nation-wide survey. |
| SO |
JOURNAL OF CLINICAL ONCOLOGY |
| SN |
0732-183X |
| PD |
JUL 15 |
| PY |
2004 |
| VL |
22 |
| IS |
14 |
| SU |
Suppl. S |
| BP |
759S |
| EP |
759S |
| UT |
ISI:000223512403010 |
| ER |
|
| PT |
J |
| AU |
Pishniak, L
Ashkenazi, A
Sadeh-Tassa, D
Yagil, Y
Figer, A |
| TI |
Depression, anxiety and world assumptions amongst cancer patients |
| SO |
JOURNAL OF CLINICAL ONCOLOGY |
| SN |
0732-183X |
| PD |
JUL 15 |
| PY |
2004 |
| VL |
22 |
| IS |
14 |
| SU |
Suppl. S |
| BP |
778S |
| EP |
778S |
| UT |
ISI:000223512403086 |
| ER |
|
| PT |
J |
| AU |
Jeffe, DB
Naughton, MJ
Weilbaecher, KN
Ali, MA
Aft, RL |
| TI |
Quality of life, depressed mood, and anxiety in women presenting with
locally advanced breast cancer |
| SO |
JOURNAL OF CLINICAL ONCOLOGY |
| SN |
0732-183X |
| PD |
JUL 15 |
| PY |
2004 |
| VL |
22 |
| IS |
14 |
| SU |
Suppl. S |
| BP |
791S |
| EP |
791S |
| UT |
ISI:000223512403138 |
| ER |
|
| PT |
J |
| AU |
Mystakidou, K
Tsilika, E
Parpa, E
Katsouda, E
Galanos, A
Vlahos, L |
| TI |
The hospital anxiety and depression scale in Greek cancer patients:
psychometric analyses and applicability |
| SO |
SUPPORTIVE CARE IN CANCER |
| AB |
Goals of work: The aim of the present study was to validate the Greek
version of the Hospital Anxiety and Depression Scale (HAD) in a
palliative care unit. Patients and methods: The scale was translated
with the "forward-backward" procedure to Greek. It was administered
twice, with a 1-week interval, to 120 patients with advanced cancer.
Together with the HAD scale, the patients also completed the
Spielberger State-Anxiety Scale (STAI-S). Main results: Factor analyses
identified a two-factor solution corresponding to the original two
subscales of the HAD, which were found to be correlated. The Greek
version of the HAD had Cronbach's alphas for the anxiety and depression
scales of 0.887 and 0.703, respectively. Validity as performed using
known-group analysis showed good results. Both anxiety and depression
subscales discriminated well between subgroups of patients differing in
disease severity as defined by ECOG performance status. Correlations
between the HAD scale and the STAI-S was 0.681 for the anxiety subscale
and 0.485 for the depression subscale. Conclusions: These psychometric
properties of the Greek version of the HAD scale confirm it as a valid
and reliable measure when administered to patients with advanced cancer. |
| SN |
0941-4355 |
| PD |
DEC |
| PY |
2004 |
| VL |
12 |
| IS |
12 |
| BP |
821 |
| EP |
825 |
| UT |
ISI:000225971100001 |
| ER |
|
| PT |
J |
| AU |
Iwamitsu, Y
Shimoda, K
Abe, H
Tani, T
Okawa, M
Buck, R |
| TI |
Anxiety, emotional suppression, before and after breast and
psychological distress cancer diagnosis |
| SO |
PSYCHOSOMATICS |
| AB |
The authors examined the influence of anxiety and emotional suppression
on psychological distress in 21 patients with breast cancer and 72
patients with benign breast tumor. The patients with breast cancer who
suppressed emotion and had chronically high levels of anxiety felt
higher levels of emotional distress both before and after the
diagnosis. Such patients need psychological interventions, including
encouragement to express and communicate their emotions, immediately
after disclosure of the diagnosis to help maintain psychological
adjustment in the face of the disease. |
| SN |
0033-3182 |
| PD |
JAN-FEB |
| PY |
2005 |
| VL |
46 |
| IS |
1 |
| BP |
19 |
| EP |
24 |
| UT |
ISI:000226153100004 |
| ER |
|
| PT |
J |
| AU |
Tsunoda, A
Nakao, K
Kamiyama, KG
Hiratsuka, K
Yamazaki, K
Yasuda, N
Tsunoda, Y
Kusanoa, M |
| TI |
Anxiety and depression and quality of life in colorectal cancer patients |
| SO |
DISEASES OF THE COLON & RECTUM |
| SN |
0012-3706 |
| PD |
JUN |
| PY |
2004 |
| VL |
47 |
| IS |
6 |
| BP |
1098 |
| EP |
1099 |
| UT |
ISI:000221776900315 |
| ER |
|
| PT |
J |
| AU |
Leon, C
Rovirosa, A
Casas, F
Farrus, B
Gic, I
Biete, A
Craven-Bartle, J
Sierra, J
Arcusa, A |
| TI |
Anxiety and depression in gynaecologic cancer patients before, during
and after brachytherapy. a randomized study |
| SO |
RADIOTHERAPY AND ONCOLOGY |
| SN |
0167-8140 |
| PD |
MAY |
| PY |
2004 |
| VL |
71 |
| SU |
Suppl. 2 |
| BP |
S74 |
| EP |
S74 |
| UT |
ISI:000222468200156 |
| ER |
|
| PT |
J |
| AU |
Macleod, U
Ross, S
Fallowfield, L
Watt, GCM |
| TI |
Anxiety and support in breast cancer: is this different for affluent
and deprived women? A questionnaire study |
| SO |
BRITISH JOURNAL OF CANCER |
| AB |
A postal questionnaire was sent to affluent and deprived women with
breast cancer in order to compare psychosocial aspects of care with the
purpose of understanding the balance of care and explaining why
deprived women have poorer outcomes. Data were collected regarding
reported sources of information, SF-36 scores and ongoing causes of
anxiety. The results demonstrate that affluent women were more likely
to have received information from their hospital specialist (94.8 vs
76.0%) and from a breast care nurse (70.1 vs 40.0%) than deprived
women. They were also more likely to have received information from
magazines (50.6 vs 33.0%), newspapers (45.5 vs 22.0%) and television
news ( 45.5 vs 26.0%). Deprived women had poorer SF-36 scores than
affluent women, and reported greater anxiety about money (12.2 vs
2.8%), other health problems (22.1 vs 8.2%) and family problems (17.5
vs 6.9%). Personal and professional support is clearly important for
patients with breast cancer. Health professionals need to be aware of
the greater psychological distress demonstrated by deprived women, even
some years after diagnosis with breast cancer, and seek to address it. |
| SN |
0007-0920 |
| PD |
AUG 31 |
| PY |
2004 |
| VL |
91 |
| IS |
5 |
| BP |
879 |
| EP |
883 |
| UT |
ISI:000223510500012 |
| ER |
|
| PT |
J |
| AU |
Edwards, B
Clarke, V |
| TI |
The psychological impact of a cancer diagnosis on families: The
influence of family functioning and patients' illness characteristics
on depression and anxiety |
| SO |
PSYCHO-ONCOLOGY |
| AB |
A diagnosis of cancer is a very stressful event for the patients and
their families. Patients, partners and other family members can suffer
from clinical levels of depression and severe levels of anxiety and
stress reactions. The similarity in levels of distress between patients
and partners and patients and offspring suggests that there are common
factors that impact on families' distress levels. The current study
examined levels of depression and anxiety in newly diagnosed adult
patients (n = 48) and their adult relatives (n = 99). Family
functioning and patients' illness characteristics were identified as
factors that might impact on families' depression and anxiety. Results
from multilevel models indicated that family functioning was important.
Families that were able to act openly, express feelings directly, and
solve problems effectively had lower levels of depression. Direct
communication of information within the family was associated with
lower levels of anxiety. Aside from differences anxiety due to cancer
type, patients' illness characteristics appear to be risk factors in
patients' but not relatives' depression and anxiety. The results from
the current study suggest that researchers and clinicians need to be
family-focused as cancer affects the whole family, not just the
patient. Copyright (C) 2003 John Wiley Sons, Ltd. |
| SN |
1057-9249 |
| PD |
AUG |
| PY |
2004 |
| VL |
13 |
| IS |
8 |
| BP |
562 |
| EP |
576 |
| UT |
ISI:000223278900006 |
| ER |
|
| PT |
J |
| AU |
Valdimarsdottir, U
Helgason, AR
Furst, CJ
Adolfsson, J
Steineck, G |
| TI |
Awareness of husband's impending death from cancer and long-term
anxiety in widowhood: a nationwide follow-up |
| SO |
PALLIATIVE MEDICINE |
| AB |
Background: We investigated the predictors and long-term consequences
of awareness time - the length of time a woman is aware of her
husband's impending death from cancer. Methods: All women (n = 506)
living in Sweden under 80 years of age who lost their husband/partner
owing to cancer of the prostate in 1996 or of the urinary bladder in
1995 or 1996 were followed with an anonymous postal questionnaire, 2-4
years after their loss. Results: We received completed questionnaires
from 379 of the widows. Of these, 55 (15%) reported an awareness time
of 24 hours or less, 56 (15%) of 3-6 months and 95 (26%) of one year or
more. The associations between the awareness time and morbidity were of
a reverted 'J-shape,' with awareness time of 24 hours or less carrying
the highest risk and 3-6/6-12 months the lowest. On comparing the
awareness time of 24 hours or less with 3-6 months (preformed response
category), the relative risks for anxiety were found to be 1.9
(1.0-3.6) (visual digital scale) and 4.5 (1.0-20.0) for intake of
tranquillising drugs. Those not informed of their husband's fatal
condition or not provided with psychological support by caregivers
during their husband's last months of life had an increased risk of a
short awareness time. Conclusions: During a man's terminal cancer
illness, the wife's awareness time varies considerably and is
influenced by information and psychological support from caregivers. A
short awareness time may result in an additional and avoidable
psychological trauma. |
| SN |
0269-2163 |
| PY |
2004 |
| VL |
18 |
| IS |
5 |
| BP |
432 |
| EP |
443 |
| UT |
ISI:000222788200005 |
| ER |
|
| PT |
J |
| AU |
Love, AW
Grabsch, B
Clarke, DM
Bloch, S
Kissane, DW |
| TI |
Screening for depression in women with metastatic breast cancer: a
comparison of the Beck Depression Inventory Short Form and the Hospital
Anxiety and Depression Scale |
| SO |
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY |
| AB |
Objective: To compare two self-report questionnaires for identifying
possible depression in women with metastatic breast cancer.
Method: We conducted structured psychiatric interviews and administered
the Beck Depression Inventory Short Form (BDI-SF) and Hospital Anxiety
and Depression Scale (HADS) to 227 women with stage IV breast cancer.
The accuracy for identifying DSM-IV-defined major and minor depression
was examined. Sensitivity, specificity, positive (PPV) and negative
(NPV) predictive values were calculated and receiver operating
characteristic curves plotted.
Results: Seventy-four (32.6%) patients satisfied DSM-IV criteria for a
depressive disorder. With a cut-off of 4, the BDI-SF had a sensitivity
of 0.84, specificity of 0.63, and PPV of 0.52. A cut-off of 11 on the
HADS-Depression scale (HADS-D) resulted in sensitivity, specificity,
and PPV of 0.16, 0.97, and 0.75, respectively. For major depression
alone, the BDI-SF with a cut-off of 5 had excellent sensitivity but
poor PPV; the HADS, with a cut-off of 7, had weak sensitivity and PPV.
Conclusions: Overall, the two scales perform similarly in identifying
major depression, while the BDI-SF is the more useful in screening for
DSM-IV major or minor depression categories in this clinical group. |
| SN |
0004-8674 |
| PD |
JUL |
| PY |
2004 |
| VL |
38 |
| IS |
7 |
| BP |
526 |
| EP |
531 |
| UT |
ISI:000222705700007 |
| ER |
|
| PT |
J |
| AU |
Consedine, NS
Magai, C
Krivoshekova, YS
Ryzewicz, L
Neugut, AI |
| TI |
Fear, anxiety, worry, and breast cancer screening behavior: A critical
review |
| SO |
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION |
| AB |
Anxiety, fear, and worry are variously described as facilitators and
barriers of breast cancer screening. However, several contradictions
are evident in this research. A review article described the literature
regarding the relations among fear, anxiety, and worry, along with
emotion regulatory styles, and breast cancer screening behaviors before
critiquing it in an attempt to uncover preliminary explanations for
these discrepancies. Three main conclusions are drawn. First, it is
suggested that researchers need to clearly define the components of
cancer and the screening process that women are afraid of as each may
bear a different relation to screening behavior. Second, greater care
needs to be taken to employ psychometrically valid and reliable
measures of fear and anxiety. Third, studies need to more
systematically test findings across the minority and ethnic groups at
greatest risk. A framework is presented and suggestions regarding the
continued development of this promising area of research are made. |
| SN |
1055-9965 |
| PD |
APR |
| PY |
2004 |
| VL |
13 |
| IS |
4 |
| BP |
501 |
| EP |
510 |
| UT |
ISI:000220724400002 |
| ER |
|
| PT |
J |
| AU |
Humphris, GM
Rogers, SN |
| TI |
Recurrence fears, anxiety and depression in oral facial cancer patients. |
| SO |
JOURNAL OF DENTAL RESEARCH |
| SN |
0022-0345 |
| PD |
DEC |
| PY |
2003 |
| VL |
82 |
| SI |
Sp. Iss. C |
| BP |
496 |
| EP |
496 |
| UT |
ISI:000189078303000 |
| ER |
|
| PT |
J |
| AU |
Osborne, RH
Elsworth, GR
Sprangers, MAG
Oort, FJ
Hopper, JL |
| TI |
The value of the Hospital Anxiety and Depression Scale (HADS) for
comparing women with early onset breast cancer with population-based
reference women |
| SO |
QUALITY OF LIFE RESEARCH |
| AB |
Background: The Hospital Anxiety and Depression Scale (HADS) is
frequently used in cancer studies, yet its utility for comparing people
with cancer with people in the community is uncertain. Methods: HADS
scores were obtained from population-based samples of women with (n =
731) and without (n = 158) early-onset breast cancer. Psychometric
properties were examined using differential item functioning (DIF)
which is the presence of systematic group differences in certain
response items independent of the trait being measured. Results: Women
with breast cancer scored lower than reference women on anxiety (mean
(SD) 7.5 (4.3) vs. 8.2 (4.0); p = 0.06) and depression (3.3 (3.2) vs.
4.2 (3.0); p = 0.003). Group differences remained following adjustment
for demographics. Time since diagnosis was not related to anxiety or
depression scores. DIF was present in two anxiety and five depression
items. Adjustment for DIF did not substantially change the anxiety or
depression group differences. Conclusion: Specific sampling or DIF
effects do not explain the observation that women with breast cancer
have lower levels of anxiety and depression than population controls.
The psychometric properties of the HADS appear to be acceptable in
these groups. |
| SN |
0962-9343 |
| PD |
FEB |
| PY |
2004 |
| VL |
13 |
| IS |
1 |
| BP |
191 |
| EP |
206 |
| UT |
ISI:000188855800021 |
| ER |
|
| PT |
J |
| AU |
Baum, C
Gessert, A |
| TI |
Mindfulness-based stress reduction (MBSR) classes as a tool to decrease
the anxiety of cancer patients |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
JAN |
| PY |
2004 |
| VL |
13 |
| IS |
1 |
| SU |
Suppl. S |
| BP |
S13 |
| EP |
S13 |
| UT |
ISI:000188425000023 |
| ER |
|
| PT |
J |
| AU |
Humphris, GM
Rogers, S
McNally, D
Lee-Jones, C
Brown, J
Vaughan, D |
| TI |
Fear of recurrence and possible cases of anxiety and depression in
orofacial cancer patients |
| SO |
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY |
| AB |
Recurrence risk in orofacial cancer patients is relatively high in
comparison to other cancers. Little information exists on whether
patients are unduly concerned over the possibility of recurrence and
the association of this concern with psychological morbidity. Aim of
study was to assess fear of recurrence and psychological morbidity in
orofacial cancer patients. Two samples of patients with orofacial
cancer were followed prospectively. First sample (n = 87) were
consecutively drawn 3 months and 7 months following initial treatment.
Second sample (n = 100) were cross-sectionally drawn from out-patient
list and followed 2 years later. A single question item was employed to
assess fear of recurrence used in previous work. Hospital Anxiety and
Depression Scale was adopted as the measure of psychological morbidity.
A prospective survey design was employed. Over 80% of patients
expressed concern over the possibility of recurrence at 3 months post
treatment. This level reduced to 72% at 7 months (P = 0.06).
Approximately two-thirds of patients sampled cross-sectionally were
concerned at both assessment occasions. Psychological morbidity was
greatest at 3 months post treatment (possible cases: anxiety 37% and
depression 28%). Women were more likely to report anxiety at possible
case level) than men 3 months following treatment (P<0.05). Patients
aged 65 or more years were less concerned about recurrence. This effect
was significant on both occasions that sample two patients were
assessed (P's<0.002). Very few patients who expressed no concern about
recurrence, at 3 months, were found to report anxiety or depression
sufficient to be recognized as a possible case (3 and 0% respectively).
The positive association between psychological morbidity and fears of
recurrence was significant at the majority of data collection points,
with the exception that depression was more independent of these
concerns. |
| SN |
0901-5027 |
| PD |
OCT |
| PY |
2003 |
| VL |
32 |
| IS |
5 |
| BP |
486 |
| EP |
491 |
| UT |
ISI:000186720500006 |
| ER |
|
| PT |
J |
| AU |
Deimling, GT
Bowman, K
Kabana, B |
| TI |
Depression, anxiety and burden of disability among older adult
long-term cancer survivors: racial and gender differences |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
JUN |
| PY |
2003 |
| VL |
12 |
| IS |
4 |
| SU |
Suppl. S |
| BP |
S121 |
| EP |
S122 |
| UT |
ISI:000183225400144 |
| ER |
|
| PT |
J |
| AU |
Roth, AJ |
| TI |
Screening for distress and anxiety in prostate cancer |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
JUN |
| PY |
2003 |
| VL |
12 |
| IS |
4 |
| SU |
Suppl. S |
| BP |
S123 |
| EP |
S124 |
| UT |
ISI:000183225400150 |
| ER |
|
| PT |
J |
| AU |
Halim, MS
Cahya, IN |
| TI |
Spiritual experience and death anxiety in Indonesian cancer patients |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
JUN |
| PY |
2003 |
| VL |
12 |
| IS |
4 |
| SU |
Suppl. S |
| BP |
S150 |
| EP |
S150 |
| UT |
ISI:000183225400227 |
| ER |
|
| PT |
J |
| AU |
Karasawa, K
Horikawa, N
Seki, K
Kohno, M
Shinoda, H
Nasu, S
Muramatsu, H
Maebayashi, K
Mitsuhashi, N |
| TI |
The progress of anxiety and depression in cancer patients who receiving
radiotherapy |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
JUN |
| PY |
2003 |
| VL |
12 |
| IS |
4 |
| SU |
Suppl. S |
| BP |
S173 |
| EP |
S173 |
| UT |
ISI:000183225400294 |
| ER |
|
| PT |
J |
| AU |
Moura, MJ |
| TI |
Depression and anxiety in parents of children with cancer |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
JUN |
| PY |
2003 |
| VL |
12 |
| IS |
4 |
| SU |
Suppl. S |
| BP |
S200 |
| EP |
S200 |
| UT |
ISI:000183225400370 |
| ER |
|
| PT |
J |
| AU |
Schweiger, C
Vollmer, TC
Wittmann, M
Hiddemann, W |
| TI |
Anxiety and depression as predictors for the maladaptive preoccupation
with death and dying in cancer patients |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
JUN |
| PY |
2003 |
| VL |
12 |
| IS |
4 |
| SU |
Suppl. S |
| BP |
S201 |
| EP |
S201 |
| UT |
ISI:000183225400374 |
| ER |
|
| PT |
J |
| AU |
Moura, MJ
Fiuza, I
Bacalhau, MR |
| TI |
Anxiety and depression evaluation in mothers of children with cancer |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
JUN |
| PY |
2003 |
| VL |
12 |
| IS |
4 |
| SU |
Suppl. S |
| BP |
S210 |
| EP |
S211 |
| UT |
ISI:000183225400401 |
| ER |
|
| PT |
J |
| AU |
Roth, A
Rosenfeld, B
Warshowsky, A
O'Shea, N
Reynolds, T
Scher, HI
Breitbart, W |
| TI |
The revised Memorial Anxiety Scale for Prostate Cancer (MAX-PC):
further validation of a scale to measure anxiety in men with prostate
cancer |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
JUN |
| PY |
2003 |
| VL |
12 |
| IS |
4 |
| SU |
Suppl. S |
| BP |
S220 |
| EP |
S220 |
| UT |
ISI:000183225400427 |
| ER |
|
| PT |
J |
| AU |
Ingram, D
Browne, G
Reyno, L
Gafni, A
Roberts, J |
| TI |
Prevalence, correlates and cost of anxiety and affective disorder in
men with prostate cancer one year after initial assessment |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
JUN |
| PY |
2003 |
| VL |
12 |
| IS |
4 |
| SU |
Suppl. S |
| BP |
S229 |
| EP |
S229 |
| UT |
ISI:000183225400451 |
| ER |
|
| PT |
J |
| AU |
Hughes, R
Angen, M |
| TI |
Causes of anxiety in women with hereditary breast and ovarian cancer |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
JUN |
| PY |
2003 |
| VL |
12 |
| IS |
4 |
| SU |
Suppl. S |
| BP |
S243 |
| EP |
S243 |
| UT |
ISI:000183225400494 |
| ER |
|
| PT |
J |
| AU |
Gil, F
Travado, L
Tomamichel, M
Grassi, L |
| TI |
Visual Analogue Scales (VAS) and Hospital Anxiety Depression (HAD)
scale as tools for evaluating distress in cancer patients: a
multi-center Southern European study |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
JUN |
| PY |
2003 |
| VL |
12 |
| IS |
4 |
| SU |
Suppl. S |
| BP |
S257 |
| EP |
S257 |
| UT |
ISI:000183225400537 |
| ER |
|
| PT |
J |
| AU |
Smith, EM
Gomm, SA
Dickens, CM |
| TI |
Assessing the independent contribution to quality of life from anxiety
and depression in patients with advanced cancer |
| SO |
PALLIATIVE MEDICINE |
| AB |
Background: The aim of palliative care services is to ensure the best
quality of life for patients and their carers. Depression is common
amongst palliative care patients and has been shown to adversely affect
quality of life. This study aimed to examine the independent
contribution of depression to quality of life. Objective: To
investigate the hypothesis that a) illness severity, pain, anxiety and
depression are all associated with impaired health-related quality of
life and b) once the effects of illness severity have been adjusted
for, there is further independent contribution to quality of life from
anxiety and depression. Method: Consecutive patients with advanced
cancer under the care of palliative care services were screened.
Sixty-eight patients were evaluated for levels of anxiety and
depression, severity of illness, pain severity and health-related
quality of life. Results: Thirty-three males and 35 females were
recruited and had an age range of 41-93 years (median 71). Seventeen
(25%) of patients were anxious [anxiety score greater than or equal to
11 on the Hospital Anxiety and Depression Scale (HADS)], 15 (22%) were
depressed (HADS depression score greater than or equal to 11). After
controlling for the effects of pain and illness severity, anxiety and
depression were independently associated with global health status,
emotional and cognitive functioning, and fatigue. Anxiety further
contributed significantly towards social functioning, nausea and
vomiting. Conclusions: This study has confirmed that pain, anxiety and
depression were associated with impaired quality of life. Anxiety and
depression contributed independently towards various dimensions of
quality of life. Longitudinal studies are required to examine the
direction of the causal association between pain and depression in
patients receiving palliative care. |
| SN |
0269-2163 |
| PY |
2003 |
| VL |
17 |
| IS |
6 |
| BP |
509 |
| EP |
513 |
| UT |
ISI:000185319800007 |
| ER |
|
| PT |
J |
| AU |
Geinitz, H
Zimmermann, FB
Thamm, R
Keller, M
Busch, R
Molls, M |
| TI |
Fatigue 2.5 years after adjuvant radiotherapy (RT) in patients with
breast cancer: Values before and immediately after treatment and their
correlation to anxiety, depression and functional limitations |
| SO |
STRAHLENTHERAPIE UND ONKOLOGIE |
| SN |
0179-7158 |
| PD |
JUN |
| PY |
2002 |
| VL |
178 |
| SU |
Suppl. 1 |
| BP |
74 |
| EP |
74 |
| UT |
ISI:000176659600292 |
| ER |
|
| PT |
J |
| AU |
Burgess, C
Ramirez, A
Cornelius, V
Love, S
Graham, J
Richards, M |
| TI |
Prevalence and risk factors for depression and anxiety in women during
the five years after a diagnosis of breast cancer |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
SEP |
| PY |
2003 |
| VL |
12 |
| IS |
6 |
| BP |
642 |
| EP |
642 |
| UT |
ISI:000184973900036 |
| ER |
|
| PT |
J |
| AU |
Mattar, PN
Killeen, K
Freier, MC
Swensen, R
Pivonka, J
Babikian, T
Salo, J
Hardesty, RA |
| TI |
Breast cancer: Does awareness of risk factors increase or decrease
anxiety? |
| SO |
JOURNAL OF INVESTIGATIVE MEDICINE |
| SN |
1081-5589 |
| PD |
FEB |
| PY |
2003 |
| VL |
51 |
| SU |
Suppl. 1 |
| BP |
S131 |
| EP |
S131 |
| UT |
ISI:000180569600235 |
| ER |
|
| PT |
J |
| AU |
Hensley, ML
Robson, ME
Kauff, ND
Korytowsky, B
Castiel, M
Ostroff, J
Hurley, K
Hann, LE
Colon, J
Spriggs, D |
| TI |
Pre- and postmenopausal high-risk women undergoing screening for
ovarian cancer: anxiety, risk perceptions, and quality of life |
| SO |
GYNECOLOGIC ONCOLOGY |
| AB |
Objective. Recommendations for women at high risk of ovarian cancer
include prophylactic salpingo-oophorectomy (PSO) or screening with
transvaginal ultrasonography (TVUS) and CA125 levels. The best strategy
for improving survival and maintaining quality of life in high-risk
women is not known. Premenopausal women may be more reluctant than
postmenopausal women to undergo PSO. However, the risk of
false-positive screening results may be more likely in premenopausal
women, posing potential psychological risk for those enrolled in
high-risk ovarian cancer surveillance programs. We sought to determine
whether anxiety, depression, perception of ovarian cancer risk, and
false-positive test frequency differed between high-risk premenopausal
and postmenopausal women initiating ovarian cancer screening.
Methods. High-risk women aged greater than or equal to 30 years
enrolling in a TVUS plus CA125 ovarian cancer screening study completed
standard QOL (SF-36), cancer-specific anxiety (IES), depression
(CES-D), and ovarian cancer risk perception measures. CA125 > 35 and
TVUS showing solid or complex cystic ovarian masses were considered
abnormal. Abnormal tests were repeated after 4-6 weeks. Persistently
abnormal tests prompted a search for malignancy. Tests that normalized
on repeat were considered false positive.
Results. One hundred forty-seven high-risk women, median age 46 (range,
30-78), 78 premenopausal and 69 postmenopausal, had greater than or
equal to 1 TVUS/CA125/outcome assessment. Premenopausal women were more
likely than postmenopausal women to consider themselves at higher risk
of ovarian cancer compared with women their age (P < 0.001) and
compared with women with similar family histories (P < 0.001). Mean
personal perception of lifetime risk of ovarian cancer among
premenopausal women was 37% (range, 0-90%) versus 26% (range, 0-60%)
among postmenopausal women (P = 0.02). While general QOL and depression
scores were similar, 38% of premenopausal women reported high anxiety
versus 27% of postmenopausal women (P = 0.03). Thirty percent of women
required repeat CA125 or TVUS after first screening; 10.8% of
premenopausal women versus 4.6% of postmenopausal women required repeat
CA125; and 23.3% of premenopausal and 20.6% of postmenopausal women
required repeat TVUS. One postmenopausal woman with persistently rising
CA125 > 100 had negative mammography, colonoscopy, and dilation and
curettage/bilateral salpingo-oophorectomy. All other abnormal tests
normalized on repeat. Two premenopausal women withdrew due to anxiety
following false-positive CA125 results. Five women (2 premenopausal, 3
postmenopausal) with normal TVUS/CA125 screening tests elected PSO,
with benign findings.
Conclusion. Premenopausal women perceive their ovarian cancer risk to
be higher, report greater ovarian cancer risk-related anxiety, and are
more likely to have false-positive screening results than
postmenopausal women. Few high-risk women elect PSO in the short term.
Knowledge of the frequency of false-positive screening results and
psychosocial outcomes is important for high-risk women choosing
strategies for managing ovarian cancer risk. (C) 2003 Elsevier Science
(USA). All rights reserved. |
| SN |
0090-8258 |
| PD |
JUN |
| PY |
2003 |
| VL |
89 |
| IS |
3 |
| BP |
440 |
| EP |
446 |
| UT |
ISI:000183682300017 |
| ER |
|
| PT |
J |
| AU |
Hartl, K
Janni, W
Kastner, R
Sommer, H
Stauber, M |
| TI |
Long-term quality of life, body image and anxiety in women after breast
cancer |
| SO |
GEBURTSHILFE UND FRAUENHEILKUNDE |
| AB |
Purpose: Research on long-term quality of life after breast cancer has
produced conflicting results. We investigated the impact of age,
recurrence, and type of primary surgery on different aspects of
long-term quality of life in women treated for breast cancer.
Methods: A total of 306 women completed the QLQ-C30 (Version 2.0)
questionnaire an average of 4.2 years after primary treatment for stage
I-Ill breast cancer. Supplementary scales included body image,
satisfaction with surgical treatment, and fear of recurrence.
Results: The women had minor impairment of quality of life (67.0) and
body image (25.9), a high degree of satisfaction with surgical
treatment (6.8), and considerable fear of recurrence (61.4). There was
no correlation between age and quality of life. Women with recurrence
did not differ from those without recurrence in the symptom scales of
the questionnaire. Women with recurrence reported lower quality of life
(P < 0.01), less satisfaction with surgical treatment (P < 0.04), and
more anxiety (P = 0.02). The QLQ-C30 questionnaire failed to
demonstrate a difference in overall long-term quality of life between
women who had undergone breast-conserving therapy and those who
underwent mastectomy. In contrast, primary surgical treatment did have
an impact on the additional psychological scales: women after
mastectomy had a less favorable body image (P < 0.01), less
satisfaction with surgical treatment (P < 0.01) but also less fear of
recurrence (P < 0.01) than women after conservative surgery.
Conclusion: These data support the hypothesis that the standardized
QLQ-C30 questionnaire does not sufficiently cover all relevant aspects
of quality of life and that it might be complemented with aspects
specific for breast cancer, such as body image, satisfaction with
surgical treatment, and anxiety. |
| SN |
0016-5751 |
| PD |
MAY |
| PY |
2003 |
| VL |
63 |
| IS |
5 |
| BP |
446 |
| EP |
452 |
| UT |
ISI:000183346900006 |
| ER |
|
| PT |
J |
| AU |
Roth, AJ
Rosenfeld, B
Kornblith, AB
Gibson, C
Scher, HI
Curley-Smart, T
Holland, JC
Breitbart, W |
| TI |
The memorial anxiety scale for prostate cancer - Validation of a new
scale to measure anxiety in men with prostate cancer |
| SO |
CANCER |
| AB |
BACKGROUND. The psychological difficulties facing men with prostate
cancer are 2 acknowledged widely, yet identifying men who may benefit
from mental health treatment has proven to be a challenging task. The
authors developed the Memorial Anxiety Scale for Prostate Cancer
(MAX-PC) to facilitate the identification and assessment of men with
prostate cancer-related anxiety. This scale consists of three subscales
that measure general prostate cancer anxiety, anxiety related to
prostate specific antigen (PSA) levels in particular, and fear of
recurrence.
METHODS. Ambulatory men with prostate cancer (n = 385 patients) were
recruited from clinics throughout the United States. Prior to routine
PSA tests, participants completed a baseline assessment packet that
included the Hospital Anxiety and Depression Scale; the Distress
Thermometer; the Functional Assessment of Cancer Therapy Scale,
Prostate Module; and measures of role functioning, sleep, and urinary
functioning. PSA values from the last three tests also were collected.
Follow-up evaluation was completed within 2 weeks after patients
learned of their PSA test result using a subset of these scales.
RESULTS. Analysis of the MAX-PC revealed a high degree of internal
consistency and test-retest reliability for the total score and for the
three subscales, although reliability was somewhat weaker for the PSA
Anxiety Scale. Concurrent validity was demonstrated by correlations
between the MAX-PC and measures of anxiety. 5 Overall changes in PSA
levels were correlated only modestly with changes in MAX-PC scores
(correlation coefficient, 0.13; P = 0.02).
CONCLUSIONS. The MAX-PC appears to be a valid and reliable measure of
anxiety in men with prostate cancer receiving ambulatory care. (C) 2003
American Cancer Society. |
| SN |
0008-543X |
| PD |
JUN 1 |
| PY |
2003 |
| VL |
97 |
| IS |
11 |
| BP |
2910 |
| EP |
2918 |
| UT |
ISI:000183022100027 |
| ER |
|
| PT |
J |
| AU |
Sundar, S
Symonds, P |
| TI |
Cancer patients' anxiety |
| SO |
LANCET |
| SN |
0140-6736 |
| PD |
MAY 17 |
| PY |
2003 |
| VL |
361 |
| IS |
9370 |
| BP |
1746 |
| EP |
1747 |
| UT |
ISI:000182919700043 |
| ER |
|
| PT |
J |
| AU |
Osborne, RH
Elsworth, GR
Hopper, JL |
| TI |
Age-specific norms and determinants of anxiety and depression in 731
women with breast cancer recruited through a population-based cancer
registry |
| SO |
EUROPEAN JOURNAL OF CANCER |
| AB |
The aim of this study was to determine population norms and
determinants of anxiety and depression in a population-based sample of
731 women with breast cancer (aged 23-60 years) with the Hospital
Anxiety and Depression scale (HADS). The prevalence of 'probable'
psychological morbidity due to anxiety was 23% and due to depression
was 3%. When the women identified as 'possible' cases were included,
the respective proportions were 45 and 12%. Higher anxiety was present
in younger, less educated women not born in Australia. There was no
clear pattern of risk factors for depression. These population-based
findings highlight the need for clinicians to be aware that age,
education and country of birth may identify a particularly vulnerable
subgroup. While brief scales such as the HADS are limited in their
ability to accurately predict a clinical diagnosis, high scores
identify those who may warrant referral for clinical evaluation. (C)
2003 Elsevier Science Ltd. All rights reserved. |
| SN |
0959-8049 |
| PD |
APR |
| PY |
2003 |
| VL |
39 |
| IS |
6 |
| BP |
755 |
| EP |
762 |
| UT |
ISI:000182554900017 |
| ER |
|
| PT |
J |
| AU |
Cheung, YL
Molassiotis, A
Chang, AM |
| TI |
The effect of progressive muscle relaxation training on anxiety and
quality of life after stoma surgery in colorectal cancer patients |
| SO |
PSYCHO-ONCOLOGY |
| AB |
The aim of the study was to evaluate the effects of the use of
progressive muscle relaxation training (PMRT) on anxiety and quality of
life in colorectal cancer patients after stoma surgery. A randomised
controlled trial was used with repeated measures assessment over 10
weeks post-stoma surgery. Fifty-nine patients participated in the study
and were randomised to a control group receiving routine care (n = 30)
and an experimental group receiving routine care and PMRT through two
teaching sessions and practice at home for the first 10 weeks. The
State-Trait Anxiety Inventory and two Quality of Life Scales were used
to collect the data of interest in three occasions, namely during
hospitalisation, at week 5 and at week 10 post-surgery. The use of PMRT
significantly decreased state anxiety and improved generic quality of
life in the experimental group (P < 0.05), especially in the domains of
physical health, psychological health, social concerns and environment.
Social relationships decreased in both groups. In relation to the
disease-specific quality of life measure, differences were observed
only in the 10-week assessment, with the experimental group reporting
better quality of life at 10 weeks, but not over time as compared to
the control group. The use of PMRT should be incorporated in the
long-term care of colorectal cancer patients, as it can improve their
psychological health and quality of life. This may be a cost-effective
intervention that needs minimal training and could easily be offered to
those patients that they would like to use it as part of the specialist
care provided to stoma patients. Copyright (C) 2002 John Wiley Sons,
Ltd. |
| SN |
1057-9249 |
| PD |
APR-MAY |
| PY |
2003 |
| VL |
12 |
| IS |
3 |
| BP |
254 |
| EP |
266 |
| UT |
ISI:000182199600004 |
| ER |
|
| PT |
J |
| AU |
Fossa, SD
Dahl, AA
Loge, JH |
| TI |
Fatigue, anxiety, and depression in long-term survivors of testicular
cancer |
| SO |
JOURNAL OF CLINICAL ONCOLOGY |
| AB |
Purpose: To investigate the prevalence of chronic fatigue (CF), the
levels of anxiety and depression, and the correlation between these
conditions in long-term survivors of testicular cancer (TCSs).
Occurrence of CF in TCSs is compared with findings in male survivors of
Hodgkin's disease (HDSs) and in males from the general population
(GenPop).
Methods: TCSs, HDSs, and two cohorts of the GenPop completed the
Fatigue Questionnaire (FQ) and the Hospital Anxiety and Depression
Scale (HADS) as part of a questionnaire survey. Cases of CF were
identified according to published cut-offs, and the levels of anxiety
(HADS-A) and depression (HADS-D) were calculated.
Results: Among 791 TCSs,16% displayed CF (HDSs, 24%; GenPop, 10%). In
the age group younger than 30 years, the prevalence of CF was higher in
TCSs than in the GenPop (P < .01). In TCSs, age, anxiety, depression,
and comorbidity were independent predictors of CF. The mean HADS-A
score in TCSs was significantly above the comparable figure of the
GenPop and similar to that of HDSs. The mean HADS-D score in TCSs was
below that of the GenPop. The highest and lowest mean scores of HADS-A
and HADS-D were observed in the youngest TCSs.
Conclusion: The prevalence of CF is less in TCSs than in HDSs but
exceeds that of the GenPop. Together with comorbidity and age, anxiety
and depression predict CF in TCSs, warranting psychiatric intervention
for cases of CF among TCSs. Anxiety is a larger problem in TCSs than
depression,. particularly among the youngest TCSs. (C) 2003 by American
Society of Clinical Oncology. |
| SN |
0732-183X |
| PD |
APR 1 |
| PY |
2003 |
| VL |
21 |
| IS |
7 |
| BP |
1249 |
| EP |
1254 |
| UT |
ISI:000181973400008 |
| ER |
|
| PT |
J |
| AU |
Sloman, R |
| TI |
Relaxation and imagery for anxiety and depression control in community
patients with advanced cancer |
| SO |
CANCER NURSING |
| AB |
A community-based nursing study was conducted in Sydney, Australia, to
compare the effects of progressive muscle relaxation and guided imagery
on anxiety, depression, and quality of life in people with advanced
cancer. In this study, 56 people with advanced cancer who were
experiencing anxiety and depression were randomly assigned to 1 of 4
treatment conditions: (1) progressive muscle relaxation training, (2)
guided imagery training, (3) both of these treatments, and (4) control
group. Subjects were tested before and after learning muscle relaxation
and guided imagery techniques for anxiety, depression, and quality of
life using the Hospital Anxiety and Depression scale and the Functional
Living Index-Cancer scale. There was no significant improvement for
anxiety; however, significant positive changes occurred for depression
and quality of life. |
| SN |
0162-220X |
| PD |
DEC |
| PY |
2002 |
| VL |
25 |
| IS |
6 |
| BP |
432 |
| EP |
435 |
| UT |
ISI:000180833900003 |
| ER |
|
| PT |
J |
| AU |
Lofters, A
Juffs, HG
Pond, GR
Tannock, IF |
| TI |
"PSA-ITIS": Knowledge of serum prostate specific antigen and other
causes of anxiety in men with metastatic prostate cancer |
| SO |
JOURNAL OF UROLOGY |
| AB |
Purpose: High or increasing prostatic specific antigen (PSA) levels may
be a source of anxiety in patients with metastatic prostate cancer.
Materials and Methods: Patients with metastatic prostate cancer
completed questionnaires, including the Prostate Cancer Specific
Quality of Life Instrument, Hospital Anxiety and Depression Scale, and
a questionnaire to assess the impact of the knowledge of PSA levels on
anxiety. These were completed at home more than 3 days before or after
a clinic appointment and returned by mail. Patient medical history was
obtained from the record.
Results: Of the 65 patients who consented to the study 52 returned the
completed questionnaires. Median age was 70 years (range 55 to 86) and
median time since diagnosis was 53 months. Of the patients 81% had
hormone resistant disease. Most reported good overall quality of life
with a median Prostate Cancer Specific Quality of Life Instrument score
of 93 (maximum 100). Of the patients 77% indicated that PSA levels were
one of the ways and 44% indicated they were the only way that they knew
whether disease was progressing. When asked to rate references for
treatment outcome, 25% of the men rated decreasing PSA and worse
physical symptoms above increasing PSA and better physical symptoms. If
measurement of PSA levels ceased, 52% of patients would believe that
their doctor was giving up on them and only 1 would be relieved. Before
receiving PSA results 76% reported some level of anxiety and 15%
reported extreme anxiety.
Conclusions: PSA related anxiety represents a substantial problem in
patients with metastatic prostate cancer. |
| SN |
0022-5347 |
| PD |
DEC |
| PY |
2002 |
| VL |
168 |
| IS |
6 |
| BP |
2516 |
| EP |
2520 |
| UT |
ISI:000179399900043 |
| ER |
|
| PT |
J |
| AU |
Petersen, RW
Quinlivan, JA |
| TI |
Preventing anxiety and depression in gynaecological cancer: a
randomised controlled trial |
| SO |
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY |
| AB |
Objective To examine the effect of counselling and relaxation
intervention on psychological symptoms in patients with gynaecological
cancer between the post-operative period and the six-week review.
Design Randomised controlled trial.
Participants Fifty-three patients with gynaecological cancer.
Setting Three Australian tertiary referral hospitals.
Methods Fifty-three patients were randomised to control or intervention
and completed the baseline Hospital Anxiety and Depression Scale (HADS)
and General Health Questionnaire-28 (GHQ-28) questionnaires. The
intervention consisted of a relaxation and counselling session
performed by a senior doctor. Follow up questionnaires were completed
at six weeks. Demographic and tumour data were collated independently.
Results Complete data were available on 50 patients. There were no
significant differences in demographic, social support or tumour
characteristics between the two groups. Multivariate analysis
determined that only the intervention and baseline score were
significant predictors of outcome. The intervention was associated with
a significant reduction in total HADS score (P = 0.002). The reduction
was seen in both anxiety and moderate depression subscales (P = 0.001
and P = 0.02). The intervention was also associated with a significant
reduction in total GHQ-28 score and in three of the four subscale
scores (somatisation, anxiety and personality development; all P <
0.02). However, no significant difference was found in the fourth
subscale of major depression.
Conclusion A relaxation and counselling intervention performed by a
treating doctor reduces psychological , symptoms in women with a new
diagnosis of gynaecological cancer. |
| SN |
1470-0328 |
| PD |
APR |
| PY |
2002 |
| VL |
109 |
| IS |
4 |
| BP |
386 |
| EP |
394 |
| UT |
ISI:000179220000007 |
| ER |
|
| PT |
J |
| AU |
Stark, D
Kiely, M
Smith, A
Velikova, G
House, A
Selby, P |
| TI |
Anxiety disorders in cancer patients: Their nature, associations, and
relation to quality of life |
| SO |
JOURNAL OF CLINICAL ONCOLOGY |
| AB |
Purpose: We aimed to estimate the prevalence and types of anxiety
disorders diagnosed according to standardized criteria in cancer
patients, to compare screening tools in detecting them, and to examine
their demographic, oncologic, and psychosocial associations.
Methods: In this cross-sectional observational study of 178 subjects
with lymphoma, renal cell carcinoma, malignant melanoma, or plasma cell
dyscrasia, we related responses to questionnaires (administered by
computer touch-screen) measuring psychological symptoms, quality of
life (QOL), and social support to standardized psychiatric interviews
and cancer management.
Results: Forty-eight percent of subjects reported sufficient anxiety
for anxiety disorder to be considered. At subsequent diagnostic
interview, 18% fulfilled International Classification of Disorders,
10th Revision criteria for anxiety disorder, including 6% of patients
who reported low levels of anxiety by questionnaire. When subjects
reported anxiety by questionnaire, if disruptive somatic anxiety was
present, this increased the probability of diagnosable anxiety disorder
from .31 to .7. The most accurate screening questionnaires were the
trait scale of the State-Trait Anxiety Inventory and the Hospital
Anxiety and Depression scale. Female sex and negative aspects of social
support were associated with anxiety disorder in multivariate analyses.
Anxiety disorder was independently associated with a deficit in QOL,
particularly insomnia.
Conclusion: Anxiety symptoms are common in cancer patients. Screening
by questionnaire seems to assess anxiety symptoms adequately but
discriminates abnormal anxiety inadequately. To improve this, we may
need to use criteria such as disruption from anxiety, as illustrated by
the impact of anxiety disorders on QOL. There seem to be few oncologic
variables that could target screening for anxiety disorders. (C) 2002
by American Society of Clinical Oncology. |
| SN |
0732-183X |
| PD |
JUL 15 |
| PY |
2002 |
| VL |
20 |
| IS |
14 |
| BP |
3137 |
| EP |
3148 |
| UT |
ISI:000176920000014 |
| ER |
|
| PT |
J |
| AU |
[Anon] |
| TI |
Swedish study examines how to predict anxiety and depression among
cancer patients |
| SO |
EUROPEAN JOURNAL OF CANCER CARE |
| SN |
0961-5423 |
| PD |
JUN |
| PY |
2002 |
| VL |
11 |
| IS |
2 |
| BP |
80 |
| EP |
80 |
| UT |
ISI:000176643800012 |
| ER |
|
| PT |
J |
| AU |
Smith, AB
Selby, PJ
Velikova, G
Stark, D
Wright, EP
Gould, A
Cull, A |
| TI |
Factor analysis of the Hospital Anxiety and Depression Scale from a
large cancer population |
| SO |
PSYCHOLOGY AND PSYCHOTHERAPY-THEORY RESEARCH AND PRACTICE |
| AB |
The Hospital Anxiety and Depression Scale (HADS) is widely used as a
tool for assessing psychological distress in patients and non-clinical
groups. Previous studies have demonstrated conflicting results
regarding the factor structure of the questionnaire for different
groups of patients, and the general population. This study investigated
the factor structure of the HADS in a large heterogeneous cancer
population of 1474 patients. It also sought to investigate emerging
evidence that the HADS conforms to the tripartite model of anxiety and
depression (Clark & Watson, 1993), and to test the proposal that
detection rates for clinical cases of anxiety and depression could be
enhanced by partialling out the effects of higher order factors from
the HADS (Dunbar et at, 2000). The results demonstrated a two-factor
structure corresponding to the Anxiety and Depression subscales of the
questionnaire. The factor structure remained stable for different
subgroups of the sample, for males and females, as well as for
different age groups, and a subgroup of metastatic cancer patients. The
two factors were highly correlated (r=.52) and subsequent secondary
factor analyses demonstrated a single higher order factor corresponding
to psychological distress or negative affectivity. We concluded that
the HADS comprises two factors corresponding to anhedonia and autonomic
anxiety, which share a common variance with a primary factor namely
psychological distress, and that the subscales of the HADS, rather than
the residual scores (e.g. Dunbar et al., 2000) were more effective at
detecting clinical cases of anxiety and depression. |
| SN |
1476-0835 |
| PD |
JUN |
| PY |
2002 |
| VL |
75 |
| PN |
Part 2 |
| BP |
165 |
| EP |
176 |
| UT |
ISI:000176382600004 |
| ER |
|
| PT |
J |
| AU |
Love, AW
Kissane, DW
Bloch, S
Clarke, DM |
| TI |
Diagnostic efficiency of the Hospital Anxiety and Depression Scale in
women with early stage breast cancer |
| SO |
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY |
| AB |
Objective: To investigate the diagnostic efficiency of the Hospital
Anxiety and Depression Scale (HADS) in patients with breast cancer.
Methods: Women (303) recently diagnosed with stage I or II breast
cancer completed the HADS and were psychiatrically assessed.
Recommended cut-off scores for Depression (D) and Anxiety (A) Scales
identified probable caseness and the accuracy was compared with DSM-IV
diagnoses. Cut-off scores were varied to establish optimal accuracy.
Results: One hundred and eleven (36.6%) met criteria for depressive
disorders and 25 (8.3%) met criteria for anxiety disorders. At the
recommended cut-off score of 11 for the D scale, positive and negative
predictive values were .75 and .64, respectively, while sensitivity and
specificity were .05 and .99, respectively. For the A scale, positive
predictive value (PPV) was .15; negative predictive value (NPV), .90;
sensitivity, .08; and specificity, .87. Reducing the cut-off score to 5
produced PPV of .63, NPV of .74, sensitivity of .49 and specificity of
.83 for the D scale; .14, .94, .75 and .45, respectively, for the A
scale. Composite scores (cut-off of 22) had a PPV of .92, NPV of .57,
sensitivity of .09 and specificity of .99.
Conclusions: Recommended cut-off scores for the HADS may result in
under-reporting of psychiatric morbidity among women with early stage
breast cancer. These results are consistent with other recent studies
of the HADS. The type of constructs measured by the scale is the likely
explanation for its limited utility when screening for psychiatric
morbidity in early stage breast cancer. |
| SN |
0004-8674 |
| PD |
APR |
| PY |
2002 |
| VL |
36 |
| IS |
2 |
| BP |
246 |
| EP |
250 |
| UT |
ISI:000175762900014 |
| ER |
|
| PT |
J |
| AU |
Rossi, GB
De Bellis, M
Marone, P
Tempesta, AM
Monsurro, MR |
| TI |
Acceptable levels of anxiety and depression are induced by genetic
testing in hereditary nonpolyposis colorectal cancer family members |
| SO |
GASTROINTESTINAL ENDOSCOPY |
| SN |
0016-5107 |
| PD |
APR |
| PY |
2002 |
| VL |
55 |
| IS |
5 |
| SU |
Suppl. S |
| BP |
AB215 |
| EP |
AB215 |
| UT |
ISI:000175348700517 |
| ER |
|
| PT |
J |
| AU |
Mykletun, A
Foss, S
Dahl, AA |
| TI |
Disability pension in surviving cancer-patients: the influence of
anxiety and depression on risk for disability pension |
| SO |
ACTA PSYCHIATRICA SCANDINAVICA |
| SN |
0001-690X |
| PY |
2002 |
| VL |
105 |
| SU |
Suppl. 411 |
| BP |
23 |
| EP |
23 |
| UT |
ISI:000175484700052 |
| ER |
|
| PT |
J |
| AU |
Hjerl, K
Andersen, EW
Keiding, N
Mortensen, PB
Jorgensen, T |
| TI |
Increased incidence of affective disorders, anxiety disorders, and
non-natural mortality in women after breast cancer diagnosis: a
nation-wide cohort study in Denmark |
| SO |
ACTA PSYCHIATRICA SCANDINAVICA |
| AB |
Objective: To investigate whether breast cancer patients have increased
incidence of psychiatric admission with affective disorders. anxiety
disorders, or non-natural mortality compared with the general female
population,
Method: Register-linkage between nation-wide registries: The Danish
Psychiatric Central Register, The Danish Cancer Registry, and The
Danish National Register of Causes of Death. A total of 61 709 women
registered with primary invasive breast cancer between 1970 and 1993
were included and 356 023 person-years were accrued.
Results: The standardized incidence ratio of first-ever psychiatric
admission with affective disorder was 1.49 (95% CI: 1.35-1.63) and with
anxiety disorder 1.25 (95% CI: 1.06-1.46). The standardized nonnatural
mortality ratio during the first year after breast cancer diagnosis was
1.54 (95% Cl: 1.27-1.87). All analyses were adjusted for age. calendar
period, and place of residence.
Conclusion: Breast cancer patients have significantly increased
incidence of psychiatric admission with affective disorders, anxiety
disorders, and non-natural mortality. |
| SN |
0001-690X |
| PD |
APR |
| PY |
2002 |
| VL |
105 |
| IS |
4 |
| BP |
258 |
| EP |
264 |
| UT |
ISI:000174880500004 |
| ER |
|
| PT |
J |
| AU |
Roth, AJ
Rosenfeld, B
Kornblith, A
Gibson, C
Scher, H
Holland, JC
Breitbart, WS |
| TI |
The memorial anxiety scale for prostate cancer (MAX-PC): Validation of
a new scale to measure anxiety in men with prostate cancer |
| SO |
PSYCHOSOMATICS |
| SN |
0033-3182 |
| PD |
MAR-APR |
| PY |
2002 |
| VL |
43 |
| IS |
2 |
| BP |
158 |
| EP |
159 |
| UT |
ISI:000174530300049 |
| ER |
|
| PT |
J |
| AU |
Devine, D
Sterner, J
Parker, P
Basen-Engquist, K
de Moor, C
Fitzgerald, M
Cohen, L |
| TI |
Social aspects of religiosity predict reductions in anxiety for women
undergoing treatment for ovarian cancer |
| SO |
PSYCHOSOMATIC MEDICINE |
| SN |
0033-3174 |
| PD |
JAN-FEB |
| PY |
2002 |
| VL |
64 |
| IS |
1 |
| BP |
122 |
| EP |
122 |
| UT |
ISI:000173760200175 |
| ER |
|
| PT |
J |
| AU |
Hurley, K
Du Hamel, K
Vickberg, S
Seremetis, S |
| TI |
Does cancer-specific anxiety facilitate or deter screening? Different
answers from breast and colon cancer screening |
| SO |
PSYCHOSOMATIC MEDICINE |
| SN |
0033-3174 |
| PD |
JAN-FEB |
| PY |
2002 |
| VL |
64 |
| IS |
1 |
| BP |
157 |
| EP |
157 |
| UT |
ISI:000173760200342 |
| ER |
|
| PT |
J |
| AU |
Fossa, SD
Dahl, AA |
| TI |
Short Form 36 and Hospital Anxiety and Depression Scale - A comparison
based on patients with testicular cancer |
| SO |
JOURNAL OF PSYCHOSOMATIC RESEARCH |
| AB |
Background: The aim of this study was to compare the scorings of
anxiety and depression assessed by the Hospital Anxiety and Depression
Scale (HADS-A [Anxiety] and HADS-D [Depression]) with the scorings on
the eight subscales of Short Form 36 (SF-36) and the Physical (PCS) and
Mental Component Summary (MCS) assessed by the same patients. Method:
In a cross-sectional study 736 long-term survivors after treatment for
testicular cancer (TC) completed HADS and SF-36. Pearson's correlation
coefficients were calculated on item and scale level to assess the
associations between the HADS and the SF-36 scales and, in particular,
between HADS and PCS and MCS, respectively. Independent predictors for
PCS and MCS were identified by linear regression analysis. Results:
HADS-A and HADS-D were significantly associated with the SF-36 summary
scales. HADS-A explained 5% of the variance of PCS and 49% of the
variance of MCS. The comparable figures for HADS-D were 10% and 45%,
respectively. In the multivariate analysis the HADS-D scoring
independently predicted the level of PCS together with the patients'
educational level, long-lasting working disability and age (variance:
30%). Both HADS-D and HADS-A remained independent parameters for MCS
(variance: 58%) together with the patient's civil status. HADS-D item
D4 ("slowed down") was similarly associated with both PCS and MCS.
Conclusion: In univariate analyses HADS-D and HADS-A were statistically
associated with PCS and MCS. The highest r values were observed for the
associations between HADS and MCS, in particular between HADS-A and
MCS. In the multivariate analyses HADS-D, but not HADS-A, contributed
to PCS, whereas both HADS-A and HADS-D were associated with MCS. This
pattern of different predictions of the summary scales of SF-36
supports a clinical practice that anxiety and depression should be
assessed separately. Additional use of a self-rating instrument for
depression and anxiety, such as HADS, is recommended when SF-36 is used
for quality of life (QL) assessment. (C) 2002 Elsevier Science Inc. All
rights reserved. |
| SN |
0022-3999 |
| PD |
FEB |
| PY |
2002 |
| VL |
52 |
| IS |
2 |
| BP |
79 |
| EP |
87 |
| UT |
ISI:000173932200004 |
| ER |
|
| PT |
J |
| AU |
Kollbrunner, J
Zbaren, P
Quack, K |
| TI |
Quality of life burden of patients with large tumor of the oral cavity.
A descriptive study of psychological effects of disease and primary
surgical therapy in 3 parts. Part 2: Working through the illness:
coping, anxiety, depression |
| SO |
HNO |
| AB |
The psychosocial effects of disfigurements and dysfunctions after
combined surgical and radio-oncological therapy of patients with large
tumors of the oral cavity (n=50) are investigated in a three-part
study. Part 1 compared the "limitations of quality of life" (LQL) of
these patients with those of patients after total laryngectomy (n=34)
and with a group of patients "without cancer"(n=40).
This second part records the coping strategies of the three groups of
patients and relates them to the following variables: anxiety (STAI),
depression (D-S'), despair (H-scale), self-image (GT), locus of control
(KKG), intellectual capacity (shortend SPM) and psychosocial burden in
early childhood (new questionnaire). The coping strategies of
"compliance" and "self-encouragement" were used most often. Patients
with a higher psychosocial burden in early childhood often chose
defensive strategies (distrust, cognitive avoidance, distraction,
reinforced control of emotions). Only few patients used strategies of
healthy regression ("coasting values", A. Maslow). It seems that no
specific single coping strategy (in particular not the frequently
recommended "positive thinking") but an individualized selection of
different strategies is of special value to patients. The self-esteem
of the patient was identified as a crucial factor in increasing the
effectiveness of coping strategies. The surgeon can support patients in
their self-esteem by showing a genuine interest not only in their state
of health but also in their personal background.
The third part of the study is focused on a search for variables which
could serve as preoperative indicators of the individual ability to
bear the burden of illness and therapy. |
| SN |
0017-6192 |
| PD |
DEC |
| PY |
2001 |
| VL |
49 |
| IS |
12 |
| BP |
998 |
| EP |
1007 |
| UT |
ISI:000173387600003 |
| ER |
|
| PT |
J |
| AU |
Mu, PF
Ma, FC
Hwang, B
Chao, YM |
| TI |
Families of children with cancer: The impact on anxiety experienced by
fathers |
| SO |
CANCER NURSING |
| AB |
By using the contextual model of family stress, this study examined
fathers' family stress experience when caring for a child receiving
cancer treatments. A descriptive correlational study was designed to
examine the relationships between fathers' uncertainty, sense of
mastery, and anxiety. Eighty fathers were recruited from two teaching
hospitals in Taiwan. A pilot study was conducted to establish the
reliability and validity of the Chinese language version of the above
instruments. These instruments showed an acceptable internal
consistency and satisfactory construct validity. Results showed that
fathers' level of education had a significant effect on paternal
anxiety. Uncertainty and fathers' education level equal to or higher
than university are good predictors of paternal anxiety, which explain
25% of the variance. The results provide insight into the paternal
experience of family stress and suggest ways to improve family-centered
nursing interventions and thereby establish better family well-being. |
| SN |
0162-220X |
| PD |
FEB |
| PY |
2002 |
| VL |
25 |
| IS |
1 |
| BP |
66 |
| EP |
73 |
| UT |
ISI:000173712200009 |
| ER |
|
| PT |
J |
| AU |
Montazeri, A
Jarvandi, S
Haghighat, S
Vahdani, M
Sajadian, A
Ebrahimi, M
Haji-Mahmoodi, M |
| TI |
Anxiety and depression in breast cancer patients before and after
participation in a cancer support group |
| SO |
PATIENT EDUCATION AND COUNSELING |
| AB |
A prospective study was conducted to assess the long-term impact of
attending a support group on the prevalence of psychological morbidity
in patients with breast cancer before and after 1-year participation in
the Iranian breast cancer support group. Psychological morbidity was
measured using the hospital anxiety and depression scale (HADS). In
addition, qualitative data were collected to throw some lights on the
topic. All current members of the three Iranian breast cancer support
groups (n = 56) were interviewed. The mean age of patients was 45.4
(S.D. = 9.2) years, most were married (n = 46, 82%), and 54% of
patients (n = 30) were diagnosed as having breast cancer from 1 to 5
years ago. While at baseline 16 patients (29%) scored high on the
anxiety sub-scale and eight patients (14%) scored high on the
depression sub-scale, at follow-up only two patients (2%) were likely
experiencing severe anxiety symptoms and there were no patients with
probable severely depressed mood. Comparing anxiety and depression at
baseline and follow-up, there was a statistically significant
difference between baseline and follow-up anxiety (P = 0.03) and
depression (P = 0.008) scores. Analysis of the qualitative data
indicated that the group involvement was the most important factor that
contributed to the patients' improved psychological wellbeing. The
findings of this prospective study suggest that participation in cancer
support groups could have a long-term effect in reducing anxiety and
depression in breast cancer survivors. (C) 2001 Elsevier Science
Ireland Ltd. All rights reserved. |
| SN |
0738-3991 |
| PD |
DEC 1 |
| PY |
2001 |
| VL |
45 |
| IS |
3 |
| BP |
195 |
| EP |
198 |
| UT |
ISI:000172639900005 |
| ER |
|
| PT |
J |
| AU |
Lloyd-Williams, M
Friedman, T
Rudd, N |
| TI |
An analysis of the validity of the Hospital Anxiety and Depression
scale as a screening tool in patients with advanced metastatic cancer |
| SO |
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT |
| AB |
Depression is difficult to diagnose in the terminally ill patient. As a
result, it frequently is not treated. This has can have an adverse
effect on quality of life and make the palliation of physical symptoms
mare difficult. In an effort to improve the detection of depression,
many palliative care teams are using the Hospital Anxiety and
Depression (HAD) scale as a screening tool. The HAD was devised for use
in general medical settings and has not been validated for use in
palliative care patients. One hundred patients receiving palliative
cape with an estimated prognosis of 6 months or less were invited to
complete the HAD and a semistructured psychiatric interview, the
Present State Examination. The depression and anxiety subscales of the
HAD showed poor efficacy for screening when used alone. The optimum
threshold was at a combined cut-off of 19, which had a sensitivity of
68% and specificity of 67%. The major construct of the HAD is
anhedonia, which may be present at the end of life due to increasing
physical illness and may not be pathognomic of a depressive illness in
this population.. We recommend, therefore, that if the HAD is used as a
screening tool in palliative care, it should be as a combined scale,
but low sensitivity and specificity may lead to poor efficacy as a
screening tool. (C) U.S. Cancer Pain Relief Committee, 2001. |
| SN |
0885-3924 |
| PD |
DEC |
| PY |
2001 |
| VL |
22 |
| IS |
6 |
| BP |
990 |
| EP |
996 |
| UT |
ISI:000172656300002 |
| ER |
|
| PT |
J |
| AU |
Neto, JP
Massoco, CO
Favare, RC |
| TI |
Effects of maternal stress on anxiety levels, macrophage activity, and
Ehrlich tumor growth |
| SO |
NEUROTOXICOLOGY AND TERATOLOGY |
| AB |
The present study analyzed the effects of maternal stress on behavior
and immune function of mice. Pregnant mice received a daily footshock
(0.4 mA) from gestational day 15 (GD 15) to GD 19. Experiments were
performed on male offspring aged 2 months. The following results were
obtained for offspring from dams stressed during pregnancy: (1)
decreased locomotor activity observed in the open-field central zone;
(2) decreased number of entries into the open arms of the plus-maze and
decreased time spent in the exploration of these arms; (3) decreased
macrophage spreading and phagocytosis, but no changes in macrophage
NO2- production, (4) increased growth of both the ascitic and solid
forms of Ehrlich tumor. These changes were unrelated to differences in
gestational parameters and did not reflect altered maternal-pup
interactions or nutritional factors. The observed data provide
experimental evidence that maternal stress alters stress/anxiety
levels, macrophage activity and Ehrlich tumor growth at the same time
and in the same litter. The data were discussed in the light of
possible neuroendocrine-immune system interactions. (C) 2001 Elsevier
Science Inc. All rights reserved. |
| SN |
0892-0362 |
| PD |
SEP-OCT |
| PY |
2001 |
| VL |
23 |
| IS |
5 |
| BP |
497 |
| EP |
507 |
| UT |
ISI:000172291800012 |
| ER |
|
| PT |
J |
| AU |
Nordin, K
Wasteson, E
Hoffman, K
Glimelius, B
Sjoden, PO |
| TI |
Discrepancies between attainment and importance of life values and
anxiety and depression in gastrointestinal cancer patients and their
spouses |
| SO |
PSYCHO-ONCOLOGY |
| AB |
Patients' satisfaction with life, viewed in terms of the discrepancy
between the perceived attainment and subjective importance of various
life values, is a less often studied phenomenon for understanding the
psychological adaptation in cancer patients. The main aim of the
present study is to investigate the relation between the degree of
attainment and importance of life values on the one hand, and anxiety
and depression, on the other. A consecutive series of 85 newly
diagnosed patients with gastrointestinal (GI) cancers, 52 potentially
cured and 33 with an advanced disease, and 26 spouses to the patients
with an advanced disease participated. The patients and spouses of
non-cured patients filled out questionnaires twice, close to the
diagnosis and after 1 (non-cured patients) or 3 months. Overall, large
discrepancies between the perceived attainment and importance of life
values were associated with high anxiety and depression. For the
patients (both cured and non-cured), the discrepancies decreased for
several life values over time, as did anxiety and depression. For the
spouses of the non-cured patients, there was no decrease either for
life value discrepancies or for anxiety/depression. This suggests that
patients, in contrast to their spouses, strive to achieve small
discrepancies between the perceived attainment and importance of life
values, as part of their adjustment to serious diseases, e.g. cancer.
Copyright (C) 2001 John Wiley & Sons, Ltd. |
| SN |
1057-9249 |
| PD |
NOV-DEC |
| PY |
2001 |
| VL |
10 |
| IS |
6 |
| BP |
479 |
| EP |
489 |
| UT |
ISI:000172156400003 |
| ER |
|
| PT |
J |
| AU |
Tashiro, M
Itoh, M
Kubota, K
Kumano, H
Masud, MM
Moser, E
Arai, H
Sasaki, H |
| TI |
Relationship between trait anxiety, brain activity and natural killer
cell activity in cancer patients: A preliminary pet study |
| SO |
PSYCHO-ONCOLOGY |
| AB |
The purpose of this study is to examine the relationship between
psychological factors, regional brain activity and natural killer cell
activity (NTKA). Eight patients with malignant diseases were studied by
FDG-PET under a resting condition. NKA and degree of anxiety and
depression were measured using Taylor's manifest anxiety scale (MAS)
and Zung's self-rating depression scale (SDS). Linear correlation of
NKA and psychological measures to the regional brain metabolism in
cancer patients was examined using statistical parametric mapping (SPM).
Positive linear correlation between NKA and regional metabolic rate
ratios was identified in the visual association cortex, anterior
cingulate gyrus (CG) and sensorimotor area, and negative correlation
was identified in the inferolateral prefrontal cortex (ILPFC),
prefrontal cortex (PFC), orbitofrontal cortex (OFC) and anterior
temporal cortex. Positive linear correlation to the MAS score was
identified in the visual association cortex, anterior CG, primary
sensorimotor area and the posterior parietal cortex, and negative
correlation was detected in the ILPFC, PFC, OFC and anterior temporal
cortex. The NKA and MAS scores positively correlated with each other (p
< 0.001).
The result might serve as supporting data for a hypothesis that
psycho-immune interaction is also mediated by the cerebral cortex and
limbic system. Copyright (C) 2001 John Wiley & Sons, Ltd. |
| SN |
1057-9249 |
| PD |
NOV-DEC |
| PY |
2001 |
| VL |
10 |
| IS |
6 |
| BP |
541 |
| EP |
546 |
| UT |
ISI:000172156400009 |
| ER |
|
| PT |
J |
| AU |
Geinitz, H
Zimmermann, FB
Stoll, P
Thamm, R
Ansorg, K
Keller, M
Molls, M |
| TI |
Correlation of fatigue, anxiety and depression during radiotherapy of
breast cancer patients |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
JUL-AUG |
| PY |
2001 |
| VL |
10 |
| IS |
4 |
| SU |
Suppl. S |
| BP |
S27 |
| EP |
S27 |
| UT |
ISI:000170484700046 |
| ER |
|
| PT |
J |
| AU |
Vollmer, TC |
| TI |
The reducing effect of bibliotherapy on cancer patients general anxiety
and mood state |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
JUL-AUG |
| PY |
2001 |
| VL |
10 |
| IS |
4 |
| SU |
Suppl. S |
| BP |
S49 |
| EP |
S50 |
| UT |
ISI:000170484700111 |
| ER |
|
| PT |
J |
| AU |
Nordin, K
Wasteson, E
Hoffman, K
Glimelius, B
Sjoden, PO |
| TI |
Discrepancies between attainment and importance of life values and
anxiety and depression in gastrointestinal cancer patients and their
spouses |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
JUL-AUG |
| PY |
2001 |
| VL |
10 |
| IS |
4 |
| SU |
Suppl. S |
| BP |
S85 |
| EP |
S85 |
| UT |
ISI:000170484700198 |
| ER |
|
| PT |
J |
| AU |
Stark, D
Kiely, M
Smith, A
Selby, P
House, A |
| TI |
Anxiety in cancer patients. |
| SO |
BRITISH JOURNAL OF CANCER |
| SN |
0007-0920 |
| PD |
JUL |
| PY |
2001 |
| VL |
85 |
| SU |
Suppl. 1 |
| BP |
65 |
| EP |
65 |
| UT |
ISI:000170065300243 |
| ER |
|
| PT |
J |
| AU |
Fujii, M
Ohno, Y
Tokumaru, Y
Imanishi, Y
Kanke, M
Tomita, T
Kanzaki, J |
| TI |
Manifest Anxiety Scale for evaluation of effects of granisetron in
chemotherapy with CDDP and 5FU for head and neck cancer |
| SO |
SUPPORTIVE CARE IN CANCER |
| AB |
The level of anxiety was examined before treatment by means of the
Manifest Anxiety Scale (MAS) in 41 patients with squamous cell
carcinoma of the head and neck. They received 5 days of neoadjuvant
chemotherapy with cisplatin (CDDP) and 5-fluorouracil (5FU).
Granisetron (KYT) was administered daily from day I to day 5. Nausea,
vomiting, appetite, and well-being were assessed during and after
chemotherapy. The relation between the effects of KYT and anxiety was
studied. Seventeen patients were proven to have anxiety and were
compared with the other 24 patients. In patients with anxiety, the
percentage wellbeing was significantly lower on days 1 and 2 (P=0.008,
0.001). The rate of freedom from nausea was significantly lower from
day 4 to day 9 for anxiety patients (P=0.010 similar to0.050). The
percentage of anxiety patients without loss of appetite was
significantly lower from day 6 to 9 (p = 0.001 similar to 0.020). The
rate of freedom from vomiting was significantly lower on days 4, 5 and
7 for anxiety patients (P = 0.024, 0.024, 0.014). The results indicate
that the effect of KYT was significantly lower from day 3 to day 7 for
anxiety patients (P = 0.008 similar to 0.045). The anxiety group had
significantly poorer well-being at the beginning of chemotherapy, and
were not responsive to KYT in the delayed phase. Our results prove that
anxiety patients show delayed emesis, and the administration of KYT is
considered insufficient. It may be important to co-administer a
tranquilizer to any patient who exhibit anxiety as defined by the MAS,
in order to reduce delayed emesis. |
| SN |
0941-4355 |
| PD |
JUL |
| PY |
2001 |
| VL |
9 |
| IS |
5 |
| BP |
366 |
| EP |
371 |
| UT |
ISI:000170133500008 |
| ER |
|
| PT |
J |
| AU |
D'Haese, S
Vinh-Hung, V
Bijdekerke, P
Spinnoy, M
De Beukeleer, M
Lochie, N
De Roover, P
Storme, G |
| TI |
The effect of timing of the provision of information on anxiety and
satisfaction of cancer patients receiving radiotherapy |
| SO |
JOURNAL OF CANCER EDUCATION |
| AB |
Background. To improve the provision of information to their
radiotherapy patients, the authors examined whether the timing of given
written information has an effect on anxiety and satisfaction. Methods.
Two sources of information were used: 1) a booklet with a description
of radiotherapy procedures and the sensations patients can experience;
2) teaching sheets with treatment, site-related information. 68
patients were randomized to a simultaneous- information group (n = 31)
and a stepwise- information group (n = 37). The patients were being
treated for cancers of the breast, lung, head, and neck or the pelvic
region. The authors analyzed the impacts of several variables on
patient learning, including anxiety, age, gender, support, referral,
stage of illness, and diagnosis. Assessments were recorded before the
simulation procedure and during the second and last weeks of treatment.
Results. The stepwise-information group was significantly less anxious
before simulation (p = 0.02) and more satisfied (p = 0.001). Of the
variables studied, only the support variable was associated with high
state anxiety (p < 0.0001). Conclusions. Provision of patient
information in a stepwise format leads to less treatment-related
anxiety and greater patient satisfaction among radiation therapy
patient undergoing simulation. |
| SN |
0885-8195 |
| PD |
WIN |
| PY |
2000 |
| VL |
15 |
| IS |
4 |
| BP |
223 |
| EP |
227 |
| UT |
ISI:000170236800009 |
| ER |
|
| PT |
J |
| AU |
Smith, EL
Hann, DM
Ahles, TA
Furstenberg, CT
Mitchell, TA
Meyer, L
Maurer, H
Rigas, J
Hammond, S |
| TI |
Dyspnea, anxiety, body consciousness, and quality of life in patients
with lung cancer |
| SO |
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT |
| AB |
Dyspnea is a common symptom of lung cancer that can impact patient
physical, social, and psychological well-being Study goals were to
evaluate quality of life (QOL) and dyspnea in;patients with lung cancer
and the relationships between QOL, dyspnea, trait anxiety, and body
consciousness. Sociodemographic and cancer-related variables (stage,
cell type, performance status) were evaluated. One hundred twenty
outpatients with stage I-IV lung cancer participated in the study.
Patients completed 5 questionnaires assessing QOL, dyspnea, trait
anxiety body consciousness, and pain. Eighty-seven percent of study
participants experienced dyspnea. Patients with high dyspnea scores had
lower QOL (P = 0. 04). Dyspnea was worse in men than in women (P 0.02),
and there was a trend towards older patients reporting more severe
dyspnea than younger patients (P = 0. OG). There was no difference in
dyspnea based on cancer stage, cell type, or performance status. Pain
and anxiety scores were higher in patients with high dyspnea (P = 0.
02, P = 0. 03). Dyspnea was more se(,ere in patients taking opioid
analgesics when compared to non-opioids or no pain medications (P = 0.
03). No significant association was found between dyspnea, anxiety, and
private body consciousness. (C) U.S. Cancer Pain Relief Committee, 2001. |
| SN |
0885-3924 |
| PD |
APR |
| PY |
2001 |
| VL |
21 |
| IS |
4 |
| BP |
323 |
| EP |
329 |
| UT |
ISI:000168042500010 |
| ER |
|
| PT |
J |
| AU |
Hurley, KE
Miller, SM
Costalas, JW
Gillespie, D
Daly, MB |
| TI |
Anxiety/uncertainty reduction as a motivation for interest in
prophylactic oophorectomy in women with a family history of ovarian
cancer |
| SO |
JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE |
| AB |
Most women at familial risk for ovarian cancer must decide about
prophylactic oophorectomy without conclusive genotypic information
about their risk level. Some women with relatively low-risk profiles
seek prophylactic oophorectomy or are recommended the procedure by
their physicians, if they appear "cancerphobic." This study
investigated the desire to reduce anxiety in relation to other factors
associated with interest in prophylactic oophorectomy in a group of
women with varying degrees of familial risk for ovarian cancer.
Ninety-four women enrolled in an ongoing program for women with a
family history of ovarian cancer received personalized risk counseling
and were classified as having a sporadic, familial, or putative
hereditary pedigree by a genetics counselor. Eligible enrollees were
interviewed by telephone about current and future interest in
prophylactic oophorectomy, perceived risk of ovarian cancer, severity
of cancer anxiety, stress-related ideation, and reasons for and against
surgery. Reduction of anxiety/uncertainty was the factor most strongly
associated with current interest in prophylactic oophorectomy,
independent of objective risk classification, perceived risk, severity
of cancer anxiety, intrusive ideation, or other variables. Future
interest in prophylactic oophorectomy was predicted by other perceived
benefits of surgery. Current, but not future, interest in prophylactic
oophorectomy appears motivated in part by seeking immediate relief from
anxiety. Interest in prophylactic oophorectomy may fluctuate based on
varying exposure to cues that trigger anxiety. Women seeking
prophylactic oophorectomy, particularly those with lower-risk family
pedigrees, should be offered options for anxiety management as part of
informed consent for prophylactic oophorectomy. |
| SN |
1524-6094 |
| PD |
MAR |
| PY |
2001 |
| VL |
10 |
| IS |
2 |
| BP |
189 |
| EP |
199 |
| UT |
ISI:000167730900010 |
| ER |
|
| PT |
J |
| AU |
Dropkin, MJ |
| TI |
Anxiety, coping strategies, and coping behaviors in patients undergoing
head and neck cancer surgery |
| SO |
CANCER NURSING |
| AB |
Background: Little is reported in the scientific literature about the
modulating effect of anxiety on the coping process before and after
surgical treatment for head and neck cancer.
Objectives: The major purpose of this article is to describe the
relationships among preoperative anxiety and use of coping strategies,
and postoperative self-care and resocialization behaviors in patients
who sustain facial disfigurement/dysfunction with head and neck cancer
surgery
Methods: Using a prospective descriptive design, 75 (N = 75) adults who
were about to sustain facial disfigurement and dysfunction associated
with head and neck cancer surgery were entered into the study. The
State Trait Anxiety Inventory and the Ways of Coping Questionnaire were
administered to the respondents. The Disfigurement/Dysfunction Scale
and Coping Behaviors Score values were calculated by the investigator.
Results: Self-care and anxiety were significantly correlated on
postoperative day 4 (r = 2.30; p < .05) and on postoperative day 5 (r =
2.35; p < .05). For the 3 days under study the relationship between
total self-care and anxiety became stronger on postoperative day 5 (r =
2.39; p < .01), indicating that self-care on postoperative day 4 is
related to reduced anxiety on postoperative day 5. In other words,
self-care appears to precede reduction in anxiety in this sample.
Secondly, there was a negative relationship between self-care and
anxiety that increased over the early postoperative period.
Conclusions: This study prospectively documents anxiety in surgical
head and neck cancer patients. The findings suggest that at a specific
point in time (postoperative day 5), self-care precedes reduction in
anxiety and that this negative relationship increases over time.
Additional investigation is now critical in order to describe long-term
recovery after surgical treatment for head and neck cancer and to
develop appropriate interventions to meet the unique needs of this
population. |
| SN |
0162-220X |
| PD |
APR |
| PY |
2001 |
| VL |
24 |
| IS |
2 |
| BP |
143 |
| EP |
148 |
| UT |
ISI:000167818600009 |
| ER |
|
| PT |
J |
| AU |
Lampic, C
Thurfjell, E
Bergh, J
Sjoden, PO |
| TI |
Short- and long-term anxiety and depression in women recalled after
breast cancer screening |
| SO |
EUROPEAN JOURNAL OF CANCER |
| AB |
The aim was to investigate the psychological consequences of further
investigation after breast cancer screening. Study participants include
509 women (61%) recalled due to suspicious findings on screening
mammograms, and a matched control group of 285 women (68%) with normal
mammograms. Psychological distress was prospectively assessed with the
Hospital Anxiety and Depression Scale (HADS). 46% of the women reported
borderline or clinically significant anxiety prior to the recall visit.
A few days after the visit, anxiety and depression had decreased
significantly (P < 0.01) in women informed about normal or benign
results at the recall clinic, while reported distress remained at
relatively high levels in women referred to surgical biopsy. The
results demonstrate the adverse short-term effect of a delay in
receiving false-positive results, but do not indicate that the recall
experience results in long-term anxiety or depression for a majority of
women. <(c)> 2001 Elsevier Science Ltd. All rights reserved. |
| SN |
0959-8049 |
| PD |
MAR |
| PY |
2001 |
| VL |
37 |
| IS |
4 |
| BP |
463 |
| EP |
469 |
| UT |
ISI:000167739600015 |
| ER |
|
| PT |
J |
| AU |
Nordin, K
Berglund, C
Glimelius, B
Sjoden, PO |
| TI |
Predicting anxiety and depression among cancer patients: a clinical
model |
| SO |
EUROPEAN JOURNAL OF CANCER |
| AB |
The aim of this study was to investigate the possibility of predicting
anxiety and depression 6 months after the cancer diagnosis on the basis
of measures of anxiety, depression (Hospital Anxiety and Depression,
HAD scale), subjective distress (Impact of Event, IES scale) and some
aspects of social support in connection with the diagnosis. A further
purpose was to attempt identification of individual patients at risk of
prolonged psychological distress, and to develop an easily applicable
clinical tool for such detection. A consecutive population-based series
of 522 newly diagnosed patients with breast, colorectal, gastric and
prostate cancer were interviewed in connection with the diagnosis and 6
months later. Anxiety and depression close to the diagnosis explained
39% of the variance in anxiety and depression 6 months later. Patients
scoring as doubtful cases/cases for HAD anxiety and/or depression were
more than 11 times more likely than non-cases to score as doubtful
cases/cases at 6 months. Addition:ll risk factors were having an
advanced disease and nobody in addition to the family to rely on in
case of difficulties. Levels of anxiety and depression at diagnosis
predict a similar status 6 months later. The results also indicate that
the HAD scale in combination with a single question about social
support may be a suitable screening tool for clinical use. (C) 2001
Elsevier Science Ltd. All rights reserved. |
| SN |
0959-8049 |
| PD |
FEB |
| PY |
2001 |
| VL |
37 |
| IS |
3 |
| BP |
376 |
| EP |
384 |
| UT |
ISI:000167269200019 |
| ER |
|
| PT |
J |
| AU |
Williams, B
Loughlin, M
Meagher, T
Williams, SJ |
| TI |
The use of the named nurse to minimise anxiety and maximise patient
communication in the rapid diagnosis of suspected lung cancer |
| SO |
THORAX |
| SN |
0040-6376 |
| PD |
DEC |
| PY |
2000 |
| VL |
55 |
| SU |
Suppl. 3 |
| BP |
A88 |
| EP |
A88 |
| UT |
ISI:000165784000350 |
| ER |
|
| PT |
J |
| AU |
Stark, DPH
House, A |
| TI |
Anxiety in cancer patients |
| SO |
BRITISH JOURNAL OF CANCER |
| AB |
Anxiety is common in cancer patient populations, and must often
initially be recognized and managed by cancer care professionals. This
article reviews the recent oncology and mental health literature on
anxiety. The aim is to help those involved in cancer patient care who
are not specialists in mental health to understand the nature of
anxiety, and discriminate morbid from normal anxiety. We review recent
research into the association of anxiety with events during diagnosis
and management of cancer, highlighting the importance of the meaning of
events to an individual as an important factor in making people
anxious. Lastly we review management strategies which might be used by
cancer care professionals, in particular the importance of an awareness
of specific patterns of communication which may alleviate or maintain
anxiety for some cancer patients. (C) 2000 Cancer Research Campaign. |
| SN |
0007-0920 |
| PD |
NOV |
| PY |
2000 |
| VL |
83 |
| IS |
10 |
| BP |
1261 |
| EP |
1267 |
| UT |
ISI:000165213800001 |
| ER |
|
| PT |
J |
| AU |
Montazeri, A
Harirchi, I
Vahdani, M
Khaleghi, F
Jarvandi, S
Ebrahimi, M
Haji-Mahmoodi, M |
| TI |
Anxiety and depression in Iranian breast cancer patients before and
after diagnosis |
| SO |
EUROPEAN JOURNAL OF CANCER CARE |
| AB |
A prospective study was conducted to measure anxiety and depression in
Iranian breast cancer patients before and after diagnosis using the
Hospital Anxiety and Depression Scale (HADS). The HADS was administered
at two points in time: before diagnosis and 3 months after. In all, 168
breast cancer patients were interviewed. While 48% of patients had
severe symptoms of anxiety at both baseline and follow-up, more than
60% of patients had no symptoms of depressive illness at pre-and
post-diagnosis assessments. Comparing anxiety and depression before
diagnosis and after 3 months, there were no significant differences
between patients' scores on anxiety (P = 0.42) and depression (P =
0.98) subscales. The results showed that patients with advanced disease
and a lower performance status were more anxious and experienced more
depression. The study findings suggest that severe symptoms of anxiety
are the most frequent symptoms in Iranian breast cancer patients. It
seems that during the process of diagnosis and 3 months after
psychological morbidity persists in patients who suffer from breast
cancer. |
| SN |
0961-5423 |
| PD |
SEP |
| PY |
2000 |
| VL |
9 |
| IS |
3 |
| BP |
151 |
| EP |
157 |
| UT |
ISI:000090132000020 |
| ER |
|
| PT |
J |
| AU |
Skarstein, J
Aass, N
Fossa, SD
Skovlund, E
Dahl, AA |
| TI |
Anxiety and depression in cancer patients: relation between the
Hospital Anxiety and Depression Scale and the European Organization for
Research and Treatment of Cancer Core Quality of Life Questionnaire |
| SO |
JOURNAL OF PSYCHOSOMATIC RESEARCH |
| AB |
Background: The emotional functioning (EF) dimension of the European
Organization for Research and Treatment of Cancer Quality of Life
Questionnaire (EORTC QLQ C33) and the Hospital Anxiety and Depression
Scale (HADS) evaluate anxiety and depression. We wanted to compare
cancer patients' responses to EF with those to HADS, as well as the
impact of anxiety and depression on the quality of life (QL) dimensions
of the EORTC QLQ C33. Method: A total of 568 cancer patients completed
both the EORTC QLQ C33 and HADS at the same occasion. The association
between the patients' EF scorings and their HADS scores was analyzed by
multiple linear regression. Gender and age were included as covariates.
Results: Statistically significant negative relations were found
between EF and HADS-A (anxiety), HADS-D (depression) and HADS-T (total
score), respectively, with the highest correlation coefficient for
HADS-A. Older patients and males reported less emotional distress
assessed by the EF scale than younger ones and females with comparable
HADS-T or HADS-D scores. Both HADS-A and HADS-D were significantly
related to other QL dimensions, and depression was a stronger predictor
for reduced QL than anxiety. Conclusion: The EF dimension of EORTC QLQ
C33 predominantly assesses anxiety, whereas depression is rated to a
lesser degree. Combined with significant age and gender relations, this
implies a risk of underdiagnosed depression, if the EORTC QLQ C33 is
used as the only instrument to screen for psychological distress in
cancer patients. As depression has a stronger impact on global QL of
cancer patients than anxiety, the use of an additional instrument is
recommended for assessment of depression. (C) 2000 Elsevier Science
Inc. All rights reserved. |
| SN |
0022-3999 |
| PD |
JUL |
| PY |
2000 |
| VL |
49 |
| IS |
1 |
| BP |
27 |
| EP |
34 |
| UT |
ISI:000090067700006 |
| ER |
|
| PT |
J |
| AU |
Shere, MH |
| TI |
Family histories of cancer in primary care - Referrals might be made on
the basis of women's anxiety |
| SO |
BRITISH MEDICAL JOURNAL |
| SN |
0959-8138 |
| PD |
OCT 14 |
| PY |
2000 |
| VL |
321 |
| IS |
7266 |
| BP |
955 |
| EP |
955 |
| UT |
ISI:000089975100035 |
| ER |
|
| PT |
J |
| AU |
Bodurka-Bevers, D
Basen-Engquist, K
Carmack, CL
Fitzgerald, MA
Wolf, JK
de Moor, C
Gershenson, DM |
| TI |
Depression, anxiety, and quality of life in patients with epithelial
ovarian cancer |
| SO |
GYNECOLOGIC ONCOLOGY |
| AB |
Objective. The aims of this study were to evaluate psychological
distress and quality of life (QOL) in patients with epithelial ovarian
cancer (EOC) and to examine the relationship between these problems and
health and demographic variables.
Methods. Of 344 consecutive patients identified, 246 completed
questionnaires. Four dimensions of QOL were assessed including
physical, functional, emotional, and social/family well-being, as well
as concerns specific to ovarian cancer patients. Depression was
measured with the Center for Epidemiologic Studies-Depression (CES-D)
scale and anxiety was measured by the State Anxiety Subscale of the
Spielberger State-Trait Anxiety Inventory. Performance status was
evaluated by the Zubrod score.
Results. Sixty-five patients (26%) had early stage disease; 181 (74%)
had advanced disease. One hundred twenty-one patients (49%) were under
active treatment, while 124 (51%) were seen for posttherapy
surveillance. Forty-eight (21%) met CES-D cutoff criteria for a
clinical evaluation for depression, and 29% scored above the 75th
percentile for anxiety. Performance status was related to depression,
anxiety, and QOL problems, except in the domain of social well-being.
Conclusions. Clinically significant depression and anxiety may be more
prevalent in patients with EOC than previously reported. Future studies
of screening for and treating psychological distress are being designed
to improve QOL in these women. (C) 2000 Academic Press. |
| SN |
0090-8258 |
| PD |
SEP |
| PY |
2000 |
| VL |
78 |
| IS |
3 |
| PN |
Part 1 |
| BP |
302 |
| EP |
308 |
| UT |
ISI:000089317000006 |
| ER |
|
| PT |
J |
| AU |
Von Essen, L
Enskar, K
Kreuger, A
Larsson, B
Sjoden, PO |
| TI |
Self-esteem, depression and anxiety among Swedish children and
adolescents on and off cancer treatment |
| SO |
ACTA PAEDIATRICA |
| AB |
Self-esteem, depression and anxiety were investigated in 51 Swedish
children and adolescents, 8-18 y, on (n = 16) and off (n = 35) cancer
treatment. The self-report measures "I Think I Am" (ITIA), the
Children's Depression Inventory (CDI) and the Revised Children's
Manifest Anxiety Scale (RCMAS) were used. Data were compared with data
previously obtained by others for healthy Swedish children. Children
and adolescents on treatment showed levels of self-esteem, depression
and anxiety comparable to those of healthy children. However, children
and adolescents off treatment reported higher depression and anxiety
levels and lower psychological well-being and physical self-esteem than
have been reported for healthy Swedish children. Seven children (14%)
reported a high level of depression, six of whom were off treatment.
The findings suggest that the period after treatment termination is
characterized by a higher risk of psychosocial problems than is the
actual treatment period. |
| SN |
0803-5253 |
| PD |
FEB |
| PY |
2000 |
| VL |
89 |
| IS |
2 |
| BP |
229 |
| EP |
236 |
| UT |
ISI:000085499900023 |
| ER |
|
| PT |
J |
| AU |
Weihs, KL |
| TI |
Disease severity, chronic anxiety, emotional constraint and emotional
style fail to predict time from breast cancer diagnosis to recurrence
diagnosis |
| SO |
PSYCHOSOMATIC MEDICINE |
| SN |
0033-3174 |
| PD |
JAN-FEB |
| PY |
2000 |
| VL |
62 |
| IS |
1 |
| BP |
135 |
| EP |
136 |
| UT |
ISI:000085423800210 |
| ER |
|
| PT |
J |
| AU |
Svedlund, J
Sullivan, M
Liedman, B
Lundell, L |
| TI |
Experience of anxiety and tension predicts tumor status in patients
facing surgery for gastric cancer |
| SO |
PSYCHOSOMATIC MEDICINE |
| SN |
0033-3174 |
| PD |
JAN-FEB |
| PY |
2000 |
| VL |
62 |
| IS |
1 |
| BP |
148 |
| EP |
148 |
| UT |
ISI:000085423800271 |
| ER |
|
| PT |
J |
| AU |
Challinor, JM
Miaskowski, CA
Franck, LS
Slaughter, RE
Matthay, KK
Kramer, RF
Veatch, JJ
Paul, SM
Amylon, MD
Moore, IM |
| TI |
Somatization, anxiety and depression as measures of health-related
quality of life of children/adolescents with cancer |
| SO |
INTERNATIONAL JOURNAL OF CANCER |
| AB |
This descriptive study of health-related quality of life of children
with cancer compared children/adolescents', parents' and teachers'
ratings for somatization, depression and anxiety to determine if there
were significant correlations among respondent scores. In addition, the
percentage of agreement among respondents and significant differences
based on age, gender, use of cranial radiation and treatment status
were measured, Forty-three children/adolescents with cancer, currently
receiving therapy for at least 1 year or who had completed therapy for
no more than 3 years (excluding children who had received bone marrow
transplants or who had brain tumors), were recruited, with a parent:
and teacher, from 3 university medical centers. The Behavioral
Assessment System for Children questionnaires for chirdren/adolescents,
parents and teachers were used. Parents reported a higher level of
depression for the children/actolescents with cancer than did the
teachers or the children/adolescents themselves. Parents reported a
higher level of anxiety for the children/adolescents than did the
teachers, High positive correlations were found among scores from
parents and teachers and among scores from parents and
children/adolescents for the anxiety and depression but not
somatization subscales, Children/adolescents and teachers had high,
positively correlated scores only for the depression subscale, High,
positive correlations were found between somatization, anxiety and
depression within each group of respondents. A significant percentage
of agreement between all respondents on ratings for at-risk status was
obtained only for the depression subscale, Age was the only variable
found to have an influence on scores and only for the anxiety subscale.
Int J. Cancer Suppl. 12:52-57, 1999. J 1999 Wiley-Liss, Inc. |
| SN |
0020-7136 |
| PY |
1999 |
| SU |
Suppl. 12 |
| BP |
52 |
| EP |
57 |
| UT |
ISI:000084615500010 |
| ER |
|
| PT |
J |
| AU |
MacBride, SK
Whyte, F |
| TI |
Attendance at cancer follow-up clinic: Does it increase anxiety or
provide reassurance for men successfully treated for testicular cancer? |
| SO |
CANCER NURSING |
| AB |
This cross-sectional descriptive study examined the meaning of the
cancer follow-up clinic for men who have been successfully treated for
testicular cancer. The sample of 62 men were selected using a
nonprobability quota sampling method before attendance at a routine
testicular cancer follow-up clinic within the Directorate of Clinical
Oncology, Western General Hospitals NHS Trust, Edinburgh, Scotland.
Subjects were given four instruments to complete immediately before
seeing the doctor in the clinic, and two instruments to complete on day
8 after the clinic appointment. Instruments included die State-Trait
Anxiety Inventory (STAI), a demographic questionnaire, and two Likert
scales adapted for use in the study: the Common Concerns about
Testicular Cancer questionnaire and the Psychological Consequences of
Screening questionnaire (PCQ). Results demonstrated that men attending
the clinic exhibit low levels of anxiety at the paints measured, but
gain a great deal of reassurance from the clinic visit. Results also
demonstrated the areas of concern about testicular cancer and its
management that influence anxiety in the follow-up clinic. |
| SN |
0162-220X |
| PD |
DEC |
| PY |
1999 |
| VL |
22 |
| IS |
6 |
| BP |
448 |
| EP |
455 |
| UT |
ISI:000084000500007 |
| ER |
|
| PT |
J |
| AU |
Patiraki, E
Gika, M
Pappa, D
Kiritsi, H
Haralambidou, E
Anagnostopoulos, F |
| TI |
Anxiety levels in family caregivers of cancer patients receiving
chemotherapy |
| SO |
EUROPEAN JOURNAL OF CANCER |
| SN |
0959-8049 |
| PD |
SEP |
| PY |
1999 |
| VL |
35 |
| SU |
Suppl. 4 |
| BP |
S38 |
| EP |
S38 |
| UT |
ISI:000083068300133 |
| ER |
|
| PT |
J |
| AU |
Nordin, K
Berglund, G
Glimellus, B
Sjoden, PO |
| TI |
Predicting anxiety and depression among cancer patients |
| SO |
EUROPEAN JOURNAL OF CANCER |
| SN |
0959-8049 |
| PD |
SEP |
| PY |
1999 |
| VL |
35 |
| SU |
Suppl. 4 |
| BP |
S276 |
| EP |
S276 |
| UT |
ISI:000083068301090 |
| ER |
|
| PT |
J |
| AU |
Heim, ME
Kunert, S
Ozkan, I |
| TI |
Anxiety and depression in cancer patients - The HADS-questionnaire as
screening instrument in cancer rehabilitation |
| SO |
EUROPEAN JOURNAL OF CANCER |
| SN |
0959-8049 |
| PD |
SEP |
| PY |
1999 |
| VL |
35 |
| SU |
Suppl. 4 |
| BP |
S281 |
| EP |
S281 |
| UT |
ISI:000083068301111 |
| ER |
|
| PT |
J |
| AU |
Lloyd-Williams, M
Friedman, T
Rudd, N |
| TI |
Should the depression sub scale of the Hospital anxiety and Depression
scale be used as a screen for depression in patients with advanced
metastatic cancer? |
| SO |
EUROPEAN JOURNAL OF CANCER |
| SN |
0959-8049 |
| PD |
SEP |
| PY |
1999 |
| VL |
35 |
| SU |
Suppl. 4 |
| BP |
S365 |
| EP |
S366 |
| UT |
ISI:000083068301465 |
| ER |
|
| PT |
J |
| AU |
Hyodo, I
Eguchi, K
Takigawa, N
Segawa, Y
Hosokawa, Y
Kamejima, K
Inoue, R |
| TI |
Psychological impact of informed consent in hospitalized cancer
patients - A sequential study of anxiety and depression using the
Hospital Anxiety and Depression scale |
| SO |
SUPPORTIVE CARE IN CANCER |
| AB |
Patients with cancer receive an explanation of their disease and the
recommended treatment when they are asked to give informed consent
(IC). In the course of this process patients suffer severe distress,
including anxiety and depression, but physicians tend to underestimate
it.;The goal of this study was to reveal the magnitude of such stress
and any changes to this during the IC process by means of the Hospital
Anxiety and Depression (HAD) scale, a self-assessment scale. Of 171
inpatients newly diagnosed with lung cancer, 119 were assessable for
serial HAD scale scores on admission, immediately after the IC process,
and at 1 and again at 2 weeks after the IC, Both anxiety and depression
scores increased significantly immediately after IC, Female patients
had significantly higher anxiety and depression scores than males at 1
week after the IC, The patients with poor performance status
demonstrated high anxiety scores on admission and immediately after the
ICI and substantial depression persisted longer in these patients. The
prevalence of high scores of more than 11 (judged as adjustment
disorder or more severe state) immediately after the IC was 50% for
anxiety and 31% for depression. The prevalence decreased significantly
within 1 or 2 weeks, but 41% and 14% of the patients still showed high
anxiety and depression scores, respectively. Physicians should be aware
of these facts and pay special attention to their patients'
psychological distress in routine clinical practice. |
| SN |
0941-4355 |
| PD |
NOV |
| PY |
1999 |
| VL |
7 |
| IS |
6 |
| BP |
396 |
| EP |
399 |
| UT |
ISI:000083322700007 |
| ER |
|
| PT |
J |
| AU |
Giarelli, E |
| TI |
Spiraling out of control: One case of pathologic anxiety as a response
to a genetic risk of cancer |
| SO |
CANCER NURSING |
| AB |
The threat of cancer can result in an existential crisis characterized
by feelings of uncertainty and fear. Anxiety, the most common response
to the threat of cancer, may be expressed in ways as varied as
individual personalities and circumstances. It is a normal response to
the threat of cancer, but in some it may deteriorate to pathologic
anxiety, and manifest somatic or avoidant patterns. members of families
diagnosed with genetic mutations that predispose to cancer are unique
in that they experience a complex chain of life events. People affected
with genetic mutations that increase the risk for the development of
cancer may be at greater risk of manifesting abnormal anxiety. Little
research exists that can guide the health professional in meeting the
needs of these individuals, which leads health practitioners to
approach their needs on the basis of combined theoretical assumptions
about the needs of people with cancer, people who have family members
with cancel; and people with recurrent cancer: Some factors may be
assessed by the health professional as an aid in identifying an
individual at increased risk of developing a psychopathology. These
factors include age and developmental level, existence of a previous
psychologic disorder, and family integrity. Advanced practice nurses
may effectively intervene in the care of these patients by (a)
accurately assessing the risk for and extent of the anxiety reaction in
individuals and family members; (b) developing management plans that
include ongoing support, education, psychotherapy, and
pharmacotherapeutics for the individual; and (c) support and
psychotherapy for the family. In this article, the pathologic anxiety
experienced by one adolescent girl diagnosed with a genetic mutation
that caused multiple endocrine neoplasia 2a is addressed, along with
the treatment of her avoidant anxiety disorder-trichotillomania. |
| SN |
0162-220X |
| PD |
OCT |
| PY |
1999 |
| VL |
22 |
| IS |
5 |
| BP |
327 |
| EP |
339 |
| UT |
ISI:000082916300001 |
| ER |
|
| PT |
J |
| AU |
Wellisch, DK
Hoffman, A
Goldman, S
Hammerstein, J
Klein, K
Bell, M |
| TI |
Depression and anxiety symptoms in women at high risk for breast
cancer: Pilot study of a group intervention |
| SO |
AMERICAN JOURNAL OF PSYCHIATRY |
| AB |
Objective: The psycho-oncology literature to date contains only one
outcome study based on a group model for high-risk relatives of breast
cancer patients. The authors set out to study the effects of group
intervention in high-risk relatives of breast cancer patients. Method:
Thirty-three high-risk relatives of breast cancer patients participated
in a six-session, 12-hour group intervention model that consisted of
educational and psychosocial components. Results: There was a
significant reduction of depression symptoms as reported on the Center
for Epidemiologic Studies Depression Scale. Similarly, there was a
significant reduction of anxiety symptoms as reported on the
State-Trait Anxiety Inventory state scale. Conclusions: In this pilot
study the investigators found the group intervention model effective at
reducing symptoms of depression and reactive (not chronic) anxiety. |
| SN |
0002-953X |
| PD |
OCT |
| PY |
1999 |
| VL |
156 |
| IS |
10 |
| BP |
1644 |
| EP |
1645 |
| UT |
ISI:000082896500028 |
| ER |
|
| PT |
J |
| AU |
Sheard, T
Maguire, P |
| TI |
The effect of psychological interventions on anxiety and depression in
cancer patients: results of two meta analyses |
| SO |
BRITISH JOURNAL OF CANCER |
| AB |
The findings of two meta-analyses of trials of psychological
interventions in patients with cancer are presented: the first using
anxiety and the second depression, as a main outcome measure. The
majority of the trials were preventative, selecting subjects on the
basis of a cancer diagnosis rather than on psychological criteria. For
anxiety, 25 trials were identified and six were excluded because of
missing data. The remaining 19 trials (including five unpublished) had
a combined effect size of 0.42 standard deviations in favour of
treatment against no-treatment controls (95% confidence interval (CI)
0.08-0.74, total sample size 1023). A most robust estimate is 9.36
which is based on a subset of trials which were randomized, scored well
on a rating of study quality, had a sample size >40 and in which the
effect of trials with very large-effects were cancelled out. For
depression; 30 trials were identified, but ten were excluded because of
missing data. The remaining 20 trials (including six unpublished) had a
combined effect size of 0.36 standard deviations in favour of treatment
against no-treatment controls (95% CI 0.06-0.66, sample size 1101).
This estimate was robust for publication bias, but not study quality,
and was inflated by three trials with very large effects. A more robust
estimate of mean effect is the clinically weak to negligible value of
0.19. Group therapy is at least as effective as individual. Only four
trials targeted interventions at those identified as-at risk of, or
suffering significant psychological distress, these were associated
with clinically powerful effects (trend) relative to unscreened
subjects. The findings suggest that preventative psychological
interventions in cancer patients may have a moderate clinical effect
upon anxiety but not depression. There are indications that
interventions targeted at those at risk of or suffering significant
psychological distress have-strong clinical effects. Evidence an the
effectiveness of such targeted interventions and of the feasibility and
effects of group therapy in a European context is required. |
| SN |
0007-0920 |
| PD |
AUG |
| PY |
1999 |
| VL |
80 |
| IS |
11 |
| BP |
1770 |
| EP |
1780 |
| UT |
ISI:000081900300015 |
| ER |
|
| PT |
J |
| AU |
Kramer, JA |
| TI |
Use of the Hospital Anxiety and Depression Scale (HADS) in the
assessment of depression in patients with inoperable lung cancer |
| SO |
PALLIATIVE MEDICINE |
| SN |
0269-2163 |
| PD |
JUL |
| PY |
1999 |
| VL |
13 |
| IS |
4 |
| BP |
353 |
| EP |
354 |
| UT |
ISI:000081926000010 |
| ER |
|
| PT |
J |
| AU |
Cain, BS
Meldrum, DR
Dinarello, CA
Meng, XZ
Joo, KS
Banerjee, A
Harken, AH |
| TI |
Tumor necrosis factor-alpha and interleukin-1 beta synergistically
depress human myocardial function |
| SO |
CRITICAL CARE MEDICINE |
| AB |
Objective: Proinflammatory cytokines such as tumor necrosis factor
(TNF)-alpha and interleukin (II)-1 beta have been implicated in the
pathogenesis of myocardial dysfunction in ischemia-reperfusion injury,
sepsis, chronic heart failure, viral myocarditis, and cardiac allograft
rejection. Although circulating TNF-alpha and IL-1 beta are both often
elevated in septic shock, it remains unknown whether TNF-alpha or IL-1
beta are the factors induced during sepsis that directly depress human
myocardial function, and if so, whether the combination synergistically
depresses myocardial function. Furthermore, the mechanism(s) by which
these cytokines induce human myocardial depression remain unknown. We
hypothesized the following: a) TNF-alpha and IL-1 beta directly depress
human myocardial function; b) together, TNF-alpha and IL-1 beta act
synergistically to depress human myocardial function; and c) inhibition
of ceramidase or nitric oxide synthase attenuates myocardial depression
induced by TNF-alpha or IL-1 beta by limiting proximal cytokine
signaling or production of myocardial nitric oxide (NO).
Design:Prospective, randomized, controlled study.
Setting: Experimental laboratory in a university hospital.
Subjects: Freshly obtained human myocardial trabeculae.
Interventions: Human atrial trabeculae were obtained at the time of
cardiac surgery, suspended in organ baths, and field simulated at 1 Hz,
and the developed force was recorded. After a 90-min equilibration,
TNF-alpha (1.25, 12.5, 125, or 250 pg/mL for 20 mins), IL-1 beta (6.25,
12.5, 50, or 200 pg/mL for 20 mins), or TNF-alpha (1.25 pg/mL) plus
IL-1 beta (6.25 pg/mL) were added to the bath, and function was
measured for the subsequent 100 mins after the 20-min exposure. To
assess the roles of the sphingomyelin and NO pathways in TNF-alpha and
IL-1 beta cross-signaling, the ceramidase inhibitor N-oleoyl
ethanolamine (1 mu M) or the NO synthase inhibitor
NG-monomethyl-L-arginine (10 mu M) was added before TNF-alpha (125
pg/mL) or IL-beta (50 pg/mL).
Measurements and Main Results:TNF-alpha and IL-1 beta each depressed
human myocardial function in a dose-dependent fashion (maximally
depressing to 16.2 + 1.9% baseline developed force for TNF-alpha and
25.7 + 6.3% baseline developed force for IL-1 beta), affecting systolic
relatively more than diastolic performance teach p < .05). However,
when combined, TNF-alpha and IL-1 beta at concentrations that did not
individually result in depression (p >.05 vs, control) resulted in
contractile depression (p < .05 vs. control). Inhibition of myocardial
sphingosine or NO release abolished the myocardial depressive effects
of either TNF-alpha or IL-1 beta.
Conclusions:TNF-alpha and IL-1 beta separately and synergistically
depress human myocardial function. Sphingosine likely participates in
the TNF-alpha and IL-1 beta signal leading to human myocardial
functional depression. Therapeutic strategies to reduce production or
signaling of either TNF-alpha or IL-1 beta may limit myocardial
dysfunction in sepsis. |
| SN |
0090-3493 |
| PD |
JUL |
| PY |
1999 |
| VL |
27 |
| IS |
7 |
| BP |
1309 |
| EP |
1318 |
| UT |
ISI:000081906300013 |
| ER |
|
| PT |
J |
| AU |
Ronson, A
Razavi, D |
| TI |
Affective and anxiety disorders in patients with cancer - Optimal
management |
| SO |
CNS DRUGS |
| AB |
Cancer, at all sites and stages (from early diagnosis to terminal
phase), has psychological effects in a significant number of patients.
Diagnosis of depression and anxiety in this patient population can be
difficult and must involve awareness of the symptoms and signs
resulting from the cancer itself and antineoplastic therapies, and the
differential diagnosis of 'function' and 'organic' mental disorders.
When prescribing psychotropic medications to patients with cancer,
particular attention should be paid to drug interactions (e.g. the
potential influence of psychoactive drugs on the metabolism of
chemotherapeutic agents). Despite provocative reports, it has to be
acknowledged that to date, there is no evidence to substantiate the
claim of a negative impact of antidepressants on cancer initiation or
prognosis. Although studies assessing the comparative effectiveness of
psychopharmacological agents are difficult to perform in patients with
cancer, the efficacy and tolerability of several antidepressants and
anxiolytics have been shown and a mixed approach, combining drug
treatments and various forms of psychotherapy, is now widely
encouraged. However, a lot of research remains to be conducted in order
to better understand the specific relationships between cancer and
psychopathology, to identify risk factors and develop preventative
strategies and to define a general model of treatment for psychiatric
disturbances in patients with cancer. |
| SN |
1172-7047 |
| PD |
AUG |
| PY |
1999 |
| VL |
12 |
| IS |
2 |
| BP |
119 |
| EP |
133 |
| UT |
ISI:000081949000005 |
| ER |
|
| PT |
J |
| AU |
Groenvold, M
Fayers, PM
Sprangers, MAG
Bjorner, JB
Klee, MC
Aaronson, NK
Bech, P
Mouridsen, HT |
| TI |
Anxiety and depression in breast cancer patients at low risk of
recurrence compared with the general population: A valid comparison? |
| SO |
JOURNAL OF CLINICAL EPIDEMIOLOGY |
| AB |
Breast cancer and its treatment have been associated with psychological
morbidity. In this study our aim was to quantify the excess anxiety and
depression resulting from breast cancer. We compared 538 newly
diagnosed breast cancer patients at low risk of recurrence (87.0%
responded) to 872 women randomly selected from the Danish general
population (69.7% responded) using the Hospital Anxiety and Depression
Scale (HADS). Contrary to expectations, the proportions classified as
"cases" of anxiety and depression were not significantly different in
the two groups. The breast cancer patients' mean HADS scores were
significantly lower than those in the general population sample
(anxiety, P = 0.021; depression, P < 0.001), indicating less anxiety
and depression. However, we question the validity of this comparison.
The HADS may not be suitable for use in the general population and
there may be methodological problems in comparisons of groups whose
life situations are very different. (C) 1999 Elsevier Science Inc. |
| SN |
0895-4356 |
| PD |
JUN |
| PY |
1999 |
| VL |
52 |
| IS |
6 |
| BP |
523 |
| EP |
530 |
| UT |
ISI:000081015300006 |
| ER |
|
| PT |
J |
| AU |
Lawvere, S
Moscato, B
Donahue, R
Mettlin, C |
| TI |
The effect of massage therapy on self-reported anxiety, depressive mood
and pain in ovarian cancer patients: Initial findings. |
| SO |
AMERICAN JOURNAL OF EPIDEMIOLOGY |
| SN |
0002-9262 |
| PD |
JUN 1 |
| PY |
1999 |
| VL |
149 |
| IS |
11 |
| SU |
Suppl. S |
| BP |
S30 |
| EP |
S30 |
| UT |
ISI:000080526500119 |
| ER |
|
| PT |
J |
| AU |
Costantini, M
Musso, M
Viterbori, P
Bonci, F
Del Mastro, L
Garrone, O
Venturini, M
Morasso, G |
| TI |
Detecting psychological distress in cancer patients: validity of the
Italian version of the Hospital Anxiety and Depression Scale |
| SO |
SUPPORTIVE CARE IN CANCER |
| AB |
The psychometric properties of the Italian version of the Hospital
Anxiety and Depression Scale and its utility as a screening instrument
for anxiety and depression in a non-psychiatric setting were evaluated.
The questionnaire was administered twice to 197 breast cancer patients
randomised in a phase III adjuvant clinical trial: before the start of
chemotherapy and at the first followup visit. The presence of
psychiatric disorders was evaluated at the followup visit using the
Structured Clinical Interview for DSM-III-R in 132 patients. Factor
analyses identified two strictly correlated factors. Crohnbach's alpha
for the anxiety and depression scales ranged between 0.80 and 0.85. At
follow-up, 50 patients (38%) were assigned a current DSM-III-R
diagnosis, in most cases adjustment disorders (24%) or major depressive
disorder (10%). Receiver operating characteristics (ROC) analysis was
used to test the discriminant validity for both anxiety and depressive
disorders. The comparison of the areas under the curve (AUC) between
the two scales did not show any difference in identifying either
anxiety (P=0.855) or depressive disorders (P=0.357). The 14-item total
scale showed a high internal consistency (alpha=0.89 and 0.88) and a
high discriminating power for all the psychiatric disorders (AUC=0.89;
95% CI=0.83-0.94). The cut-off point that maximised sensitivity (84%)
and specificity (79%) was 10. These results suggest that the total
score is a valid measure of emotional distress, so that the Italian
version of HADS can be used as a screening questionnaire for
psychiatric disorders. The use of the two subscales as a 'case
identifier' or as an outcome measure should be considered with caution. |
| SN |
0941-4355 |
| PD |
MAY |
| PY |
1999 |
| VL |
7 |
| IS |
3 |
| BP |
121 |
| EP |
127 |
| UT |
ISI:000079908300004 |
| ER |
|
| PT |
J |
| AU |
Holden, RJ
Pakula, IS |
| TI |
Tumor necrosis factor-alpha: is there a continuum of liability between
stress, anxiety states and anorexia nervosa? |
| SO |
MEDICAL HYPOTHESES |
| AB |
Since the time of Freud, psychiatry has embraced the proposition that
physiological and/or psychological stress precipitates various
psychiatric disorders. To this effect, we propose that a continuum of
liability obtains between stress, anxiety states and anorexia nervosa -
a continuum which is grounded on a cytokine profile common to each of
these conditions. For example, the biological response to stress,
anxiety states and anorexia nervosa includes the elevation of
interleukin-1 beta (IL-1 beta) and tumor necrosis factor-alpha
(TNF-alpha), and downregulation of interferon-gamma (IFN-gamma).
Sustained elevation of IL-1 beta and TNF-alpha dysregulates both
somatostatin and insulin secretion, the tatter of which influences
regional cerebral blood flow (rCBF) and brain energy metabolism. In
addition, IL-1 beta and TNF-alpha influence the expression of certain
crucial neuropeptides, which are known to be associated with anxiety
states and anorexia nervosa. These neuropeptides include:
beta-endorphin, cholecystokinin (CCK), neuropeptide Y (NPY) and
vasoactive intestinal peptide (VIP). beta-endorphin effects glucose
metabolism in the limbic system, CCK increases the release of
beta-endorphin from the anterior pituitary, NPY is a powerful
anxiolytic that regulates beta-endorphin and insulin, while VIP
indirectly regulates the expression of TNF-alpha through the inhibition
of interleukin-4 (IL-4). |
| SN |
0306-9877 |
| PD |
FEB |
| PY |
1999 |
| VL |
52 |
| IS |
2 |
| BP |
155 |
| EP |
162 |
| UT |
ISI:000079688900010 |
| ER |
|
| PT |
J |
| AU |
Brain, K
Norman, P
Gray, J
Mansel, R |
| TI |
Anxiety and adherence to breast self-examination in women with a family
history of breast cancer |
| SO |
PSYCHOSOMATIC MEDICINE |
| AB |
Objective: Previous research has indicated low rates of adherence to
monthly breast self-examination (BSE) in women with a family history of
breast cancer, and anxiety has been identified as a major factor that
may interfere with regular self-examination. However, the direction of
the relationship between anxiety and BSE frequency remains unclear,
with some studies indicating that high anxiety promotes adherence and
others indicating that it leads to avoidance. The aim of the present
study was to clarify the relationship between anxiety and adherence to
breast self-examination by comparing the impact of general anxiety with
that of cancer-specific anxiety on BSE frequency. Methods: A sample of
at-risk women (N = 833) completed a questionnaire regarding BSE
frequency, general anxiety, breast cancer worries, perceived risk of
breast cancer, and family history of breast cancer. Women who
self-examined infrequently (N = 211), appropriately (N = 462), or
excessively (N = 156) were compared on these variables. Results:
Statistical analyses indicated that general anxiety differentiated only
between excessive self-examiners and less frequent self-examiners, with
excessive self-examiners reporting significantly higher general
anxiety. Breast cancer worries differentiated between all three groups
in a linear fashion, with increasing cancer worries associated with
higher levels of BSE. Conclusions: In some at-risk women, high cancer
anxiety may lead to high general anxiety and precipitate hypervigilant
breast self-examination rather than avoidance. These findings are
discussed in relation to psychoeducational interventions and genetic
counseling services for women with a family history of breast cancer. |
| SN |
0033-3174 |
| PD |
MAR-APR |
| PY |
1999 |
| VL |
61 |
| IS |
2 |
| BP |
181 |
| EP |
187 |
| UT |
ISI:000079301000010 |
| ER |
|
| PT |
J |
| AU |
Hall, A
A'Hern, R
Fallowfield, L |
| TI |
Are we using appropriate self-report questionnaires for detecting
anxiety and depression in women with early breast cancer? |
| SO |
EUROPEAN JOURNAL OF CANCER |
| AB |
The aim of this prospective study was to identify the psychiatric
morbidity associated with the diagnosis and treatment of early breast
cancer. At each of five time points, 269 women were interviewed using a
shortened version of the Present State Examination (PSE) and 266
completed self-assessment questionnaires, the Hospital and Anxiety
Depression Scale (HADS) and the Rotterdam Symptom Checklist (RSCL).
This paper compares the ability of the questionnaires to detect
psychiatric morbidity with that of the PSE. The majority of women who
experienced anxiety and/or depression did so within 3 months of their
initial surgery. The clinical interview identified anxiety disorder in
132 of 266 women (49.6%) and depressive illness in 99/266 (37.2%)
during the first 3 months. Using the recommended threshold of greater
than or equal to 11 for caseness, the sensitivities for both tests were
very low at 24.2% (HADS anxiety) and 14.1% (HADS depression) and 30.6%
(RSCL psychological distress scale). Lowering the threshold value to
greater than or equal to 7 on the HADS improved the sensitivity to 72%
for the anxiety subscale, but it remained low at 37.4% for the
depression subscale. A threshold of greater than or equal to 7 for the
RSCL scale raised sensitivity to 66.7%. Lowering the threshold values
raised the sensitivity of both the instruments but decreased their
specificity: the lower the threshold, the greater the number of women
who were identified as false positives which would increase the work
load for clinic staff if used as a screening tool. Given that the HADS
was inadequate in discriminating for depressive illness, it was not
surprising that its use as a unitary scale with a threshold value as
low as 12 resulted in a sensitivity of only 42.7%. In the light of
these findings, we question the use of both the HADS and the RSCL as
suitable research or screening instruments for detection of
psychological morbidity in early breast cancer. (C) 1999 Elsevier
Science Ltd. All rights reserved. |
| SN |
0959-8049 |
| PD |
JAN |
| PY |
1999 |
| VL |
35 |
| IS |
1 |
| BP |
79 |
| EP |
85 |
| UT |
ISI:000078642500017 |
| ER |
|
| PT |
J |
| AU |
Payne, DK
Hoffman, RG
Theodoulou, M
Dosik, M
Massie, MJ |
| TI |
Screening for anxiety and depression in women with breast cancer -
Psychiatry and medical oncology gear up for managed care |
| SO |
PSYCHOSOMATICS |
| AB |
In this study 275 women with breast cancer attending ambulatory breast
cancer clinics in two sites were evaluated for psychological distress
by rising three self-report instruments: a visual analogue scale for
psychological distress, the Hospital Anxiety and Depression Scale, and
the Brief Symptom Inventory. Results suggest that significant
psychological distress exists in ambulatory women with breast cancer;
all three instruments effectively measured that level of distress.
Implications for the use of these instruments in educating oncological
staff members, documentations of psychiatric services are discussed. |
| SN |
0033-3182 |
| PD |
JAN-FEB |
| PY |
1999 |
| VL |
40 |
| IS |
1 |
| BP |
64 |
| EP |
69 |
| UT |
ISI:000078232900009 |
| ER |
|
| PT |
J |
| AU |
Nordin, K
Glimelius, B |
| TI |
Predicting delayed anxiety and depression in patients with
gastrointestinal cancer |
| SO |
BRITISH JOURNAL OF CANCER |
| AB |
The aim of this study was to examine the possibility of predicting
anxiety and depression 6 months after a cancer diagnosis on the basis
of measures of anxiety, depression, coping and subjective distress
associated with the diagnosis and to explore the possibility of
identifying individual patients with high levels of delayed anxiety and
depression associated with the diagnosis. A consecutive series of 159
patients with gastrointestinal cancer were interviewed in connection
with the diagnosis, 3 months (non-cured patients only) and 6 months
later. The interviews utilized structured questionnaires assessing
anxiety and depression [Hospital Anxiety and Depression (HAD) scale],
coping [Mental Adjustment to cancer (MAC) scale] and subjective
distress [Impact of Event (IES) scale]. Patient anxiety and depression
close to the diagnosis were found to explain approximately 35% of the
variance in anxiety and depression that was found 6 months later. The
addition of coping and subjective distress measures did little to
improve that prediction. A model using (standardized) cut-off scores of
moderate to high anxiety, depression (HAD) and intrusive thoughts (IES
subscale) close to the diagnosis to identify patients at risk for
delayed anxiety and depression achieved a sensitivity of 75% and a
specificity of 98%. Levels of anxiety and depression at diagnosis
predicted a similar status 6 months later. The results also indicated
that the HAD scale in combination with the IES intrusion subscale may
be used as a tool for detecting patients at risk of delayed anxiety and
depression. |
| SN |
0007-0920 |
| PD |
FEB |
| PY |
1999 |
| VL |
79 |
| IS |
3-4 |
| BP |
525 |
| EP |
529 |
| UT |
ISI:000078165200023 |
| ER |
|
| PT |
J |
| AU |
Boermeester, F
Berard, RMF |
| TI |
Factor structure of the Hospital Anxiety and Depression Scale in cancer
patients |
| SO |
SOUTH AFRICAN MEDICAL JOURNAL |
| AB |
Objectives. The Hospital Anxiety and Depression Scale (HADS) has been
shown to be an effective screening tool for oncology settings. Its
increasing popularity in various parts of the world highlights the need
for continuous psychometric evaluation, in particular with regard to
the cross-cultural validity of the instrument, and to debates regarding
the appropriate use of the scale.
Method. The HADS was completed by 456 cancer patients attending an
oncology outpatient clinic at Groote Schuur Hospital, a large tertiary
care institution in Cape Town, South Africa. Internal reliability
coefficients were calculated and the factor structure of the HADS was
assessed using a principal component analysis.
Results. The results are consistent with previous data reported from
the UK, and therefore support the bidimensionality of the HADS in
cancer patients. The depression subscale appears to measure a
relatively homogeneous construct representing the symptom of anhedonia.
Conclusion. The HADS can be a used in under-resourced and under-staffed
oncology settings and still emerge as a robust screening instrument. |
| SN |
0038-2469 |
| PD |
NOV |
| PY |
1998 |
| VL |
88 |
| IS |
11 |
| SU |
Suppl. 2 |
| BP |
1495 |
| EP |
+ |
| UT |
ISI:000077601100005 |
| ER |
|
| PT |
J |
| AU |
Thomas, R
Brown, C
Dalton, L
Welton, S
Stockton, D |
| TI |
Anxiety and depression - Effect on patients preferences for information
following a diagnosis of cancer |
| SO |
ANNALS OF ONCOLOGY |
| SN |
0923-7534 |
| PY |
1998 |
| VL |
9 |
| SU |
Suppl. 4 |
| BP |
141 |
| EP |
141 |
| UT |
ISI:000076947100667 |
| ER |
|
| PT |
J |
| AU |
Aziz, Z
Qazi, S
Akram, S
Latif, T
Rehman, A |
| TI |
Prevalence of anxiety and depression in cancer patients receiving
chemotherapy |
| SO |
ANNALS OF ONCOLOGY |
| SN |
0923-7534 |
| PY |
1998 |
| VL |
9 |
| SU |
Suppl. 4 |
| BP |
143 |
| EP |
143 |
| UT |
ISI:000076947100678 |
| ER |
|
| PT |
J |
| AU |
Ozet, A
Isikhan, V
Arpaci, F
Ozturk, B
Komurcu, S |
| TI |
Interpersonal sensitivity, depression and anxiety positions of patients
with breast cancer |
| SO |
ANNALS OF ONCOLOGY |
| SN |
0923-7534 |
| PY |
1998 |
| VL |
9 |
| SU |
Suppl. 4 |
| BP |
147 |
| EP |
147 |
| UT |
ISI:000076947100693 |
| ER |
|
| PT |
J |
| AU |
Julian-Reynier, C
Eisinger, F
Chabal, F
Aurran, Y
Bignon, YJ
Nogues, C
Machelard, M
Maugard, C
Vennin, P
Sobol, H |
| TI |
Time elapsing from cancer diagnosis and anxiety in women attending
cancer genetic clinics |
| SO |
ONCOLOGY REPORTS |
| AB |
The aim of this study was to investigate the effects of cancer genetic
consultations on feelings of anxiety in women with breast/ovarian
cancer. Among the 138 women attending six French clinics during a
one-year period, 115 (83.3%) answered pre-and post-consultation
questionnaires. The state anxiety score (Spielberger's STAI) was lower
(paired t-test, p<0.001) after the consultation (34.7+/-9.4) than
before (38.8+/-10.5). The time elapsing since cancer diagnosis
(r=-0.28, p=0.007) was the main predictor of the decrease in anxiety.
The patients consulting earlier after their cancer was diagnosed were
more anxious before the consultation than those consulting later:
whereas their anxiety states after the consultation were similar. The
consultation effectively decreased the anxiety observed and the anxiety
felt by cancer patients before the consultation may constitute an
anticipatory stress response that should be investigated. |
| SN |
1021-335X |
| PD |
JUL-AUG |
| PY |
1998 |
| VL |
5 |
| IS |
4 |
| BP |
885 |
| EP |
888 |
| UT |
ISI:000074173100020 |
| ER |
|
| PT |
J |
| AU |
Hoffman, R
Payne, D
Theodoulou, M
Massie, MJ |
| TI |
Screening for anxiety & depression in women with breast cancer |
| SO |
PSYCHOSOMATICS |
| SN |
0033-3182 |
| PD |
MAR-APR |
| PY |
1998 |
| VL |
39 |
| IS |
2 |
| BP |
225 |
| EP |
229 |
| UT |
ISI:000073267900086 |
| ER |
|
| PT |
J |
| AU |
Montazeri, A
Milroy, R
Hole, D
McEwen, J
Gillis, CR |
| TI |
Anxiety and depression in patients with lung cancer before and after
diagnosis: findings from a population in Glasgow, Scotland |
| SO |
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH |
| SN |
0143-005X |
| PD |
MAR |
| PY |
1998 |
| VL |
52 |
| IS |
3 |
| BP |
203 |
| EP |
204 |
| UT |
ISI:000072362700014 |
| ER |
|
| PT |
J |
| AU |
[Anon] |
| TI |
Beat breast cancer anxiety |
| SO |
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION |
| SN |
0098-7484 |
| PD |
FEB 25 |
| PY |
1998 |
| VL |
279 |
| IS |
8 |
| BP |
574 |
| EP |
574 |
| UT |
ISI:000072041900008 |
| ER |
|
| PT |
J |
| AU |
Brewin, CR
Watson, M
McCarthy, S
Hyman, P
Dayson, D |
| TI |
Memory processes and the course of anxiety and depression in cancer
patients |
| SO |
PSYCHOLOGICAL MEDICINE |
| AB |
Background. Intrusive memories of stressful events, many involving
illness and death, are found in a minority of depressed cancer
patients, and may predict the course of anxiety and depression.
Method. Matched samples of mild to moderately depressed and
non-depressed cancer patients were followed up after 6 months. Anxiety
and depression at follow-up were related to measures of intrusive
memories of stressful life events and autobiographical memory
functioning that had been assessed at baseline.
Results. Levels of anxiety and depression remained fairly constant over
time in the two groups, and the depressed group continued to experience
high levels of intrusive memories. The presence of intrusive memories
at baseline, and the extent to which these memories were consciously
avoided, predicted greater anxiety at follow-up, even after controlling
for initial severity of physical and psychiatric symptoms. None of the
measures of memory functioning predicted levels of depression at
follow-up.
Conclusions. Intrusive memories appear to be a marker of more prolonged
psychopathology in cancer patients and may respond to direct
therapeutic intervention. |
| SN |
0033-2917 |
| PD |
JAN |
| PY |
1998 |
| VL |
28 |
| IS |
1 |
| BP |
219 |
| EP |
224 |
| UT |
ISI:000071746500022 |
| ER |
|
| PT |
J |
| AU |
Hughes-Benzie, R
Perras, H
Graham, I
Coyle, D |
| TI |
Characteristics of a Canadian population at risk for hereditary
colorectal cancer: Demographics, risk perception, anxiety and
depression levels. |
| SO |
AMERICAN JOURNAL OF HUMAN GENETICS |
| SN |
0002-9297 |
| PD |
OCT |
| PY |
1997 |
| VL |
61 |
| IS |
4 |
| SU |
Suppl. S |
| BP |
A189 |
| EP |
A189 |
| UT |
ISI:000071446001092 |
| ER |
|
| PT |
J |
| AU |
Wilkinson, S |
| TI |
Aromatherapy as an anxiety management programme for patients with cancer |
| SO |
EUROPEAN JOURNAL OF CANCER |
| SN |
0959-8049 |
| PD |
SEP |
| PY |
1997 |
| VL |
33 |
| SU |
Suppl. 8 |
| BP |
279 |
| EP |
279 |
| UT |
ISI:A1997XX83000278 |
| ER |
|
| PT |
J |
| AU |
Aass, N
Fossa, SD
Dahl, AA
Moe, TJ |
| TI |
Prevalence of anxiety and depression in cancer patients seen at the
Norwegian Radium Hospital |
| SO |
EUROPEAN JOURNAL OF CANCER |
| AB |
The aim of this study was to investigate the prevalence of anxiety and
depression in cancer patients seen at the Norwegian Radium Hospital,
using the Hospital Anxiety and Depression Scale (HADS), the EORTC
QLQ-C33 and an ad hoc designed questionnaire. In addition, information
about the patients' malignant disease and treatment was obtained. The
prevalence of anxiety and depression among 716 evaluable patients was
13% and 9% respectively, as assessed with HADS. In hospitalised
patients, the risk of psychiatric distress was approximately twice that
of patients in the outpatient clinic. Female patients reported
significantly more anxiety than men. Patients <30 or >70 years old
expressed less anxiety than all other patients. Age or gender had no
influence on the occurrence of depression. Impaired ability to continue
professional work and/or daily life activities, impaired social life
and previous psychiatric problems were significantly correlated with
anxiety and depression as were impaired physical function, fatigue and
pain. The prevalence of depression, but not anxiety, increased in the
presence of distant metastases, with less than a month since diagnosis,
and with relapse or progression. In the logistic regression analysis, a
history of previous psychiatric problems and impaired social life were
correlated with both anxiety and depression. Female gender, impaired
physical activity and impaired social role function were additional
predictive parameters for anxiety, whereas fatigue predicted
depression. Careful attention should be paid to cancer patients
displaying these problems in order to diagnose and treat depression and
anxiety disorders. (C) 1997 Elsevier Science Ltd. |
| SN |
0959-8049 |
| PD |
SEP |
| PY |
1997 |
| VL |
33 |
| IS |
10 |
| BP |
1597 |
| EP |
1604 |
| UT |
ISI:A1997YD33400017 |
| ER |
|
| PT |
J |
| AU |
Hodgson, C
Higginson, I
McDonnell, M
Butters, E |
| TI |
Family anxiety in advanced cancer: a multicentre prospective study in
Ireland |
| SO |
BRITISH JOURNAL OF CANCER |
| AB |
Six home care services in Southern Ireland collected data on a total of
757 patients over a 6-month period. Patient and family wellbeing were
measured using the staff-rated Support Team Assessment Schedule and
Karnofsky Index. Five hundred and eight patients died while in care,
75% of whom died at home. At referral, 32% of families were rated as
having severe or overwhelming anxiety. During the last week of care,
anxiety remained severe for 26% of family members. Patient and family
well-being were inter-related, and there were significant interactions
between family anxiety and patient physical and psychological symptoms,
and communication. Discriminant analysis produced two predictive
models. In model 1,family anxiety at referral strongly predicts family
anxiety in the last week of life. In model 2, family anxiety at
referral is excluded from the analysis, and the significant predictor
factors at referral for family anxiety in the last 4 weeks of life are
patient symptom control, sex of patient, diagnosis and patient age. |
| SN |
0007-0920 |
| PD |
NOV |
| PY |
1997 |
| VL |
76 |
| IS |
9 |
| BP |
1211 |
| EP |
1214 |
| UT |
ISI:A1997YD13400016 |
| ER |
|
| PT |
J |
| AU |
Allen, R
Newman, SP
Souhami, RL |
| TI |
Anxiety and depression in adolescent cancer: Findings in patients and
parents at the time of diagnosis |
| SO |
EUROPEAN JOURNAL OF CANCER |
| AB |
Adolescent cancer is uncommon and presents an exceptional stress for
the young patient and their parents. The emotional needs of adolescents
with cancer are a major factor in the recommendation for the
establishment of adolescent cancer units in major cancer centres in the
U.K. However, there have been no prospective, longitudinal studies
assessing the psychological impact of a diagnosis of cancer on the
adolescent patient and their family. In 1994 we began a longitudinal
study of the emotional impact of the diagnosis of cancer in patients
and their families presenting to an adolescent cancer unit and of the
coping strategies they employ. This first report presents the results
of the study at the time of diagnosis in 42 adolescents, 34 mothers and
27 fathers. The Beck Depression Inventory (BDI) was used to assess
depression and anxiety levels were measured using Spielberger's State
Trait Anxiety Inventory (STAI). Adolescents and their parents completed
the questionnaires on first admission to the adolescent cancer unit.
The median time since cancer diagnosis was approximately 3 weeks. To
provide normative data for the U.K, adolescent population, control
values were obtained from 173 pupils of the same age and background.
The results showed that, contrary to expectation, adolescents with
cancer were no more anxious or depressed than the control adolescent
population. Nevertheless, a substantial minority of patients and
controls had elevated anxiety or depression scores. Girls were
significantly more anxious (P=0.011) and depressed (P<0.0001) than
boys. Mothers were the most anxious family members and were
significantly more anxious than fathers (P=0.038). Parental anxiety
scores, especially mothers, were much higher than reported norms. There
was no significant difference between mothers' and fathers' depression
scores. Although at the time of diagnosis adolescent cancer patients
are not more anxious or depressed than their healthy peers, many
adolescents without cancer are anxious or depressed. Staff on
adolescent cancer units should therefore be aware of the frequency of
emotional disturbance in this population. Mothers are the most anxious
family members. Although the findings are relatively reassuring at the
time of diagnosis, follow-up data from this cohort will show whether
anxiety and depression change with treatment involving intensive
chemotherapy, surgery and radiotherapy and will indicate the coping
strategies which patients and their families adopt in dealing with both
the disease and its treatment. (C) 1997 Published by Elsevier Science
Ltd. |
| SN |
0959-8049 |
| PD |
JUL |
| PY |
1997 |
| VL |
33 |
| IS |
8 |
| BP |
1250 |
| EP |
1255 |
| UT |
ISI:A1997XR38300026 |
| ER |
|
| PT |
J |
| AU |
Payne, D
Theodoulou, M
Darby, A
DeAngelis, C
Massie, MJ |
| TI |
Screening for anxiety and depression in breast cancer patients |
| SO |
PSYCHOSOMATICS |
| SN |
0033-3182 |
| PD |
MAR-APR |
| PY |
1997 |
| VL |
38 |
| IS |
2 |
| BP |
213 |
| EP |
214 |
| UT |
ISI:A1997WL68300103 |
| ER |
|
| PT |
J |
| AU |
Nakada, S
Nagao, K
Takiguchi, Y
Tatsumi, K
Kuriyama, T |
| TI |
Quality of life and anxiety before and after lung cancer chemotherapy:
Relationship to patient's personality |
| SO |
INTERNAL MEDICINE |
| AB |
The purpose of the study was to assess the quality of life (QOL) and
anxiety in 50 inpatients with primary lung cancer and examine the
influence of their personalities on the QOL assessment, We used a
psychological personality test to evaluate the patient's personality,
then followed the course of QOL and anxiety before and after
chemotherapy. To measure QOL, we used Holmes's QOL checklist, and the
State-Trait Anxiety Inventory was adopted to estimate the patient's
anxiety, Eighty courses of chemotherapy were administered, and QOL
evaluations were performed 235 times, By using factor analysis, the
somatic, social and psychological factors were extracted which
confirmed the reliability and validity of the QOL checklist, The
psychological QOL score showed a correlation with A (Adult) and AC
(Adapted Child) of the five ego states in the Egogram. Therefore, it is
important to survey the patients' personalities in order to grasp their
QOL accurately. |
| SN |
0918-2918 |
| PD |
AUG |
| PY |
1996 |
| VL |
35 |
| IS |
8 |
| BP |
611 |
| EP |
616 |
| UT |
ISI:A1996VL38200007 |
| ER |
|
| PT |
J |
| AU |
Razavi, D
Allilaire, JF
Smith, M
Salimpour, A
Verra, M
Desclaux, B
Saltel, P
Piollet, I
GauvainPiquard, A
Trichard, C
Cordier, B
Fresco, R
Guillibert, E
Sechter, D
Orth, JP
Bouhassira, M
Mesters, P
Blin, P |
| TI |
The effect of fluoxetine on anxiety and depression symptoms in cancer
patients |
| SO |
ACTA PSYCHIATRICA SCANDINAVICA |
| AB |
Little has been done to study the effectiveness of antidepressants in
controlling anxiety/depression in a population of cancer patients. A
double-blind placebo-controlled study was therefore designed to assess
the effectiveness of 20 mg fluoxetine, Of 115 cancer patients who
fulfilled entry criteria for levels of distress, 45 patients were
randomized to a fluoxetine treatment group (FA) and 46 patients to a
placebo group (PA) after a 1-week placebo period designed to exclude
placebo responders. The Montgomery and Asberg Depression Scale (MADRS),
the Hamilton Anxiety Scale (HAS), the Hospital Anxiety and Depression
Scale (HADS), the Revised Symptom Checklist (SCL90-R) and the Spitzer
Quality of Life Index (SQOLI) were used to assess the efficacy of
fluoxetine. The response rate, defined by a HADS score lower than 8
after 5 weeks of treatment, was not significantly higher in the FA
group (11%) compared to the PA group (7%). Compared to the PA group,
patients in the FA group showed a significantly greater decrease in
SCL90-R mean total score after 5 weeks, but not a greater decrease in
HADS mean score. No difference between the two groups was found in
observer-reported assessments (MADRS, HAS and SQOLI). Significantly
more drop-outs were observed in the FA group (n=15) than in the PA
group (n=7), although the frequencies of side-effects were not
significantly different. |
| SN |
0001-690X |
| PD |
SEP |
| PY |
1996 |
| VL |
94 |
| IS |
3 |
| BP |
205 |
| EP |
210 |
| UT |
ISI:A1996VJ34200012 |
| ER |
|
| PT |
J |
| AU |
Nordin, K
Glimelius, B
Pahlman, L
Sjoden, PO |
| TI |
Anxiety, depression and worry in gastrointestinal cancer patients
attending medical follow-up control visits |
| SO |
ACTA ONCOLOGICA |
| AB |
Anxiety, depression and worry were assessed in 141 consecutive
gastrointestinal cancer patients scheduled for follow-up control
visits, Participants completed two questionnaires, one including the
Hospital Anxiety and Depression Scale (HAD) in conjunction with the
visit and one completed after, The overall levels of anxiety before,
during and after the visit were low, There were no differences between
those who were considered cured and those who were not. Anxiety levels
after the visit were higher for those patients for whom less than one
year had passed since diagnosis. Mean HAD scores for anxiety and
depression were 4.2 and 4.3 respectively, Women reported a higher
degree of anxiety than men. Using a score of 8 or more for
'borderline-possible cases', 15% fell into these categories on the
anxiety scale and 12% on the depression scale, About 30% of the
patients worried about seeing a new physician and 25% about what the
examination or tests would show, It is concluded that regular,
scheduled control visits pose a significant threat to the psychological
well-being of only a minority of gastrointestinal cancer patients. |
| SN |
0284-186X |
| PY |
1996 |
| VL |
35 |
| IS |
4 |
| BP |
411 |
| EP |
416 |
| UT |
ISI:A1996UX51000005 |
| ER |
|
| PT |
J |
| AU |
Thirlaway, K
Fallowfield, L
Hunnerley, H
Powles, T |
| TI |
Anxiety in women 'at risk' of developing breast cancer |
| SO |
BRITISH JOURNAL OF CANCER |
| AB |
Do family history clinics offering counselling, surveillance and
preventative programmes alleviate or exacerbate anxiety in women at a
high risk of developing breast cancer? In this study risk perceptions
and anxiety of 99 'at risk' women participating in the Tamoxifen
Prevention Trial were compared with those of 87 'at risk' women not
attending any specialist clinic who were recruited from the National
Breast Screening Programme (NBSP). Most anxiety was found in NBSP women
with a family history. Women attending the family history clinic and
participating in the trial had anxiety scores comparable with 86 women
recruited from the NBSP who did not have a family history. We conclude
that such specialist clinics do not see a selected group of the most
anxious 'at risk' women nor does participation in tamoxifen prevention
programmes appear to increase anxiety. |
| SN |
0007-0920 |
| PD |
JUN |
| PY |
1996 |
| VL |
73 |
| IS |
11 |
| BP |
1422 |
| EP |
1424 |
| UT |
ISI:A1996UN61600019 |
| ER |
|
| PT |
J |
| AU |
Weist, MD
Finney, JW |
| TI |
Training in early cancer detection and anxiety in adolescent males: A
preliminary report |
| SO |
JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS |
| AB |
Because of concerns about increasing anxiety in a population that is at
relatively low risk for developing cancer, some investigators have
recommended that training in testicular self-examination (TSE) not be
provided to adolescent males. However, empirical findings documenting a
link between training in cancer detection and increased anxiety in
adolescent males are lacking. In this preliminary study, we assessed
whether training in TSE was actually associated with elevated state
anxiety in two samples of adolescent males (29 ninth graders and 30
college underclassmen). For both groups, anxiety scores were well
within normal limits at postassessment, indicating that a purported
cost of the procedure may in fact not exist. |
| SN |
0196-206X |
| PD |
APR |
| PY |
1996 |
| VL |
17 |
| IS |
2 |
| BP |
98 |
| EP |
99 |
| UT |
ISI:A1996UF57500006 |
| ER |
|
| PT |
J |
| AU |
Last, BF
vanVeldhuizen, AMH |
| TI |
Information about diagnosis and prognosis related to anxiety and
depression in children with cancer aged 8-16 years |
| SO |
EUROPEAN JOURNAL OF CANCER |
| AB |
The aim of this study was to test the hypothesis that being openly
informed about the diagnosis and prognosis benefits the emotional
well-being of children with cancer. A stratified sample of 56 children
with cancer aged 8-16 years and their parents participated. The parents
were interviewed about the information they had given to their child.
Self-report questionnaires were administered to the children measuring
anxiety and depression. Children who received open information about
their diagnosis and prognosis at the initial stage of the disease
showed significantly less anxiety and depression. Our findings suggest
that parents should be advised to inform their child with cancer openly
and soon after the initial diagnosis. Physicians should offer help to
the parents in dealing with the difficult task of confronting the child
with the diagnosis, prognosis and treatment. |
| SN |
0959-8049 |
| PD |
FEB |
| PY |
1996 |
| VL |
32A |
| IS |
2 |
| BP |
290 |
| EP |
294 |
| UT |
ISI:A1996UA83200022 |
| ER |
|
| PT |
J |
| AU |
Drossaert, CCH
Boer, H
Seydel, ER |
| TI |
Perceived risk, anxiety, mammogram uptake, and breast self-examination
of women with a family history of breast cancer: The role of knowing to
be at increased risk |
| SO |
CANCER DETECTION AND PREVENTION |
| AB |
Since women with a first-degree relative with breast cancer are at
increased risk for breast cancer, it is of special importance that they
adhere to early detection programs. In this study, women with (389) and
without (3295) a family history of breast cancer were compared with
respect to risk perception, breast cancer anxiety, and early detection
behavior. Special attention was paid to the role of knowing that family
history is a breast cancer risk factor. It was found that 46% of
''family history positives'' did not know that their risk was increased
by their family history. Still, family history positives had increased
risk perception; our results suggest that this was partly caused by
their knowing they belonged to a risk group and partly by their having
experienced the disease at close range. Although family history
positives had higher risk perceptions, no differences in early
detection behavior were found. This could not be attributed to high
anxiety levels. Implications for health education are discussed. |
| SN |
0361-090X |
| PY |
1996 |
| VL |
20 |
| IS |
1 |
| BP |
76 |
| EP |
85 |
| UT |
ISI:A1996TY26200010 |
| ER |
|
| PT |
J |
| AU |
Kash, KM
Holland, JC
Jacobsen, PB
Osborne, MP
Miller, DG |
| TI |
Measuring breast cancer anxiety |
| SO |
PSYCHOSOMATICS |
| SN |
0033-3182 |
| PD |
MAR-APR |
| PY |
1996 |
| VL |
37 |
| IS |
2 |
| BP |
200 |
| EP |
201 |
| UT |
ISI:A1996TX04500067 |
| ER |
|
| PT |
J |
| AU |
Lampic, C
vonEssen, L
Larsson, G
Pettersson, VW
Sjoden, P |
| TI |
Perceptions of the importance of caring behaviours and patient anxiety
and depression levels in cancer patient-staff dyads |
| SO |
EUROPEAN JOURNAL OF CANCER |
| SN |
0959-8049 |
| PD |
NOV |
| PY |
1995 |
| VL |
31A |
| SU |
Suppl. 5 |
| BP |
1441 |
| EP |
1441 |
| UT |
ISI:A1995TH91901436 |
| ER |
|
| PT |
J |
| AU |
JULIANREYNIER, C
CHABAL, F
SOBOL, H
AURRAN, Y
NOGUES, C
VENNIN, P
BIGNON, YJ
ROUMAGNAC, M
MAUGARDLOUBOUTIN, C
VERSINI, S
SERIN, D
MICHEL, JP
EISINGER, F |
| TI |
RISK PERCEPTION, ANXIETY AND ATTITUDES TOWARDS PREDICTIVE TESTING ALTER
CANCER GENETIC CONSULTATIONS |
| SO |
AMERICAN JOURNAL OF HUMAN GENETICS |
| SN |
0002-9297 |
| PD |
OCT |
| PY |
1995 |
| VL |
57 |
| IS |
4 |
| SU |
Suppl. S |
| BP |
1722 |
| EP |
1722 |
| UT |
ISI:A1995RW68701720 |
| ER |
|
| PT |
J |
| AU |
TADMOR, OP
ZLOTOGORSKI, Z
GALRONDUNIEC, M
RABINOWITZ, R
NEUMAN, M
BELLER, U
DIAMANT, YZ |
| TI |
THE EFFECT OF FEEDBACK ON ANXIETY LEVELS DURING ULTRASOUND SCANNING FOR
OVARIAN-CANCER |
| SO |
ULTRASOUND IN OBSTETRICS & GYNECOLOGY |
| AB |
Women undergoing ultrasound scanning for the detection of ovarian
cancer benefit psychologically from the examination, which has been
shown to reduce levels of anxiety, depression, hostility and complaints
about somatic symptoms. However, it is not completely clear what
aspects of the ultrasound examination are responsible for these
effects, and how these beneficial psychological effects vary under
different circumstances. This study examined, in particular, the effect
of various levels of feedback on patients' anxiety levels before and
after ultrasound examination.
Two hundred and seven women were randomly assigned to two different
experimental conditions: high feedback and low feedback. The subjects'
levels of anxiety (both trait and state anxiety) were measured
immediately before and after the ultrasound examination. The women's
individual risk factors for ovarian cancer were also recorded.
This study showed a significant decrease in the level of trait anxiety
following ultrasound scanning. The decrease in anxiety did not relate
to the level of feedback provided to the patients, nor to the woman's
degree of risk for ovarian cancer. The results are discussed in terms
of possible implications for clinical care and the allocation of
resources in the medical system. |
| SN |
0960-7692 |
| PD |
AUG |
| PY |
1995 |
| VL |
6 |
| IS |
2 |
| BP |
135 |
| EP |
139 |
| UT |
ISI:A1995RR87200012 |
| ER |
|
| PT |
J |
| AU |
SUTTON, S
SAIDI, G
BICKLER, G
HUNTER, J |
| TI |
DOES ROUTINE SCREENING FOR BREAST-CANCER RAISE ANXIETY - RESULTS FROM A
3 WAVE PROSPECTIVE-STUDY IN ENGLAND |
| SO |
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH |
| AB |
Objective - To investigate whether mammography raises anxiety in
routinely screened women who receive a negative result.
Design - Prospective design in which women completed questionnaires at
three key points in the breast screening process: at baseline (before
being sent their invitation for breast screening), at the screening
clinic immediately before or after screening, and at follow up, about
nine months after baseline. Information was obtained from non-attenders
as well as from attenders.
Setting - Bromelia District Health Authority, served by the South East
London Breast Screening Service.
Participants - Two overlapping samples were used. Sample A comprised
1500 women aged 50-64 who were due to be called for first round
screening at a mobile screening unit. Altogether 1021 (68%) returned a
usable questionnaire and 795 of these (78%) also provided adequate
information at nine month follow up: there were 695 attenders
(including 24 women who received false positive results) and 100
non-attenders. Sample B consisted of 868 women who attended the
screening unit in a three month period, 732 (84%) of whom provided
adequate data. A total of 306 attenders (including 10 who received
false positive results) occurred in both samples and provided adequate
information on all occasions. The main analyses were based on these 306
women plus the 100 nonattenders. The analysis of retrospective anxiety
took advantage of the larger sample size of 695 attenders.
Main results - On average, the women were not unduly anxious at any of
the three points in the screening process. Among attenders, there was
no difference between anxiety levels immediately before and immediately
after screening. Anxiety was lowest at the clinic and highest at
baseline but the changes were very small in absolute terms. Anxiety did
not predict attendance: there were no differences in anxiety levels
between attenders and non-attenders at baseline. As expected, women who
received false positive results recalled feeling extremely anxious
after they had received the referral letter but their retrospective
anxiety was also higher than in the negative screenees at earlier
stages in the breast screening process. They also reported having
experienced more pain and discomfort during the x ray.
Conclusions - Anxiety does not seem to be an important problem in
routinely screened women who receive a negative result. This finding is
very reassuring in relation to a major criticism of breast screening
programmes. Thus, apart from maintaining current procedures such as
keeping waiting times to a minimum, there seems to be no need to
introduce special anxiety reducing interventions into the national
programme. On the other hand, the findings for women who received false
positive results suggest that there are aspects of the experience of
being recalled for assessment after an abnormal mammogram that warrant
further attention. The relationship between contemporaneous and
retrospective anxiety should also be studied. |
| SN |
0143-005X |
| PD |
AUG |
| PY |
1995 |
| VL |
49 |
| IS |
4 |
| BP |
413 |
| EP |
418 |
| UT |
ISI:A1995RN93600014 |
| ER |
|
| PT |
J |
| AU |
TYC, VL
BARCLAY, DR |
| TI |
NONPHARMACOLOGIC INTERVENTIONS FOR TREATMENT-RELATED ANXIETY AND
DISTRESS IN PEDIATRIC CANCER-PATIENTS |
| SO |
INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY |
| AB |
Children with cancer must contend with a number of medical stressors
including painful procedures and chemotherapy-induced side effects.
Several nonpharmacological/psychological interventions are available to
the pediatric cancer patient for the management of treatment-related
anxiety and distress. We describe specific methods of intervention used
with children and adolescents and the factors affecting treatment
effectiveness. We also review, in greater detail, the empirical support
for the efficacy of different interventions such as hypnosis,
progressive muscle relaxation training, distraction, multicomponent
cognitive-behavioral packages, and parent-mediated programs. Particular
attention is given to the application of these approaches to the
reduction of acute procedural distress, chemotherapy distress, and
distress associated with noninvasive procedures. Collectively, the
research suggests that nonpharmacological interventions are effective
in reducing distress. The implications of these findings and several
methodological and practical issues for future research are discussed. |
| SN |
1070-2903 |
| PY |
1995 |
| VL |
2 |
| IS |
3 |
| BP |
243 |
| EP |
254 |
| UT |
ISI:A1995RJ13200011 |
| ER |
|
| PT |
J |
| AU |
POROCH, D |
| TI |
THE EFFECT OF PREPARATORY PATIENT EDUCATION ON THE ANXIETY AND
SATISFACTION OF CANCER-PATIENTS RECEIVING RADIATION-THERAPY |
| SO |
CANCER NURSING |
| AB |
Facing treatment of cancer with radiation therapy causes anxiety for
most prospective patients. The purpose of this study was to test the
effectiveness of preparatory patient education in reducing anxiety and
improving satisfaction during the course of treatment. A
quasiexperimental time series design was used to compare two groups of
25 patients, matched according to treatment type and gender, who were
commencing radiation therapy for the first time. The experimental
group received two structured teaching interventions incorporating
sensory and procedural information designed to familiarize the patient
with the forthcoming experience. The theoretical basis for the
intervention arose from Johnson's work (1973) on preparing patients for
threatening events. The control group received the standard
information that was current in the Radiation Therapy Department where
the study was conducted. The results indicated that the experimental
group was significantly less anxious and significantly more satisfied
during radiation therapy than their counterparts in the control group,
and the effects were maintained throughout the treatment period of up
to 7 weeks. |
| SN |
0162-220X |
| PD |
JUN |
| PY |
1995 |
| VL |
18 |
| IS |
3 |
| BP |
206 |
| EP |
214 |
| UT |
ISI:A1995QZ94700005 |
| ER |
|
| PT |
J |
| AU |
VELIKOVA, G
SELBY, PJ
SNAITH, PR
KIRBY, PG |
| TI |
THE RELATIONSHIP OF CANCER PAIN TO ANXIETY |
| SO |
PSYCHOTHERAPY AND PSYCHOSOMATICS |
| AB |
The interaction between pain and anxiety in the setting of somatic
illness is a widely recognised association. More accurate knowledge
about the association and also about the means of assessing anxiety in
a clinical setting are of use to the clinician. The present study used
the Hospital Anxiety and Depression Scale for assessment of anxiety,
and the set of linear analogue scales for detecting the presence and
severity of anxiety and pain in an oncology clinic, where patients were
undergoing active treatment for cancer. The relationship between pain
and anxiety was found to be significant, even when the possible
mediating effect of the variables of illness severity and age were
removed. The need for detecting anxiety in order to plan treatment
strategy is emphasised. |
| SN |
0033-3190 |
| PY |
1995 |
| VL |
63 |
| IS |
3-4 |
| BP |
181 |
| EP |
184 |
| UT |
ISI:A1995QY56500008 |
| ER |
|
| PT |
J |
| AU |
KASH, KM
HOLLAND, JC
MILLER, DG
OSBORNE, MP |
| TI |
DOES ANXIETY INTERFERE WITH ADHERENCE TO SCREENING BEHAVIORS IN WOMEN
AT GENETIC RISK FOR BREAST-CANCER |
| SO |
PSYCHOSOMATICS |
| SN |
0033-3182 |
| PD |
MAR-APR |
| PY |
1995 |
| VL |
36 |
| IS |
2 |
| BP |
176 |
| EP |
176 |
| UT |
ISI:A1995QJ70900042 |
| ER |
|
| PT |
J |
| AU |
MILLAR, K
JELICIC, M
BONKE, B
ASBURY, AJ |
| TI |
ASSESSMENT OF PREOPERATIVE ANXIETY - COMPARISON OF MEASURES IN PATIENTS
AWAITING SURGERY FOR BREAST-CANCER |
| SO |
BRITISH JOURNAL OF ANAESTHESIA |
| AB |
We have compared three measurements of anxiety to determine their
equivalence in assessing anxiety before surgery. Forty-four patients
awaiting breast cancer surgery completed the state scale of the
state-trait anxiety inventory (STAI), the hospital anxiety and
depression scale (HAD) and a 100-mm visual analogue scale (VAS).
Analysis restricted to correlations between the scales gave the
misleading impression that VAS scores were inconsistent with those of
the HAD and STAI. However, when scores were considered in relation to
normative cut-off values to categorize anxiety levels, the three scales
showed good agreement. We conclude that the scales were equivalent in
their assessment of anxiety before surgery, but that reference to
normative data was important in establishing such equivalence and in
determining the patient's state. |
| SN |
0007-0912 |
| PD |
FEB |
| PY |
1995 |
| VL |
74 |
| IS |
2 |
| BP |
180 |
| EP |
183 |
| UT |
ISI:A1995QD91500014 |
| ER |
|
| PT |
J |
| AU |
LAMPIC, C
WENNBERG, A
SCHILL, JE
GLIMELIUS, B
BRODIN, O
SJODEN, PO |
| TI |
COPING, PSYCHOSOCIAL WELL-BEING AND ANXIETY IN CANCER-PATIENTS AT
FOLLOW-UP VISITS |
| SO |
ACTA ONCOLOGICA |
| AB |
Coping, psychosocial well-being, situation-specific anxiety and
cancer-related worry were assessed in 197 consecutive cancer patients
attending follow-up visits. Participants completed questionnaires on
three occasions: at the follow-up visit, some days later (n = 175) and
three weeks later (n = 125). High levels of coping styles 'Anxious
Preoccupation' and 'Helplessness/Hopelessness' were associated with low
levels of psychosocial well-being, more situation-specific anxiety and
more cancer-related worry. High levels of 'Fighting Spirit' and
'Fatalistic' were found to be associated,vith high psychosocial
well-being and, for 'Fighting Spirit', also with less cancer-related
worry, Patients with a 'dismal' prognosis were found to have higher
levels of 'Helplessness/Hopelessness' than patients with a more
'favorable' prognosis. Clinical implications of these findings are
discussed. |
| SN |
0284-186X |
| PY |
1994 |
| VL |
33 |
| IS |
8 |
| BP |
887 |
| EP |
894 |
| UT |
ISI:A1994QB69100007 |
| ER |
|
| EF | |
|
